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Executive summary 
Mother-to-child HIV transmission (MTCT) is the main source of HIV infection among children 
under the age of 15. The majority of these transmissions occur in utero and during the intra-partum 
period and are associated with high rate of mortality in the first year of life. Virtual elimination of 
peri-natal HIV transmission has become the global target following the availability of highly 
efficacious prophylactic medications. However, persistent programmatic challenges where the 
epidemic is most severe are threatening the realization of the target. These challenges include 
unsolved issues related to HIV testing, ensuring access and adherence to prophylaxis medication, 
access to safe delivery services, access to infant follow up and partner involvement in PMTCT 
programmes. This thesis aims at addressing these issues and to assess the impact of the national 
PMTCT programme in Addis Ababa, the capital of Ethiopia.   
The study uses cross-sectional, mixed methods and prospective cohort designs. Retrospective data 
were collected in 2009 from the national PMTCT programme in Addis Ababa. In the cross-sectional 
design, 663,603 pregnant mothers attending a national PMTCT programme across the city over a 
six years period were studied. Trends in PMTCT service utilization were analysed, and the rate of 
MTCT was assessed in relation to changes in HIV testing policy and changes in prophylactic 
medication regimen. In the mixed methods design, focus group discussions were conducted first to 
inform a Theory of Planned Behaviour (TPB) questionnaire. The TPB was applied to explain 
intended and actual HIV testing. Three thousand and thirty three first time antenatal attendees 
completed the baseline TPB interviews and 2,928 completed their follow up. The prospective cohort 
study enrolled 282 HIV-positive mothers. The study assessed the proportions of mothers and infants 
who adhered to medication recommendations and exposed infants follow up. In the same cohort, the 
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rate of intra-partum transfers and associated adverse outcomes were assessed among the 228 
mothers who reported to have given birth.  
In the trend analysis a year by year increase in the proportion of mothers receiving HIV counselling 
and testing was observed between 2004 and 2009. In parallel with the increased number of mothers 
receiving HIV testing, the HIV prevalence showed a steady decline. Substantial increase in HIV 
testing occurred following the shift to routine opt-out approach. The data collected using the mixed 
methods design following the implementation of opt-out testing approach revealed that intention 
and type of pre-test counselling/information received were independent, significant determinants of 
HIV testing. Further analysis showed that the majority of mothers who had low intention to test 
were also tested. Positive attitude towards HIV testing and approval from social network were 
significant determinants of intended use of HIV testing.  
In the trend analysis the proportions of mothers and infants receiving medication for prophylaxis 
did not show progress over the years. One year after the shift to routine opt-out approach, only 53% 
of the mothers and 47% of the infants had received medication. The cohort data further revealed 
gaps in initiating medication during pregnancy (82%) and ingestion of the medication at birth by 
mother-infant pairs (68%). Delivering at a health facility was an independent determinant of 
mother-infant pairs’ ingestion of medication at birth.  
Overall, 75% of the mothers in the cohort gave birth at emergency obstetric and neonatal care 
(EmONC) facilities and 42% of them were transferred between facilities during the intra-partum 
period. Multiple transfers happened to 36% of the mothers due to practical constraints within the 
health system. Mothers in their second pregnancy were less likely to be transferred than mothers in 
their first pregnancy. The rate of stillbirths was high. Transferred mothers were about six times more 
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likely to experience stillbirth than mothers who did not. There was no significant association 
between stillbirth and syphilis test result, mothers’ CD4 cell count and initiating lifelong ART.  
Both the trend and the cohort data showed sub-optimal infant follow up services. A small proportion 
of the exposed infants were HIV tested. The cumulative HIV infections among babies on single 
dose nevirapine (sdNVP) regimen who were tested at 18 months were 14.9% in 2007. In 2009, 
among infants on combined ZDV regimen the rates of MTCT were 8.2% and 8.4% at six weeks 
postpartum in the trend data and in the cohort respectively.   
The proportion of partners involved in PMTCT programme remained low. In the cohort the majority 
of the HIV-positive mothers had disclosed their HIV sero-status to their partner and about one-third 
of the partners who underwent HIV testing were sero-discordant.  
  
The PMTCT programme has expanded rapidly and has been accompanied by an increased rate of 
testing. However, the performance of the health system was inadequate in providing subsequent 
PMTCT services for HIV-positive mothers. Missed opportunities to prophylactic medication 
uptake, intra-partum care, infant follow up and partner involvement in the PMTCT programme 
could undermine the effectiveness of the PMTCT programme and negatively impact the survival of 
exposed infants. This should be a matter of immediate concern and a topic of further research.  
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Introduction  
Brief overview of the HIV/AIDS epidemic  
Since the first AIDS case report in 1981, about 60 million people have been infected with HIV and 
about 25 million have died of AIDS. Currently, there are about 33.3 million HIV-positive people 
around the world and about 10% are children under the age of 15 years [1]. This figure includes the 
2.6 million new infections that occurred in 2009. The main modes of transmission are sexual contact, 
mother-to-child, needle sharing and contaminated blood and body fluids. The predominant mode of 
transmission varies from region to region; in sub- Sahara Africa heterosexual, in Western Europe and 
the Americas homosexual, and Eastern Europe and Southeast Asia needle sharing [2, 3]. The modes 
of transmission seem to determine the nature of the epidemic. Heterosexual transmission is largely 
causing generalized epidemics while needle sharing and heterosexual transmissions are causing 
concentrated epidemics [1]. A generalized epidemic is characterized by an HIV prevalence among 
pregnant women in a country exceeding 1% consistently and involving more than specific high risk 
groups [3].  
Most countries in the sub-Saharan region are experiencing a generalized epidemic. The epidemic 
peaked in the late 1990s. Substantial decline in the HIV/AIDS incidence has been reported in many 
sub-Sahara African countries since then [1]. The rate of infection in 2009 was down by about 20% 
in the region compared to 2005. In the same year, 2.2 million people were newly infected with HIV 
and 1.3 million died of AIDS. In total, about 22.5 million HIV-positive people are living in the 
region. Of these, over half are women and about 10% are children under the age of 15 years. There 
are great variations in HIV prevalence within the region. (Fig 1). The southern Africa countries have 
the highest prevalence; South Africa (17.8%), Botswana (24.8%), Swaziland (25.9%), Zimbabwe 
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(14.3%) followed by countries in eastern Africa; Kenya (6.3%), Uganda (6.5%), Tanzania (3.4%) 
and Ethiopia (2.4%). In western Africa, the HIV prevalence is in general lowest but countries like 
Cameroon (5.3%), Central African Republic (4.7%), Côte d’Ivoire (3.4%), Gabon (5.2%), and 
Nigeria (3.6%) have higher prevalence [1]. 
Fig 1: HIV prevalence among adults aged 15-49 years old in sub-Saharan Africa 20091
Although Ethiopia is among the countries having a lower HIV prevalence in the region (2.3%), it is 
the highest HIV/AIDS burden country next to South Africa because of the large population size [1]. 
Like in many other sub-Saharan African countries the HIV incidence in Ethiopia has declined by 
about 25% between 2001 and 2009 [1]. The infection in Ethiopia is still biased towards women and 
urban populations. The prevalence among women is 1.5 times higher than among men. Urban areas 
carry the brunt of the epidemic with 7.7% prevalence compared to rural areas with 0.9% prevalence 
[4]. Addis Ababa, where this work is done has the highest HIV prevalence (9.2 %), and the highest 
number of HIV infected people (200,000) in the country.  
                                                
1 Joint United Nations programme on HIV/AIDS. UNAIDS report on the global AIDS epidemic 2010.  
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In Ethiopia, the antenatal surveillance system has been used since 1989 to assess HIV prevalence 
trends. This estimate is used as population prevalence proxy to guide HIV prevention efforts. For 
the surveillance, leftover blood samples collected for routine syphilis testing are used. The samples 
are unlinked and anonymously collected for a period of three months biannually [5]. Owing to the 
high HIV prevalence among women, the low antenatal service coverage and the skewed distribution 
of antenatal surveillance sites in Ethiopia [6, 7], the antenatal HIV prevalence estimates were found 
to overestimate the population prevalence. In the 2005 Ethiopian demographic and health survey, 
the HIV prevalence among the general population was 1.4%, whereas it was 3.5% in antenatal 
sentinel reports [4, 8]. This huge discrepancy called for reconciliation of the two estimates. 
Subsequently, the national prevalence estimate was adjusted to 2.1% for the year 2007.  
Mother-to-child HIV transmission (MTCT)  
Mother-to-child HIV transmission was first recognized to be the major source of HIV infection 
among children under the age of 15 years in the mid-1980s [9]. In 2009 alone, about 360,000 new 
HIV infections had occurred among children globally; 130,000 in sub-Saharan Africa [1]. There is a 
declining trend in the occurrence of new infection and AIDS related mortality among children in the 
region. Although the mortality in 2009 was said to be 20% less compared to 2004, 320,000 children 
died of AIDS related causes. By 2009, over 14,000 Ethiopian children were estimated to acquire new 
HIV infections from their mothers and about 4,000 died of AIDS related causes [6]. MTCT can occur 
during pregnancy, labour, delivery and through breast-feeding [10]. The rate of transmission varies 
from 20% to 45% [11]. (Table  1). About 5-10% of the infections occur during pregnancy mainly 
towards the end of the pregnancy.
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Table 1: Estimated timing and risk of mother-to-child HIV transmission 1  
Rate of MTCT in % Timing 
No breast-feeding  
  
Breast-feeding 
through 6 months  
Breast-feeding through  
18 to 24 months 
Intra-uterine                                     5 to 10 5 to10 5 to 10 
Intra-partum                                    10 to 20 10 to 20 10 to 20 
Post-partum breast-feeding 
Early (first 2 months) 
Late (after 2 months) 
5 to 10 
1 to 5 
5 to 10 
5 to 10 
Overall                                            15 to 30 25 to 35 30 to 45 
Maternal immunological status and viral load are significant predictors of MTCT [10]. The MTCT is 
highest during the early and late phase in the natural course of the HIV infection. The early phase of 
the infection marks high viral replication before the immune system takes control of the replication 
[12]. (Fig  2). In later phases, due to a compromised immune system, there is a decrease in the cluster 
of differentiation 4 (CD4) cell count accompanied by an increase in viral load which favour the risk 
of MTCT [10]. The other risk factors favouring MTCT include presence of other sexually 
transmitted infections during pregnancy, uterine infection, invasive obstetric procedures, modes of 
delivery and infant feeding practices [10, 13-17]. 
                                                
1 De Cock et, al.: Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into 
policy and practice.  
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Fig 2: Typical course of HIV infection 1  
Prevention of mother-to-child HIV transmission programmes (PMTCT) 
A four pronged comprehensive strategies encompassing primary, secondary and tertiary preventions 
where mother’s and infants’ survival are at the core has been proposed for PMTCT. To facilitate 
implementation of these strategies, guidelines have been developed internationally by the Joint 
United Nations programme on AIDS (UNAIDS) and the World Health Organization (WHO), and at 
national levels governments often adapt the international guidelines taking into consideration the 
local contexts. These prevention strategies are integrated in existing maternal and child health 
programmes and are implemented mainly under the auspices of the health system. The first prong is 
HIV prevention among the mothers to be, the second prong is prevention of unintended pregnancies 
among HIV-positive mothers, the third prong is the prevention of vertical transmission and the 
fourth prong is provision of treatment, care and support to HIV-positive mothers, their children and 
family. The effectiveness of the PMTCT programmes is largely dependent on proper 
                                                
1 Pantaleo G. and Fauci A: The immunopathogenesis of human immunodeficiency virus infection.  
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implementation and utilization of the recommended services. In industrialized countries, where the 
recommended services are properly implemented, MTCT is on the verge of elimination, whereas it 
still represents a threat to child survival in many resource-poor settings [1].
The recent UNAIDS report has created optimism about the success of the PMTCT programmes all 
over the world [1]. The report highlights 32% reduction in global incidence of MTCT and 24% 
reduction in the sub-Saharan African region in the past five years largely due to proper 
implementation of the third and the fourth prongs which are also the main focus of this study. The 
third prong addressing the prevention of vertical HIV transmission has four major components. 
These are HIV counselling and testing, provision of prophylactic/therapeutic ARV drugs for 
mothers and their infants, safe obstetric practices for HIV-positive mothers and infant feeding 
counselling and support. Moreover, partner involvement in PMTCT and exposed infant follow up 
are important aspects of the prevention of vertical HIV transmission programmes. All these services 
are integrated within the continuum of existing maternal and child health care services. 
HIV counselling and testing 
HIV counselling and testing for PMTCT was first recommended by the Centre for Disease Control in 
1985 [9]. The early recommendations were focusing on the then risk groups such as injecting drug 
users, prostitutes and those with history of sexual transmitted infection. Due to the unavailability of 
ART prophylaxis at that time, the HIV testing was just to screen out HIV-positive cases for further 
counselling that could help to reduce MTCT. The HIV testing was offered in an opt-in approach 
where clients’ autonomy and confidentiality were the core principles. It is also referred to as 
voluntary counselling and testing (VCT) and individual pre- and post-test counselling is part of it. 
Following the report on the first efficacious ARV prophylactic drug for PMTCT, the Centre for 
Disease Control revised the HIV counselling and testing recommendations in 1995 [18]. This 
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revision underscores the need to offer HIV counselling and testing to all antenatal attendees 
irrespective of their risks. In 2001, the Centre for Disease Control made yet another revision in HIV 
testing approach [19]. The focus of this revision was to mainstream routine HIV counselling and 
testing into existing peri-natal care programmes and extending to intra-partum and postpartum 
testing. Following the revision, the routine HIV testing has been successfully adopted and integrated 
into the peri-natal care programmes in many industrialized countries.   
In 2003, the joint United Nations and WHO set a target to provide free antiretroviral treatment (ART) 
for three million people living in resource-poor settings by 2005 (‘3 by 5 initiative’) [20]. Shifting 
the HIV testing approach from opt-in to routine opt-out in antenatal setting was considered crucial to 
facilitate women’ access to ARV prophylaxis so as to reach the target [21]. Following the WHO 
recommendations, Botswana, with one of the worst epidemics in the world, became the first country 
in sub-Saharan Africa to implement the routine opt-out approach [22]. Implementation of routine 
opt-out approach has brought significant improvement in acceptability of HIV testing with rates of 
testing increasing from 55% to about 100% [23-27]. Likewise, the rate of HIV testing in Ethiopia has 
shown significant improvement following the shift to routine opt-out approach [6, 28, 29].  
Despite the substantial success in the rate of testing, arguments are still going on about the potential 
violation of “mothers’ autonomy” and insufficiency of the HIV counselling in the routine opt-out 
approach. Proponents of the routine opt-out approach defended this policy from the perspective of 
public health. Routine opt-out testing creates opportunities for mothers who otherwise may not test 
before it is too late [26, 30-32]. This could facilitate access to prophylaxis, treatment, care and 
support which could ultimately reduce the MTCT and the burden of HIV/AIDS. Offering HIV 
testing routinely like other antenatal tests can also normalize HIV testing and reduce stigma attached 
to HIV-positive test results. By contrast, several studies in resource-poor settings show 
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implementation gaps endangering the effectiveness of the routine opt-out approach [33-35]. 
According to these studies, several mothers in resource-poor settings for cultural and socio-economic 
reasons are less empowered to actively opt-out the HIV testing offer. Some mothers may accept 
testing advice since they fear negative consequences that may affect their subsequent antenatal care, 
while others they lack awareness of their right to refuse HIV testing. Studies from Tanzania and 
Kenya show that the pre-test information is in practice less informative with respect to the possibility 
of opting out, and much emphasis is put to getting the mothers tested [35, 36].  
The tension between increasing the rate of testing and the potential violation of ethical principles has 
dominated the available literature on routine antenatal opt-out testing [26, 30, 35-37]. However, the 
fundamental behavioural determinants of the routine antenatal HIV testing seem not to be 
emphasized. Cognitive behavioural theories have been widely applied to HIV preventive behaviours 
[38-43]. Of these theories, empirical works based on the theory of planned behaviour have shown 
that the intention to take voluntary HIV counselling and testing is mainly determined by a person’s 
evaluation of the benefits of HIV testing (attitude) and other people’s approval or disapproval of the 
testing (subjective norm) [40, 41]. Hence, identifying behavioural determinants of routine HIV 
testing and addressing them accordingly could help to bridge the tension between maximizing the 
rate of testing and respecting the mothers’ autonomy. 
Antiretroviral (ARV) prophylaxis  
In 1994, a multi-centre clinical trial that was conducted in industrialized countries reported the 
efficacy of the first ARV prophylaxis for PMTCT [44]. In this double blind clinical trial mothers 
were randomized to receive zidovudine (ZDV) prophylaxis or placebo. ZDV was initiated at 14-34 
weeks of gestation to be taken five times daily as intravenous doses during the intra-partum period. 
Infants were given ZDV syrup six times daily from birth up to six weeks postpartum. An interim 
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analysis showed a 67.5% reduction in MTCT at the age of 18 months. Eventually ZDV has become 
the first proven prophylaxis for PMTCT. ZDV is a class of ART called Nucleoside Reverse 
Transcriptase Inhibitor that can block the action of an HIV enzyme called reverse transcriptase which 
is necessary for viral replication [45].  
However, the complexity and cost of this long course ZDV regimen hampered its potential benefit in 
resource-poor settings experiencing the highest HIV burden. With the aim to come up with less 
complex and cheaper ZDV regimen, a clinical trial was conducted in Thailand that enrolled 397 HIV-
positive mothers from 1996 to 1997 [46]. ZDV was given to mothers from 36 weeks of gestation 
twice daily and every three hours during the intra-partum period. The findings showed a 51% 
reduction in the risk of HIV transmission among infants who were tested at two months postpartum. 
This simplified short course ZDV has substantially reduced the cost from 800 to 50 United States 
Dollar [47]. Yet, even the reduced cost was not affordable to many resource-poor settings. 
Later, a clinical trial was conducted in Uganda from 1997 to 1999 [48] . The trial enrolled 626 HIV-
positive women to assess the efficacy of single dose Nevirapne (sdNVP) regimen. NVP is one of the 
Non-Neucloside Reverse Transcriptase Inhibitors which prevents the action of reverse transcriptase 
that helps to translate viral deoxyribonucleic acid to ribonucleic acid [45]. In this trial single-dose 
NVP was given to mothers to be taken during labour and to infants within 72 hours after birth. All 
the mothers were advised to exclusively breast feed. The risk of HIV transmission was reduced by 
47% at six weeks and by 41% at 18 months [48, 49]. The single-dose NVP regimen has shown 
comparable efficacy with the short course ZDV regimen. This regimen also provided additional cost 
saving with better infant survival at 18 months. Consequently, single-dose NVP regimen was scaled 
up in resource-poor settings.  
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In the course of implementation, the safety of sdNVP regimen has become a growing concern for 
two major reasons [10, 50, 51]. First, NVP is associated with liver toxicity [50]. Second, the regimen 
is prone to drug resistance as it is a mono-therapy and a single point mutation is enough for the NVP 
to confer drug resistance [10, 51]. To counteract the emergency of drug resistance and to achieve 
high level of viral suppression, a multi-drug prophylaxis regimen takes hold of the recommendations 
from 2006.  
In the 2006 WHO recommendations, the cut-off  point to initiate lifelong ART was CD4 cell count of 
less than 200 cells per micro liter [52]. Whilst mothers with CD4 cell count over 200 cells per micro 
liter should receive ZDV twice daily from 28 weeks of gestation plus NVP and lamivudine during 
the intra-partum period and a seven day tail of ZDV and lamivudine during the postpartum. For the 
infants, ZDV plus sdNVP should be given at birth and a 7 day tail of ZDV. However, if the mothers 
received the medication for less than one month, the infants’ prophylaxis should be extended to one 
month.  
The most recent revision in the WHO guidelines recommends prophylaxis initiation for mothers 
with a CD4 count above 350 cells per micro liter, otherwise lifelong ART irrespective of their 
clinical stage [52]. Several first line recommendations are made available. The choice of 
appropriate regimen can be made by individual countries depending on their local circumstances. 
This revision also highlights early initiation of the prophylaxis at 14 weeks gestation and to 
continue throughout the breast-feeding period. These multidrug extended medication regimens can 
substantially reduce the MTCT among breast-feeding infants. 
Despite availability of various efficacious prophylactic ARV drugs, ensuring the required level of 
medication utilization and adherence remains challenging especially in resource-poor settings [53, 
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54]. A report on 16 sub-Sahara African countries shows that over 85% of them have prophylaxis 
coverage less than 60%, worse still Ethiopia achieved only about 20% coverage (Fig 3). Proper 
adherence to a given medication regimen is mandatory in order to achieve high and sustained level 
of viral suppression [55]. Poor adherence could result in sub-optimal viral suppression favouring 
drug resistance, treatment failures and increase the risk of MTCT.  
Fig 3: Coverage of antenatal care services and services for PMTCT among women living with in 
high HIV prevalence countries, size of bubble proportional to HIV-positive pregnant women 1
                                                
1 Joint United Nations programme on HIV/AIDS: UNAIDS report on the global AIDS epidemic 2010. Geneva. 
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Safe obstetric practices  
About 70% of the MTCT in non-breast-feeding infants and about 50% in breast-feeding infants 
occur during the intra-partum period [11]. The risk of intra-partum transmission increases with intra-
partum bleeding, premature rupture of membrane, delayed labour duration after membrane rupture, 
chorioamnionitis and cervico-vaginal infection [10, 13]. Certain obstetric procedures such as 
episiotomy and artificial rupture of amniotic membrane are also associated with increased risk of 
MTCT. Through provision of quality obstetric care at the right time, the risk of intra-partum MTCT 
can be reduced. Several studies have shown a reduced risk of MTCT in mothers with elective 
caesarean delivery before the onset of labour [10]. Meta-analysis that compiled over 8,500 patient 
data from 15 prospective cohort studies conducted between 1985 - 1999 showed a 50% reduced risk 
of MTCT in the elective caesarean delivery group compared to the group who did not have elective 
caesarean delivery [56]. Subsequently, caesarean delivery has become the preferred mode of delivery 
in most industrialized settings. Recent researches however, report no additional benefits of caesarean 
delivery over spontaneous vaginal delivery if mothers received proper prophylaxis and have a viral 
load of 400 and less copies/ml [57]. The risks of caesarean delivery seem to outweigh its potential 
benefit in resource-poor settings. Hence, spontaneous vaginal delivery is for practical and technical 
reasons still the preferred mode of delivery in those settings.  
To ensure the quality of intra-partum obstetric care, both skilled attendant at birth and institutional 
delivery are considered vital. Institutional delivery not only helps to ensure safe delivery but also 
facilitates access to prophylaxis medication for HIV-positive mothers and their infants. In 
Botswana, where almost 100% of all births are attended by skilled health professionals at health 
facilities, over 95% of infants received the ARV prophylaxis, whereas in Ethiopia with 18% rate of 
institutional delivery less than 20% of infants received the prophylaxis [1, 28]. On top of its  
potential contributions for the reduction of MTCT, quality intra-partum obstetric care remains the 
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best strategy for improving maternal and peri-natal outcomes [58]. In many resource-poor settings, 
however, the intra-partum obstetric care is often sub-optimal and delayed.  
Delay to receive appropriate intra-partum obstetric care can be detrimental to maternal and peri-
natal survival [59, 60]. Delays can happen in making decision to seek care (“first delay”),  in 
reaching health facilities (“second delay”)  and in receiving appropriate care in a health facility 
(“third delay”) [60-62]. Maternal disabilities such as obstetric fistula and incontinence are common 
consequences of delays in receiving appropriate intra-partum care for obstructed labour [63]. 
According to studies from resource-poor settings, the “third delay” significantly contributes to 
maternal morbidity and mortality [59, 64]. In a study from Uganda, about 50% increased risks of 
peri-natal deaths occurred among mothers who experienced the third delays [62]. Large scale 
studies have also reported an inverse correlation between stillbirths and the quality and quantity of 
obstetric care provided during pregnancy and delivery [65, 66]. The lack of prompt attention after 
reaching facilities is reported to account for about 25% of the intra-partum stillbirths. These delays 
often indicate poor quality care and can be minimized through improved competence of health 
professionals, provision of supplies and accountability mechanisms [67].  
Infant feeding counselling and support 
The MTCT through breast-feeding constitutes 10-15% of the total infections [11]. Mastitis, cracked 
nipple, inflammation affecting infants oral and gastrointestinal tract can increase the risk of MTCT 
[17]. Complete avoidance of breast milk eliminates the postnatal transmissions. Exclusive formula 
feeding is preferred infant feeding method where infant formula is affordable, feasible, acceptable, 
sustainable and safe (AFASS) [68]. Yet, exclusive formula does not seem practical in resource-poor 
settings, and can do more harm than good. In those settings, better overall infant survival has been 
reported among infants receiving exclusive breast-feeding than those receiving exclusive formula, 
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although the rate of HIV infection seems to be a little bit higher among exclusive breast fed infants. 
Mixed feeding carries the greatest risk of MTCT [68].  
The risk of acquiring HIV also increases with increasing duration of breast-feeding [14, 15, 68-70]. 
There is 10% additional risk of MTCT for infants receiving breast-feeding for 12 months and 17.5% 
for those receiving for 18 to 24 months [11]. This has motivated the search for strategies to make 
breast-feeding safer. Infant feeding recommendations have been continuously updated in line with 
scientific advances. The most recent recommendations seem to be more accommodating which  
promotes exclusive breast-feeding up to six months, complementary feeding from six months and to 
continue breast-feeding up to 12 months given that either the mother or their infant take proper 
prophylactic medication throughout the breast-feeding period [68].  
Exposed infant follow up  
Follow up for infants born to HIV-positive mothers is extremely important to improve their 
survival. Proper infant follow up services provide opportunities for the provision of appropriate 
infant feeding counselling and support, provision of co-trimoxazole prophylaxis to prevent serious 
opportunistic infections, for early infant diagnosis and for early initiation of ART for HIV infected 
infants. It is shown that about 50% of infants who acquire HIV in utero and during the intra-partum 
period die before the first year of life [69, 71-73]. Provision of co-trimoxazole prophylaxis at four to 
six weeks postpartum can reduce morbidity and mortality among exposed infants by preventing the 
occurrence of serious opportunistic infections such as pneumocystis pneumonia [71, 74].  
Formerly, infant diagnosis was based on antibody testing at the age of 18 months. This antibody test 
has little survival benefit for those who acquire the infection in utero and during the intra-partum 
period as the majority of these infants could die before they reach 18 months [72]. The high 
Successes and challenges of the national PMTCT programme  
15
mortality among infected infants could be prevented through early diagnosis and early initiation of 
ART. Currently, polymerase chain reaction which detects viral deoxyribonucleic acid is used for 
early infant diagnosis [72, 73]. The test is done from dried blood spot taken from infants. Despite its 
potential benefits, exposed infant follow up services are poorly integrated into existing child health
programmes. Only 15% exposed infants around the world are tested for HIV [73] while only 22%, 
37% and 38% of HIV-positive infants initiated ART in Senegal, Uganda and Cambodia respectively 
[75].  
Partner involvement in PMTCT programme   
Partner involvement in PMTCT programme is vital in resource-poor settings, in particular where 
partners have a significant role in mothers’ decision to seek PMTCT services. Most importantly, it 
could help to reduce the risk of MTCT by preventing new infections among mothers and improve 
communication between the couples. Mothers can acquire new infection during pregnancy and any 
time during the breast-feeding period from their partner. Recent sero-conversion is associated with 
an increased risk of MTCT due to the high viral replication during the early phase of the HIV 
infection [76]. Moreover, the rate of discordance ranges from 36-85% in Eastern and Southern 
African region [77]. Recent data show that discordant couples are the newly identified high risk 
group in Ethiopia [7]. HIV negative partners of the HIV-positive mothers are also at risk of 
horizontal transmission from their wives.  
A review on couple centred counselling shows that partner involvement in HIV testing not only 
helps to increase disclosure, condom use and uptake of ARV prophylaxis but also contributes to the 
lower rate of sero-conversion compared to individual counselling [78]. A recent multisite 
randomized trial demonstrated that early initiation of ART for infected partners can reduce the risk 
of heterosexual horizontal HIV transmission by 96% compared to delayed ART initiation [79]. 
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Other studies conducted in Botswana, Kenya and Uganda have reported that pre-exposure ARV 
prophylaxis could significantly reduce the risk of horizontal heterosexual HIV transmission in 
general and among discordant couples in particular [80-82]. Partner testing and involvement in 
PMTCT programme can create an opportunity for identifying at risk partners for early initiation of 
ART or pre-exposure ARV prophylaxis which could ultimately contribute to the success of the HIV 
prevention efforts. 
The PMTCT programme and PMTCT service utilization in Ethiopia  
Before the introduction of the PMTCT programme a clinical trial was conducted in three selected 
public health facilities in Addis Ababa from 2001 to 2003. The trial, is called the Nigat project, 
which assessed infant feeding among HIV-positive mothers [83]. The findings suggested that 
adherence to exclusive breast-feeding was poor and that early weaning was common. The free 
PMTCT programme was launched in 2004. In the first year, 32 health facilities provided the 
programme across the country. The programme has been scaled up rapidly and by 2010 1,352 health 
facilities were providing the programme. As the proportions and number of mothers undergoing  
HIV testing have increased, the HIV prevalence has shown a steady decline [6]. Nonetheless, the 
proportion of mothers and infants receiving prophylaxis medication remains low with little 
improvement over the years. (Fig 4).  
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Fig 4: Number of pregnant women attended in PMTCT facilities, who received pre-test counselling 
and HIV testing between 2006 and 2010 (left) and number of mothers who tested positive and those 
who received prophylaxis during pregnancy between 2006 and 2010 (right).1
Large variation in HIV prevalence and PMTCT service utilization across the nine regions in the 
country was reported in 2010 [6]. The Southern and Somali regions reported the lowest sero-
prevalence (0.8%), whereas Addis Ababa City Council reported the highest prevalence (4.6%). 
Oromia and Amhara have shown poor achievement in mothers’ prophylaxis medication uptake i.e 
52% and 41% respectively. By contrast, in Harari 100% and in Beninshangul Gumuz 68% of the 
mothers received prophylaxis medication. Infant prophylaxis coverage was generally low except in 
Harari region where 87% of the infants had received prophylaxis at birth. Diredawa is the only City 
Council where equal number of mothers and infants received prophylaxis.  
                                                
Federal HIV/AIDS Prevention and Control Office: Annual performance report of multisectoral HIV/ AIDS response 
2002 E.C. (2009/2010).  
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The PMTCT programme and the millennium development goals (MDG)  
HIV/AIDS continues to be a threat to health and development especially in resource-poor settings. 
The PMTCT programmes however, have a great potential in reducing suffering in children and 
mothers due to HIV. The programmes have a wider scope that can address three of the eights 
Millennium Development Goals (MDG.). The UN set a target to reduce by two thirds the mortality 
rate among children under five, to reduce by three quarters the maternal mortality ratio and to halt 
and begin to reverse the spread of HIV/AIDS [84]. The goals were set based on the 1990 state of 
health in a country as a reference point to measure progress in 2015. Due to the rapid progression of 
the HIV epidemic in sub-Saharan Africa in the 1990s, progress towards the health related MDGs 
has been slow.  
In a study from South Africa that used verbal autopsy to determine attributable causes of death, 
43% of the deaths among children between one and four years were attributed to HIV/AIDS [85]. 
Another study also reported 53% mortality among HIV infected children by the age of 18 months, 
whereas only 4% among non-infected children [69]. In a study from Ethiopia a five fold increase in 
mortality among women between 33 to 39 years was reported in 2001 compared to 1984 [86]. In the 
same study the mortality in the age group 25 to 49 years showed a significant year by year increase 
compared to the five to 14 years old children. By contrast, a study conducted after the introduction 
of free ART in Ethiopia showed that the mortality among women had declined by about 50% in 
2007 compared to 2001 [87]. The majority of the women who initiated lifelong ART are identified 
in PMTCT programmes. In 2009 about 50% of the HIV-positive mothers’ around the world were 
assessed for their eligibility to initiate ART for their own health in PMTCT programmes and 15% of 
them had initiated lifelong ART. Successful implementation of a PMTCT programme could save the 
lives of many children as well as mothers [88]. Friberg and colleague stated that “South Africa has 
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the potential to reverse trends of increasing child mortality and even shift to being on track to 
achieving MDG 4 with rapid scale up of PMTCT, a context specific intervention”[67]. 
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Rationale of the study 
Virtual elimination of peri-natal HIV transmission has become the global target following the 
availability of highly efficacious prophylactic medications [89]. However, persistent programmatic 
challenges where the epidemic is most severe are threatening the realization of the target. These 
challenges include unsolved issues related to HIV testing, ensuring access and adherence to 
prophylaxis medication, access to safe delivery services, access to infant follow up and partner 
involvement in PMTCT programmes. This thesis aims at addressing these issues and to assess the 
impact of the national PMTCT programme in Addis Ababa and are presented in four papers.  
The PMTCT programme in Ethiopia is scaling up rapidly [6, 7, 90]. In the meantime, PMTCT 
programme implementation strategies have been frequently changing nationally and internationally 
[21, 52, 68, 71, 73, 91, 92]. However, little has been documented about the national PMTCT 
programme performance and PMTCT service utilization in general and following policy changes in 
particular. The impact of the national PMTCT programme in averting new HIV infections has not 
been assessed. Paper I assessed the trends in PMTCT programme performance across the years and 
the impact of the programme in terms of averted infections.    
Following the introduction of the opt-out approach remarkable achievements in terms of reduced 
missed opportunities to HIV counselling and testing have been reported from many resource-poor 
settings including Ethiopia [6, 22-24, 26, 93, 94]. However, several researchers argue against the 
opt-out approach, that some pregnant mothers are testing despite their lack of intention to test [33, 
35, 36]. Nevertheless, there is lack of evidence about the fundamental behavioural factors 
determining the intended and actual HIV testing among those who tested despite their low intention. 
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Paper II therefore aimed to identify determinants of intended and actual HIV testing using the 
Theory of Planned Behaviour (TPB).  
In a recent estimate only 54% of the HIV-positive mothers in sub-Saharan Africa receive 
prophylactic medication during pregnancy [1]. This coverage is far behind the 80% target to achieve 
virtual elimination of MTCT by 2015. Worse still, there is little progress in prophylactic medication 
use by mother-infant pairs at birth. This is a critical area that deserves investigation because, unless 
both mothers and their infants are taking the prophylaxis, the preventive efficacy of the medication 
will be compromised [95, 96]. Moreover, prophylaxis received by the mothers during pregnancy 
has been used as a proxy to calculate potential averted infections [1, 6, 28, 52, 89]. This could lead 
to an overestimation if there is a big gap in prophylaxis received during pregnancy and taking it at 
birth. The agreement between prophylaxis collection during pregnancy and actual ingestion at birth 
remains largely unexplored. Exposed infant follow up facilitates access to early infant diagnosis, 
provision of co-trimoxazole prophylaxis, provision of infant feeding counselling and support and to 
facilitate access to ART for HIV-positive infants [71-74]. In particular, early infant diagnosis is vital 
as over 50% of the HIV infected infants die before 1 year of age [71]. Despite its importance little is 
known about the exposed infant follow up services in Ethiopia. Hence, Paper III assessed adherence 
to prophylactic medication regimen and infant follow up.  
About 50% and 70% of the HIV transmission among breast-feeding and formula feeding infants 
respectively are occurring towards the end of pregnancy and during the intra-partum period [11]. 
Optimal obstetric care during the intra-partum period is vital to ensure safe delivery and prophylaxis 
ingestion by the mothers and their infants. Institutional delivery continues to be an important 
determinant of ARV prophylaxis ingestion and is associated with low risk of MTCT [97, 98]. In 
Ethiopia coverage of institutional delivery and ARV prophylaxis is below 20% while poor quality  
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intra-partum services is commonplace [1, 6, 28]. Nonetheless, little is known about HIV-positive 
mothers’ access to safe obstetric care and possible hindrances to access intra-partum care. Paper IV  
examined HIV-positive mothers access to obstetric care and outcomes of pregnancy.  
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Objectives  
General objective  
To assess performances of the national PMTCT programme and examine potential challenges to the 
implementation of the PMTCT programme in Addis Ababa.  
Specific objectives  
1. To examine trends in comprehensive PMTCT service utilization and to assess the rate of MTCT 
in relation to policy changes. 
2. To explain pregnant mothers’ intended- and actual HIV testing behaviour using the theory of 
planned behaviour. 
3. To assess adherence to HIV preventive medication regimen and infant follow up.  
4. To examine HIV-positive mothers' access to safe obstetric care and pregnancy outcomes. 
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Methodology  
Overviews of the study context  
Ethiopia is situated in east Africa sharing borders with Djibouti, Eretria, Kenya, Somalia, Sudan and 
South Sudan. The country is occupying a total area of 1.1 million square kilometres. The country is 
divided into nine regional states and two city councils, which are further divided into 801 smaller 
administrative units (Woredas) [28]. Owing to decentralization of decision making, the 
administrative units are mandated to do basic planning and political administration including 
matters related to health since 2002. According to reports, Ethiopia is the second most populous 
country in Africa next to Nigeria [7]. About 80 million people who are speaking over 80 different 
languages are living in the country [8]. Women in reproductive age and children under the age of 15 
years constitute about two thirds of the population. Eighty five percent of the population are living 
in rural areas dependent on subsistent farming [99]. The country’s economy is relying on 
agricultural production where coffee remains the major export item. The total share of health budget 
as a proportion of total budget was about 10% in 2009 [28].  
According to the 2007 census, only 42% of the population over 10 year of age are literate; 51% 
males and 35% females [8]. About two thirds and 60% of the population have access to safe water 
and safe excreta disposal, respectively [28]. Ethiopia has been implementing a three-tier health 
service delivery system; the Primary Health Care Units at the bottom of the pyramid, General 
Hospitals in the middle and Specialized Hospitals on the top of the pyramid [28]. In 1997, the 
country endorsed a health system reform called Health Sector Development Programme in order to 
increase the effectiveness of the health system [28]. The reform is a 20 years strategy aimed at 
achieving improved health and sustainable development.  
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The primary health service coverage has reached 90% in 2008 following implementation of health 
extension programme [28]. The health extension programme was launched to achieve universal 
primary health service coverage in the country. Between 2003 and 2010, the programme had trained 
and deployed over 30,000 female health cadres to provide basic health services to the rural 
communities.  
Currently, 65.5% of children under one year of age are fully immunized and the under-five child  
mortality rate has declined to 109/1,000 in 2008 compared to 148/1,000 in 2000 [100]. In 2008, 
67.7% of the pregnant mothers attended antenatal care at least once. Although there is some 
improvement in safe delivery practices compared to the 1990s, it remains the lowest in the world. In 
2010 only 18% of the pregnant mothers accessed intra-partum care at health facilities [8]. Of a total 
of 751 health facilities providing essential obstetric care services across the country only 10% were 
considered fully functioning (unpublished data, collected by Addis Ababa Fistula Hospital, 
Ethiopian Road Authority and the World Bank). Owing to the low coverage and poor quality intra-
partum obstetric care, the neonatal and maternal mortality remains high at 39/1,000 live births and 
590/100,000 live births respectively [100, 101]. (Table 1).  
The available health facilities and the majority of the health manpower are concentrated in the 
urban areas [28]. About 20% of the health professionals are working in Addis Ababa where less 
than 5% of the country’s population are residing. This has left the majority of the rural population to 
rely on the health extension workers. 
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Table 2: Selected health and health related indicators for Ethiopia and for Addis Ababa, estimates 
from Ministry of Health and United Nation Development Programme1,2
Indicator  Ethiopia Addis Ababa 
Total population (according to 2007 census)  77,812,236 2,854,462 
Life expectancy at birth (in years) - Male (Female)  53.5 (55.4) 54.1(55.8) 
Health service coverage (%) 90.0 100 
Antenatal service coverage (%) 67.7 111.5 
Institutional delivery rate (%) 18.4 62.5 
Children fully immunized (%) 65.5 77.6 
Access to safe water (%) 66.2 95.0 
Access to safe excreta disposal (%) 60.0 76.0 
Infant mortality rate per 1,000 live births 77 71 
Maternal mortality per 100, 000 live births 590 **NA 
Adult HIV prevalence (%) 2.3 8.5 
HIV prevalence among pregnant mothers (%) 2.0 4.0 
* Health professional to population ratio  1:3030 1:543 
Midwife to population ratio  1:56,427 1:11,699 
* Health professionals include doctors, nurses, midwives, health officers, **NA- data not available  
The study settings  
Addis Ababa is home to about three million culturally and religiously diverse people. The city is 
administratively divided into 10 sub-cities with varying population sizes. (Fig 5).  
                                                
1 Federal ministry of finance and economic development. Ethiopia: 2010 MDGs report, trends and prospect for meeting 
MDGs by 2015. 
2 Federal Ministry of Health. Health and health related indicators 2008/2009.  
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Fig 5: The study area  
Of the 54 health facilities providing integrated peri-natal care and PMTCT services across the city 
about half are public health centres [28]. Despite the proportional distribution of public and private
facilities, the public health centres remain the major service providers. These facilities offer antenatal 
care to 90% of the pregnant mothers, assist 90% institutional deliveries and manage 80% of obstetric 
complications (unpublished data, collected by Addis Ababa Fistula Hospital, Ethiopian Road 
Authority and the World Bank). Emergency Obstetric and Neonatal Care (EmONC) is provided 
across the city both in private and public facilities. Basic EmONC is provided in the public health 
centres and hospitals provide comprehensive EmONC. Mothers identified to have serious obstetric 
complications in the basic EmONC facilities before and after the onset of labour should usually be 
referred to comprehensive EmONC units. The health services are fairly accessible with a median 
distance to the nearest referral centre is about five km. 
Free PMTCT programme was launched in the city in 2004 in selected public health facilities and 
from 2007 the programme was expanded to private health facilities [7]. Like most antenatal care 
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services, PMTCT services were provided free of charge in public health facilities while payments 
were applied in private health facilities. The services had been offered in accordance with the first 
national PMTCT guidelines that recommended an opt-in HIV testing approach, sdNVP regimen and 
rapid antibody testing of infants at the age of 18 months. In 2007, the guidelines were revised and 
advocated routine opt-out HIV testing approach, combined ZDV regimen and antigen based infant 
HIV testing at six weeks postpartum. Nonetheless, early recommendations on partner testing 
irrespective of the mother’s HIV status, exposed infant follow up and referral of the mothers for 
treatment, care and support remained unchanged with renewed emphasis in the revised guidelines 
[91]. Despite the revisions in the national guidelines that advocate for opt-out approach, the opt-in 
HIV testing approach remained the standard of practice in private health facilities.  
There has been regular monitoring and evaluation of the PMTCT programme in Addis Ababa as part 
of the national HIV/AIDS prevention and control programme [102]. For monitoring and evaluation a 
monthly reporting form containing output indicators was distributed to all service outlets by 
respective sub-city health bureau. The health facilities filled out the reports and sent them to their 
respective sub-city where the compilation of the reports was taking place. According to the 2010 
annual performance report, about 55, 000 pregnant mothers attended PMTCT programmes across the 
city, 79% tested for HIV and 4.6% were HIV-positive [6]. However, only 53% of the positive 
mothers and 38% of their infants received ARV prophylaxis. When the actual utilization was 
compared with the plan, about 77% achievement was reported in HIV testing, whereas only 18% in 
ARV prophylaxis uptake. 
Successes and challenges of the national PMTCT programme  
29
The study designs and data collection procedures  
This thesis used cross-sectional, mixed methods and prospective cohort designs. (Table 3). The 
cross-sectional study compiled six years retrospective PMTCT reports. The mixed methods and the 
cohort data were collected from mothers who attended 12 public health centres and three private 
hospitals. A four-to-one public to private ratio was used in selecting the health facilities considering 
the fact that about 80% to 90% of the pregnant mothers in the city received care from public health 
facilities. Then individual health facilities were selected on the basis of high client flow and to have 
representation of all the 10 sub-cities.  
Paper I 
In total 663,603 antenatal care attendees registered in PMTCT programme across the city were 
studied. Monthly PMTCT reports were collected from all the 10 sub-cities health bureau in 2009. 
The reports were also collected from Addis Ababa City Administration Health Bureau and Intra-
health (an NGO working on PMTCT) for validation.  
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Table 3: A summary of the study designs, the data sources, the study participant and the study 
outcomes in this thesis 
Paper Study design  Study 
population  
Study 
period  
Main study outcomes  
I - Promising outcomes of a 
national programme for the 
prevention of mother-to-
child HIV transmission  
Cross-
sectional 
retrospective 
trend 
analysis    
663,603 ANC 
attendees 
2004-2009 •  Proportion of mothers tested for 
HIV 
•  HIV prevalence  
•  Proportion of mother and infants 
who received prophylaxis  
•   HIV infection among infants  
•    Proportion of partners tested   
II - Applying the Theory of 
Planned Behaviour to 
explain HIV testing in 
antenatal settings  
Sequential 
mixed 
methods  
ANC attendees;  
27 for FGDs  
3033 for 
questionnaire 
interviews  
January to 
March 
2009 
• Intention to test for HIV  
• Actual HIV testing  
III - Current status of 
medication adherence and 
infant follow up in the 
prevention of mother-to-
child HIV transmission 
programme  
Prospective 
cohort study 
282 HIV-
positive mothers 
and their infants 
January to 
December 
2009 
• Proportion of mothers who 
received prophylaxis during 
pregnancy   
• Proportion of mother-infant 
pairs who ingested prophylaxis at 
birth   
• Proportion of infants brought 
for early infant diagnosis  
• Rate of MTCT  
IV- A cohort study on 
obstetric care for HIV-
positive women in Addis 
Ababa: Intra-partum 
transfers and associated 
delays 
Prospective 
cohort study  
282 HIV-
positive  
mothers  
January to 
December 
2009 
• Proportion of mothers 
transferred during the intra-partum 
period  
• Rate of stillbirth   
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Paper II 
The study on HIV testing behaviour used a sequential exploratory mixed methods design. A mixed 
methods is an evolving design that combines qualitative and quantitative research methods in the 
same study in several ways [103]. Combining the two methods enhance the validity of the study by 
counteracting each other’s limitations. In our study the qualitative method played a supportive role 
for the main quantitative interview. Data were collected at different points within the study in 
January and February, 2009. The focus group discussions (FGDs) were conducted first to inform the 
Theory of Planned Behaviour (TPB) questionnaire. According to Creswell and Zhang “In an 
exploratory sequential design, the intent of the research initially is to explore a construct because it 
is not adequately addressed in the literature, is poorly measured or conceptualized, or is being 
studied in a population for which the research questions are unknown. After the initial qualitative 
exploration, the investigator follows up with a quantitative data collection phase to determine if the 
qualitative findings can be generalized to a sample of a population” [104].  
The TPB was applied to determine intended and actual HIV testing as it is a widely used social 
cognitive theory in preventive behaviours including HIV [38-40, 105, 106]. The TPB focuses on 
proximal determinants of behaviours that can easily be targeted in behaviour change intervention 
[107, 108]. In the TPB, the distal determinants of behaviour are assumed to be mediated through the 
proximal determinants and are less focused upon. Moreover, the distal determinants including 
socio-demographic, cultural and environmental factors seem to be difficult to target in behaviour 
change interventions [108]. The TPB includes perceived behavioural control (PBC) on a level with 
attitude and subjective norm as predictors of behavioural intention, implying that the three 
predictors influence subsequent behaviour indirectly through behavioural intention. In turn, 
intention is the key proximal predictor of behaviour. According to the TPB, behavioural intention is 
a function of attitude, reflecting a favourable or unfavourable evaluation of the particular behaviour 
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and subjective norm. The subjective norm refers to the perceived social pressure to perform the 
behaviour. Perceived behavioural control reflects the ease or difficulty associated with performance 
(Fig 6). Although numerous empirical works have provided support for the power of TPB in 
predicting intention and behaviour, there remains a substantial amount of variance that is not 
explained by the TPB. Variables outside the TPB such as past behaviour and descriptive norms have 
residual effects on intention and behaviour after the TPB variables have been taken into account 
[42, 109-111] and they were included in this study. The study was conducted in three phases. 
Fig 6: Theory of Planned Behaviour framework applied to predict intended and actual HIV testing 
First phase: The focus group discussions  
Focus group discussion is a discussion intended to grasp opinions of a group of informants about a 
topic of interest [112]. In this thesis the FGDs were conducted to capture contextual barriers to HIV 
testing in antenatal settings to inform the questionnaire interview. A FGD guide was developed in 
English based on literature review. Then the guide was translated in to Amharic, which is the official 
language of Ethiopia. Both the principal investigator and the informants were conversant with the 
language. The questions in the guide were “what factors or circumstances would enable you to test 
for HIV upon first time antenatal attendance?”, “what factors or circumstances would make it 
difficult for you to test for HIV upon first time antenatal attendance?” and “ are there any other 
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issues that come to mind when you think of HIV testing upon first time antenatal attendance?”. Three 
FGDs were conducted with a group of seven, eight and 12 purposefully selected first time antenatal 
attendees in natural settings. Natural settings here refer to the antenatal clinics. Qualitative research 
highly valued collection of data in natural settings for deeper understand of research issues [113]. 
The FDGs were conducted in three different health facilities before the mothers received pre-test 
counselling. Volunteer mothers who were waiting for antenatal check-up had participated in the 
discussion. The principal investigator, who has experience in qualitative data collection and analyses, 
moderated and facilitated all the FGDs. Prior to the discussion the purpose of the study was 
explained and informed consent was obtained. During the discussions the mothers identified three 
potential barriers to HIV testing including “scared to test”, “concerns about confidentiality” and “fear 
of disclosing HIV-positive results”. Later they were probed as to whether “fear of stigma and/or 
discrimination”, “fear of being chased from home in the case of positive test result” and “fear that 
they would be denied of proper care” would affect their decision to test. Of the probed questions only 
“fear of discrimination” was mentioned as a potential barrier to HIV testing. The discussions 
continued until the point where no new ideas were brought up. Conflicting opinions were brought up 
for further discussion and consensuses were reached in most of the cases. Notes taken during the 
FGDs were read before the next FGD to identify emerging themes. No new themes were identified.  
All the potential barriers identified by the participants were included in the questionnaire and used to 
measure the concept of perceived behavioural control. None of the FGD participants were included 
in the subsequent questionnaire interviews. 
Based on the findings from the FGDs and following a “manual for constructing a TPB 
questionnaire in health services researches literatures” [114] a standard TPB questionnaire was 
developed. In the questionnaire all the constructs including the behaviour of interest (HIV testing) 
were defined in terms of Target, Action, Context and Time elements. Target here refers to “the 
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pregnant mothers”; Action refers to “testing”; Context refers to “antenatal settings”; and Time refers 
to “upon first time attendance”.  
Second phase: The TPB questionnaire interviews   
Prior to actual interviews, the standard TPB questionnaire was first translated into Amharic then back 
translated to English for validation by a professional translator. Then pre-test interviews were 
conducted among 100 first time antenatal attendees prior to actual data collection. The pre-test 
interviews revealed areas that required more clarification. However, none of the pre-tested 
questionnaires were included in the main study. Mothers who were attending antenatal care for the 
first time in the current pregnancy in selected health facilities during the study period and who 
consented to be followed up were included in the study. Known HIV-positive mothers were excluded 
as they were not eligible for further testing. For the questionnaire interviews 17 college students who 
had no health related background were recruited to minimize information bias. They were given two 
days training and all participated in the pre-testing of the questionnaire under close supervision of the 
principal investigator. The questionnaire interviews were administered before the mothers received 
pre-test counselling in a face-to-face interview. The interviews were conducted individually in a 
quiet corner of the antenatal waiting areas. At the end of each day the completed questionnaires were 
handed to PMTCT counsellors who did the follow up. The study covered 44.3% (3,028) of the 
eligible mothers. Of these, 1.5% (49) refused to participate while 3,033 completed the questionnaire 
interviews (Fig 7). Here, intention to test for HIV was the intermediate outcome. 
Third phase: The follow up  
The follow up from questionnaire interviews to HIV testing took one to five hours. Consequently, the 
study was considered as a fixed cohort. “In cohort studies on acute disease without induction period 
and a short time of follow up, like outbreaks, the risk of disease can be estimated directly using the 
cumulative incidence given a fixed cohort with fixed period of follow up and a low fraction of drop-
outs” [115]. The follow up data were collected by the PMTCT counsellors from PMTCT logbooks. 
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The PMTCT counsellors were routinely conducting the HIV testing and registering whether the 
mother received pre-test counselling (group or individual), testing, post-test counselling and the HIV 
test results. These questions were also the variables obtained during the follow up. The registration 
was done anonymously using the mothers antenatal number as a unique identifier. To be consistent, 
these unique identifiers were used in the questionnaires. Thirty three PMTCT counsellors were 
trained on how to collaborate with the field assistants and on how to do the follow up. The principal 
investigator supervised the counsellors when they obtained follow up data for the first time. 
Inconsistencies were validated by crosschecking with the mothers’ antenatal folder. The study team 
were checking and collecting the questionnaires every day. Of the 3,033 mothers who completed the 
TPB interview in the second phase, 2,928 were assessed objectively whether they actually tested for 
HIV or not during the follow up (Fig 7). The final outcome measured was actual HIV testing.  
Fig 7: Flow chart of paper I - paper IV, data collection methods, sample sizes and variables  
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Paper III and IV 
Paper III and IV used a general cohort consisting of HIV-positive mothers followed from January to 
December 2009 (Fig 7). HIV-positive mothers who were attending the PMTCT programme during 
the study period, those who were attending selected health facilities and those who were willing to be 
followed up to six weeks postpartum were included. Mothers who were not residing in the city were 
excluded. Trained PMTCT counsellors collected all the data.  
At enrolment, mothers were interviewed using a semi-structured follow up format. To minimize the 
possibility of having incomplete data and losses to follow up; first, data were obtained from the 
mothers themselves and from logbooks in the facilities. Second, the follow up schedules of the 
cohort were made to coincide with the mothers’ regular peri-partum visits. These visits were at 28 
weeks, 36 weeks, at delivery, six days postpartum and six weeks postpartum. For mothers who were 
transferred to other health facilities and for those who gave birth at home, follow up data were 
collected when they came for six days’ postpartum care. Reasons for the first transfer were obtained 
from logbooks at the health centres. Since the reasons for subsequent transfers were not recorded, the 
mothers were asked directly what was said to them. The cohort enrolled 282 HIV-positive mothers 
and followed them until six weeks postpartum. Abortion, death of a mother and stillbirth were study 
endpoints. Mothers were regarded as lost to follow-up when they had not shown up for regular visits 
and or when it was impossible to trace them.  
Study variables  
The study variables for paper I obtained from the monthly PMTCT reports were pregnant mothers 
who received pre-test counselling, HIV testing and post-test counselling; HIV-positive mothers who 
received prophylaxis medication, infant feeding counselling and those who referred for treatment, 
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care and support; exposed infants who received prophylaxis medication and those who tested for 
HIV and number of partners who tested for HIV.   
In paper II, the questionnaire interview covered demographic and obstetric information, PMTCT 
knowledge, perceived risk, TPB variables and questions related to actual HIV testing. (Fig 7 and 
Annex 5). The TPB variables were assessed in relation to testing for HIV upon first time antenatal 
care attendance. A five point response scale was used ‘very likely’ (5) to ‘very unlikely’ (1),‘very 
certain’ (5) to ‘very uncertain’ (1) and from ‘strongly agree’ (5) to ‘strongly disagree’ (1). A sum 
score was constructed by adding the items corresponding to each variable. The higher the score the 
more positive the attitude, the stronger the intention, the stronger the subjective norm and the more 
barriers perceived with respect to HIV testing. For use in a logistic regression model later, perceived 
barrier and previous HIV testing experiences were dichotomized. Mothers who scored greater than or 
equal to the mean score were considered to have perceived barriers to test for HIV; otherwise they 
were considered to have no perceived barriers. Mothers who had HIV testing experience/with partner 
were grouped as “Yes”; otherwise they were regarded as “No”. To assess mothers’ knowledge on 
PMTCT, a list of prevention interventions was presented with a possibility to choose more than one. 
Accordingly, mothers who chose more than one intervention were considered knowledgeable; 
otherwise not knowledgeable. Actual HIV testing was assessed objectively through information 
obtained from the PMTCT logbooks.   
Variables collected in paper III and IV are presented in fig 7 and annex 6. Reasons for transfers 
during the intrapartum period were inquired in an open ended question and later they were coded into 
three categories: obstetric complications, practical constraints (including lack of bed and lack of 
electric power supply) and reason not stated.  
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Sample size considerations  
In paper I monthly PMTCT reports from February 2004 to August 2009 were collected from all the 
sub-cities.  
Sample size for the cohort was calculated based on the outcome variable that would give the 
maximum sample, i.e in a population of about 1,500 HIV-positive pregnant mothers [6], 32% 
mother-infant pairs’ adherence to prophylaxis at birth [54], with a precision of 5%, confidence level 
of 95% and 10% contingency. Based on this calculation a total of 274 HIV-positive mothers were 
required for the follow up. To get this number in a city where the estimated HIV prevalence among 
pregnant mothers was reported to be 7.4%, about 3,000 mothers were required to get tested. 
However, during the actual data collection the HIV prevalence in the city was found to be 4.6%, 
much lower than the report. As a result the questionnaire interviews were extended to 5,000. Known 
HIV-positive mothers who were not eligible for TPB questionnaire interviews were included in the 
cohort follow up. As a result the mothers enrolled in the cohort study in paper III and IV were 282. 
In paper II responses from 3,082 mothers interviewed between January and February were analysed 
in line with the first proposal.  
Data analysis  
The qualitative data analysis was conducted concurrent with data collection [113]. The notes were 
translated into English by the principal investigator. Doing the translation helped to get familiarized 
with the contents of the FGDs. The notes were read and re-read in the initial phase of the data 
analysis. Then recurring themes were sorted and phrases such as scared to test, fear of disclosure, 
confidentiality concern and fear of discrimination were used for labelling. 
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All the quantitative data were double entered in separate datasets in Microsoft Excel spread-sheets. 
The two datasets were compared for consistencies by creating a check file. The retrospective reports 
were analysed using Excel Pivotal tables and charts. Prevalence and Relative Risk (RR) were 
determined and χ2 test for trend was analysed using the Epicalc 2000 software.  
In paper II-IV, after checking the consistencies in the Microsoft Excel programme, data were 
transferred to SPSS version 17 for analysis. Descriptive statistics and Pearson Chi- Square were 
done to describe the characteristics of the mothers in the study. Fisher’s Exact Tests were used to 
check baseline differences in demographic, obstetric and other characteristics between mothers who 
completed their follow up and those who did not when the expected counts in the cells were less 
than five. 
In paper II, internal consistency reliability was conducted using Chronbach’s alpha. Pearson’s 
correlation was used to examine bivariate linear relationship between intention and the TPB 
variables, PMTCT knowledge and previous HIV testing experiences. Multiple linear regression 
analysis was applied in prediction of intention from TPB and external variables to calculate R2 and 
 values, separately for mothers attending private- and public health care facilities and separately 
for each health centre and hospital. Logistic regression analysis was applied in prediction of actual 
HIV testing to examine the relative contribution of theoretical and external variables and to assess 
the fit of the model in terms of Nagelkerke R Square. Despite using a cohort design, Odds Ratio 
(OR) was used as an effect measure taking into consideration the fixed follow up time, little losses 
to follow up and the low prevalence of not testing for HIV in antenatal settings. Moreover, under 
rare disease assumption, the OR may be an acceptable approximation of the risk ratio [116-118]. To 
examine possible moderation effect of type of pre-test counselling upon the intention-behaviour 
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relationship, a two way interaction term between intention and type of pre-test counselling was 
added to the regression model and tested for statistical significance. Sensitivity, specificity and 
predictive values were calculated to examine the nature of intention-behaviour relationship. 
In paper III bivariate analyses were done to identify association between mother-infant pairs 
ingesting medication at birth and socio-demographic characteristics, obstetric characteristics, CD4
cell count and gestational age at enrolment, type of prophylaxis initiated, place of delivery, 
disclosing HIV status, partner involvement in HIV counselling and testing, partner testing and 
partner test result. Variables with p-value less than 0.05 in the bivariate model were included in the 
multivariate logistic regression model to control for potential confounding effect. Proportion of 
exposed infants brought for early infant diagnosis was calculated among live births, while the rate 
of MTCT was calculated among infants who had documented six weeks HIV test result.   
In paper IV, the main outcome variables were transfer during the intra-partum period and rate of 
stillbirth. The rate of institutional delivery was calculated among mothers enrolled into the study 
while comparison between transferred and not transferred during the intra-partum period was made 
for mothers who completed the study. The rate of intra-partum transfers was calculated among 
mothers who visited health facilities during labour and delivery. The rate of stillbirths was 
calculated among the total births and stratified by transfer status. As 19% of the mothers were lost 
to follow up by the time of delivery, sensitivity analyses were done to assess potential biases due to 
the loss to follow up.    
P-values <0.05 were considered significant and 95% confidence interval (CI) was used. 
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Ethical considerations   
The study was reviewed and approved by the Ethical committee of Addis Ababa City Administration 
Health Bureau in Ethiopia and the Regional Committee for Medical Research Ethics in Western 
Norway (Annex 1). Study permits from Addis Ababa City Administration Health Bureau and 
respective sub cities were obtained. Data were collected anonymously to respect mothers’ privacy 
and to ensure confidentiality. Prior to the interviews, information was provided to each mother about 
the objective of the study, the possibility to withdraw anytime if they did not want to continue and 
how the data were to be handled after collection (Annex 2). The HIV-positive mothers were followed 
up by their respective PMTCT counsellors for confidentiality reasons and to avoid unnecessary 
disclosure. The mothers’ antenatal numbers were used as a unique identifier in the questionnaire 
interviews as well as in the follow up.   
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Synopsis of the papers 
Paper I: Outcomes of a national PMCT programme  
This paper examined trends in PMTCT service utilization and assessed the rate of MTCT in relation 
to policy changes in the national PMTCT programme. A total of 663,603 antenatal care attendees 
were registered in the PMTCT programme in Addis Ababa between February 2004 and August 
2009. The proportion of mothers who received HIV counselling and testing among new antenatal 
care attendees increased from 50.7% (95% CI 50.2-51.2) in 2007 to 84.5% (95% CI 84.1- 
84.9) in 2009 following the shift to routine opt-out testing. Nevertheless, in 2009 only 53.7% of the 
positive mothers and 40.7% of their infants received ARV prophylaxis. The HIV prevalence among 
antenatal attendees decreased significantly from 10.5% in 2004 to 4.6% in 2009 in parallel to the 
increased number of mothers being tested. The HIV-positive mothers were over 18 times (RR 18.5, 
p<0.0001) more likely to be referred for treatment, care and support in 2009 than in 2004. The 
proportion of partners tested for HIV remained extremly low over the years at about 5%, although 
the absolute number was increasing year by year. Only 10.6% (95% CI 9.9-11.2) of the HIV 
exposed infants had been tested for HIV. The cumulative probability of HIV infection among babies 
on sdNVP regimen who were tested at  18 months was 14.9% (95% CI 9.8-22.1) in 2007, whereas 
it was 8.2% (95% CI 5.55-11.97) among babies on ZDV regimen who were tested at  45 days in 
2009.  
Paper II: Applying the Theory of Planned Behaviour to explain HIV testing  
Focusing a cohort of pregnant mothers attending public and private antenatal care facilities, this 
mixed methods study applied an extended version of the Theory of Planned Behaviour (TPB) to 
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explain intended- and actual HIV testing. Mothers attending public health facilities were 
significantly different from mothers attending private health facilities with respect to socio-
demographic and obstetric characteristics (p<0.01). The TPB explained 9.2% and 16.4% of the 
variance in intention among public- and private health facility attendees. Intention and perceived 
barrier explained 2.4% and external variables explained 7% of the total variance in HIV testing. 
Positive and negative predictive values of intention were 96% and 6% respectively. Across both 
groups, subjective norm explained substantial amount of variance in intention, followed by 
attitudes. Mothers intended to test for HIV if they perceived social support and anticipated positive 
consequences following test performance. Type of counselling did not modify the link between 
intended and actual HIV testing.  
Paper III: Adherence to prophylactic medication regimen and infant follow up  
This study assessed the proportions of mothers and infants who adhered to prophylactic medication 
regimen and the proportions of exposed infants who were followed up in the PMTCT programme. 
Two hundred and eighty two mothers were enrolled; 10 had an abortion, five changed health 
facilities, 13 changed address, two died and 10 were lost to follow up for unknown reason. In total 
232 (82%, 95% CI 77-86%) mothers initiated medication during pregnancy; 154 (64%) combined 
ZDV prophylaxis and 78 (33%) lifelong ART. Seven mothers actively refused medication 
prescription. Only 171 (60%, 95% CI 55-66%) mothers ingested their medication at birth. Among 
the 228 mothers who reported to have given birth, 217 were singleton live births, two twins live 
births and nine stillbirths. Of the 221 live births infants (included the two twins) 191 (87%, 95% CI 
81-90%) ingested their medication at birth. Of the 219 live births (twin birth were counted once) 
148 (68%, 95% CI 61-73%) mother-infant pairs ingested their medication at birth. Mother-infant 
pairs who were attended in health facilities at birth were more likely (Adjusted OR 6.7 95% CI 
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2.90-21.65) to ingest their medication than those who were attended at home. By six weeks 
postpartum, 189 (86%, 95% CI 80-90%) infants received their first pentavalent vaccine but only 
115 (52%, 95% CI 45-58%) of them attended early infant diagnosis. Seventy one infants (32%, 
95% CI 26-39%) had documented HIV test results and six (8.4%) were HIV-positive. No significant 
differences were observed among infants receiving different feeding modalities with respect to 
MTCT. Hundred and sixty mothers (57%) disclosed their HIV-positive status to their partners, 82 
partners were involved in HIV counselling and testing, 109 partners reported to be tested and 34 
(31%) partners were sero-discordant. 
Paper IV: Intra-partum transfer associated delays and pregnancy outcome 
This study used the same cohort data as in paper III. Of the 282 mothers enrolled, 211 (75%) mothers 
gave birth at Emergency Obstetric and Neonatal Care (EmONC) facilities and 17 (6%) at home and 
54 women were lost to follow up by the time of delivery (reasons for lost to follow up are presented 
in paper III). Of the mothers who gave birth at EmONC facilities 42% were transferred between 
health facilities during the intra-partum period and 36% were transferred twice and more. Sixty four 
percent of the first time transfers were due to obstetric complications, while all subsequent transfers 
were due to practical constraints. Lack of bed was the sole reason for transfers from comprehensive 
EmONC facilities. Mothers in their second pregnancy were less likely (OR 0.3 95% CI 0.2-0.6) to be 
transferred than mothers in their first pregnancy. The rate of stillbirths was 39/1000 live births. 
Mothers who were transferred during the intra-partum period were 5.8 times (95% CI 1.2-28.8) more 
likely to experience stillbirths than those mothers who did not. The rate of stillbirths was not 
significantly associated with the syphilis test result, the CD4 count or initiating lifelong ART.  
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Discussion  
Discussions of methods 
The study designs  
This thesis used cross-sectional, mixed methods and prospective cohort designs. Combining 
different designs and methods is, from a methodological perspective, considered vital to improve 
the validity of the findings.   
The cross-sectional design was chosen because of its strength to collect large data in a short time 
period, although this design has its own limitations to make causal and temporal inference. This 
design was valuable to collect six years retrospective routine PMTCT reports for trend analysis.  
The sequential exploratory mixed methods design was valuable in paper II for comprehensive 
understanding of the behavioural determinants of antenatal HIV testing. Through FGD, context 
specific barriers were captured and used as a knowledge base to develop the TPB questionnaire. In 
spite of the stated strengths, conducting mixed methods study was a time consuming endeavour. 
The follow up part of this study was analysed as a fixed cohort due to short time period between 
exposure and outcome. The short follow up period reduced loss to follow up. Moreover, in TPB, 
intention is often considered an unstable measure as things that crop up between intention measure 
and actual behaviour could influence the initial intention. Having a very short follow up from this 
perspective is a strength of our study. Yet, from theoretical perspective short follow up does not 
allow for calculating incidence rates that cohort studies are often praised for [117]. Despite the short 
time interval between intention measure and actual HIV testing pre-test information/counselling 
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were given to the mothers after intention measure. This seemed to have influenced most of the low 
intenders to take HIV testing.  
The strength of the prospective cohort design lies in its ability to make causal and temporal inference 
between exposure and outcome, given that potential systematic and random errors are taken care of  
[119].  
Selection bias 
Selection bias is a systematic error resulting from faults in selection of participants [117, 119]. 
Cohort studies that collect exposure data before the occurrence of an outcome are less likely to 
experience selection bias. This thesis used general cohort in paper II, III and IV with internal 
comparison groups. Such cohorts are less vulnerable to systematic error in selection of participants 
as the internal comparison groups are decided later in the study process. In paper II, all first time 
antenatal attendees were enrolled while comparison between high and low intenders in actual HIV 
testing was done later. In paper III and IV, all HIV-positive mothers attending selected health 
facilities were followed while internal comparison were made during data analysis.  
Information bias 
Information bias is also called misclassification that occurs when there is error in the information 
collected about or from the study participants [117, 119]. Misclassification can be differential, if the 
bias is related to either an exposure or an outcome. Recall bias is one form of information bias more 
common in studies relying on retrospective information. Despite using retrospective information, 
recall bias in the present study (paper I) was less likely as the data were obtained from records. 
However, ensuring data quality and completeness are the major drawbacks of using routine records 
especially in resource-poor settings where the quality of reports are often questionable [102]. 
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Limiting the study objective to those indicators that could be calculated from the reports and using 
multiple data sources ensured 93% complete data.
The prospective designs are less prone to recall bias as the potential predictors are recoded at the 
beginning of the study. However, social desirability bias can happen in prospective studies. Since 
most of the outcome data in our study were obtained from logbooks and were objective, the risk of 
social desirability bias was less likely.  
The validity and reliability of a study can easily be affected by measurement errors. Validity refers 
to the ability of the instrument to measure what is supposed to measure, while reliability refers to 
the stability, consistency and equivalence of measurements taken [113]. To ensure content validity 
of the questionnaire in paper II, a guide was used to develop a standard TPB questionnaire and to 
grasp contextual factors FGDs were conducted. The construct validation of the TPB variables 
showed significant correlation between intention and attitude, intention and subjective norm as 
proposed in the TPB. Examination of the observed theoretical associations is as much a test of the 
theory as it’s is a test of its validity 
The questionnaire reliability was checked through pre-test interviews prior to actual data collection. 
The internal consistency reliability of a test is widely assessed by Cronbach’s alpha coefficient, the 
coefficient value ranges from 0 to +1, the higher the score the more reliable the instrument is [113]. 
In paper II, the Cronbach’s alpha coefficients were 0.75 for attitude and subjective norm and 0.92 
for intention, indicating the high internal consistencies of the constructs. The questionnaire 
interviews were done by several field assistants. This would have introduced intra-rater and inter-
rater variability if not for the intensive calibration procedure done. Polit and Black pointed out that 
the reliability of observational studies can be enhanced through calibration process [113]. 
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Employing field assistants sharing similar educational background and gender were intended to 
reduce inter-rater variability. Moreover, the follow up data in paper II, III and IV were collected by 
experienced PMTCT counsellors who had sufficient knowledge on PMTCT and all of them were 
well acquainted with most of the questions in the follow up format. Owing to their ample 
experiences in routine reporting, one day training was considered sufficient for them. However, 
hiring these counsellors for the follow up could have introduced some sort of social desirability bias 
to the study. This could be a non-differential misclassification which bias the effect estimate 
towards the null.   
Losses to follow up are potential threats to the validity of cohort studies [101, 113, 117, 119]. 
Information bias due to loss to follow up is a serious concern in this work. In paper IV, no outcome 
data (i.e. intra-partum transfer) were available for 19% of the cohort. This would have resulted in 
differential misclassification if mothers with missing information were different from those for 
whom outcome was recorded. Analysis of the baseline characteristics did not show any significant 
difference between mothers who completed their follow up and those who did not for the variables 
measured. The losses to follow up were anticipated by the fact that HIV/AIDS is still a disease with 
stigma, the possibility of abortion among mothers enrolled in early pregnancy, the low rate of 
institutional delivery in the city (44%) and the high reported dropout rate in PMTCT programmes. 
Hence, we extended our effort in tracing the loss to follow up using several contact points.  
Moreover, the sensitivity analysis had shown no effects on the findings. 
Confounding and interaction  
Confounding is a mixing of effect that can lead to erroneous conclusion [117, 119]. Compared to 
experimental designs where participants are assigned randomly, observational studies relying on 
natural assignment of participants often encounter confounding. During data collection potential 
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confounders can be minimized through random allocation, restriction and matching of participants 
while during data analysis stratification and use of multivariate model can help to control for 
confounding effect [117, 119]. Most socio-demographic variables can confound observational 
studies and should be accounted for. Multivariate logistic regression analyses were employed to 
control for potential confounding effect by including variables with p-value less than 0.2 in 
bivariate analysis.  
Interaction or effect modification is when the association between exposure and outcome varies 
with the level of a third variable [117]. Like confounding, interaction can also lead to erroneous 
conclusion and it is necessary to account for its effect during analysis. In paper II, we assessed 
possible interaction between intentions to test for HIV and the type of pre-test information/ 
counselling the mothers received. Both intention and type of pre-test counselling can increase the 
mothers’ likelihood of taking an HIV test independent of one another. Possible interaction effect 
was checked whether actual HIV testing was different among high and low intender depending on 
the type of pre-test counselling they received. There was no significant interaction between 
intention and type of pre-test counselling received.  
Random error 
Random errors can seriously affect the precision of an epidemiologic study and should be 
minimized [117, 119]. Confidence intervals and p-values are often used to assess the precision of a 
study in reference to the null hypothesis (the hypothesis of no association between exposure and 
outcome). Confidence intervals are more informative than p-values as it can indicate both the point 
estimate and the sample distribution. If the confidence interval includes one, it indicates the lack of 
association between exposure and outcome. The further the point estimates from one the stronger is 
the association between the exposure and the outcome. Type I error (), is when one falsely detects 
Successes and challenges of the national PMTCT programme  
50
an association between exposure and outcome in the absence of any association. The common 
threshold for type one error (p-value) is 5%. Type II () error, is when one fails to detect association 
between exposure and outcome where there is an association. This corresponds to the power of the 
test with a common threshold value of 80%. This error can be minimized by increasing sample size. 
In the cohort, the sample size was calculated to achieve a 5% precision, with a 95% confidence 
level. The sample sizes were sufficient enough to detect association between exposure and main 
outcomes. 
External validity  
The external validity of an epidemiological study is concerned with the generalizability of the 
findings to other populations and/or settings [117, 119]. Measures intended to improve internal 
validity such as selecting homogenous sample could be counterproductive for ensuring external 
validity. Some of the potential threats to external validity of observational studies are selection of 
samples which are not representative of the study population, non-random selection of samples and 
Hawthorne effect [119]. To ensure representation, in paper I, the entire PMTCT reports from all the 
10 sub-cities were collected.  
In paper II-IV, although a non-probability sampling was applied in selection of the study sites, 
attempts were made to improve representation. First, all the sub-cities were included. Second 
proportional allocation of public and private health facilities depending on the proportion of 
pregnant mothers being served in those facilities was considered. Third a large proportion of the 
eligible mothers were included i.e. 44% in paper II and 60% both in paper III and IV. Moreover, less 
stringent exclusion criteria were used to maximize representation. The lack of consideration of the 
design effect in determining the sample size could have implied a too limited sample size with lack 
of statistical power. However, when adjusting for design effect in the statistical analyses- the  major 
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results remained almost unchanged. Still the study may not be representative of the whole nation 
where the majority of the mothers are living in rural areas with poor access to PMTCT programmes. 
However, since it was generated from a national programme, lessons learnt herein could benefit the 
PMTCT programme across the country.  
Being a health facility based study, the external validity of the findings could have been limited if 
over 90% of the mothers were not attending ANC. In paper III and IV, potential Hawthorne effect is 
a concern due to the training given to the PMTCT counsellors who followed the mothers, the 
compensation for transport and the follow up care given to the mothers. These could have some 
positive influence on mothers’ adherence to the PMTCT recommendations. 
The rate of MTCT was examined based on infants tested for HIV, which could be actually 
underestimated due to the large loss to follow up. Considering the lack of a system to trace loss to 
follow up, our findings still highlight the potentially averted infections.   
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Discussion of the main findings  
The PMTCT programme expansion and the declining HIV prevalence  
This study showed marked increase in PMTCT programme attendance accompanied by a 
substantial increase in the proportion of mothers receiving HIV counselling and testing. The HIV 
prevalence among these mothers has declined steadily paralleling the increased number of mothers 
tested for HIV and the expansion of the programme. A similar declining trend in HIV prevalence 
has been observed among the general population and from a sentinel surveillance report in Ethiopia 
[6, 7]. The declining trend in HIV prevalence can probably be attributed to the expansion of the 
national PMTCT programme and the inclusion of reports from private facilities where the HIV 
prevalence among ANC attendees is generally lower than among public facilities attendees. In the 
sentinel surveillance reports, as the number of sentinel sites increased, the estimated HIV 
prevalence decreased [7]. More importantly, synergy between the natural progressions of the HIV 
epidemic, increasing access to ART, behaviour changes among the general population in terms of 
increased condom use and reduced risky sexual behaviour could have contributed to the decline [6, 
8].   
   
Behavioural determinants of routine opt-out HIV testing and issues of informed decision  
Our study demonstrates a marked improvement in the rate of HIV testing following the introduction 
of the routine opt-out approach. Similar successes have been reported from many resource-poor 
settings that have implemented routine opt-out testing [22, 23, 26, 54]. The present study showed 
that the majority of mothers had high intention to test upon their first antenatal visit even before 
they received pre-test counselling. This indicates that HIV testing taking place in antenatal settings 
has become a common knowledge. A survey conducted in 2004 in Addis Ababa showed that over 
75% of the antenatal attendees had knowledge about MTCT/ PMTCT and favourable attitude 
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towards antenatal HIV testing [120]. In our study mothers intended to test for HIV if they 
anticipated positive consequences and approval from social network. Consistent with our findings 
studies about intended use of VCT services also identified attitude and subjective norm to be the 
strongest predictors [40, 41]. Hence, educational messages to increase mothers’ motivation to test 
should target attitude that mothers hold about the positive consequence of HIV test. Moreover, 
increasing awareness about the importance of HIV testing to the mothers’ wider social network 
could have positive impact on the mothers’ motivation to test.   
Despite intention being the strongest independent significant determinant of actual HIV testing, 
large proportions of non-intenders were tested. The large proportion of low intenders who ended up 
in testing may be related to more unstable measure of behavioural intention i.e intention might 
change over time with events that crop up between the assessment of intention and behaviour. In 
this study the pre-test counselling/information offered to participants probably contributed to a 
change in mother’s initial intention. In this regard the pre-test counselling/information given to the 
low intenders in particular seem to positively influence them to change their initial lack of intention. 
The high rate of testing among the low intenders could also be related to poor pre-test information 
and to the power imbalance between the counsellors and the mothers. Several studies from sub-
Saharan Africa have shown that the information given to pregnant mothers in the group pre-test 
sessions was inadequate and mainly focused on getting the mothers tested without enabling them to 
opt out if they did not intend to test [35-37]. Several researchers also argue that many mothers in 
resource-poor settings are less empowered to actively opt-out the testing offer and might accept 
testing just to conform to the antenatal routines [33, 35, 37]. Here there is a need to come up with 
strategies to maximize the sensitivity of routine opt-out approach to enhance the mothers’ autonomy 
to make an informed decision. Based on our findings it will be important to create awareness about 
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the benefit of antenatal HIV testing to motivate non-intenders. So that the fundamental principle of 
informed consent is not violated and that testing follows an informed choice.  
Sub-optimal adherence to prophylactic medication regimen 
The present study findings suggested that irrespective of the changes in prophylaxis regimen there 
was little progress in prophylactic medication utilization over the years. Several empirical works 
within and outside Ethiopia have also reported sub-optimal utilization of prophylaxis medication. 
This could be attributed to the lack of tailored strategies to improve adherence to prescribed 
medication and regular follow up. At the time the “ 3 by 5 initiative ” was embarked, shifting the 
HIV testing approach was considered a way forward to recruit those who are eligible for ART [31]. 
Years of experiences with antenatal routine opt-out testing however, have shown great challenges to 
ensure access to ARV prophylaxis despite the large proportion of mothers being identified HIV-
positive. Although routine testing importantly creates opportunities for mothers who may not have 
come to know their HIV sero-status otherwise, the poor link between being identified HIV positive 
and ARV utilization may threaten the justification of the routine testing recommendation.   
The study documented that there was progressive and marked decline in adherence to prophylactic 
medication regimen across the peri-natal period, 82% during pregnancy while 68% at birth by 
mother-infant pairs. Similar findings have been reported from several Sub-Saharan African 
countries where the gap between initiating medication during pregnancy and taking it at birth ranges 
from 10 to 26% [54, 98, 121]. High coverage and quality intra-partum obstetric care could largely 
account for these differences. In Botswana for instance, 94% of mothers have access to safe 
institutional delivery and over 90% of HIV-positive mothers received prophylactic medications at 
birth [97], whereas in Addis Ababa only 44% mothers have access to institutional delivery [122]. 
Institutional delivery was a significant determinant of mother-infant pairs ingesting medication at 
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birth, which is in agreement with findings from other resource-poor settings [97, 98]. In many 
settings including Ethiopia infants are given prophylaxis within 72 hours of birth at the health 
facility. Infants delivered at home cannot get the prophylactic medication unless they are brought to 
health facilities. Facilitating access to prophylaxis medication in the case of home birth should be 
focused upon.  
The gaps in receiving medication during pregnancy and mother-infant pairs taking of the drug at 
birth could undermine the PMTCT programme effectiveness. Optimal efficacy of the medication 
can be achieved only when mother-infant pairs are taking the medication as prescribed. In a 
randomized controlled trial conducted in Tanzania, South Africa and Uganda the rate of MTCT was 
8.9% where mother-infants pairs received the intra-partum and postpartum prophylaxis doses, 
whereas the rate was 14.2% where only mothers received the intra-partum dose [95]. Moreover, the 
proportion of mothers receiving medication during pregnancy is a proxy indicator currently used for 
measuring PMTCT programme success; hence the gaps could threaten the validity of this indictor. 
Particularly in resource-poor settings where there are marked gaps in antenatal care and institutional 
delivery coverage, this indicator could overestimate the PMTCT programme effectiveness. 
Challenges to access intra-partum obstetric care and adverse pregnancy outcomes  
Safe obstetric practice is an important component of the PMTCT programme due to the high rate of 
intra-partum MTCT. However, this component has received the least attention from health care 
actors as well as in the PMTCT literature. The majority (75%) of the mothers in this study visited 
EmONC facilities for intra-partum care compared to 44% among the general population of mothers. 
This difference could be due to the promotion of safe obstetric practice for the reduction of MTCT, 
which may reflect that the message of safe delivery has reached out to the target groups. In addition 
it is an indication of mothers' high motivation to secure an HIV negative status of their baby. 
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However, the study project activity (Hawthorne effect) in terms of improved follow up, the 
compensation for transport and the training given to the study counsellors could have positive 
influence on the mothers’ motivation to seek institutional delivery. 
Forty two percent of the mothers who visited basic EmONC facilities for delivery were transferred 
between EmONC facilities during the intra-partum period. This rate is much higher than the 15% 
expected rate of referrals due to obstetric complications and the 19% rate of referrals observed in a 
large scale study from south East Asia [60, 123]. The high rate of transfer in our study indicates that 
despite the expressed goal of reducing maternal and peri-natal mortality, the health system appeared 
unable to take advantage of the mothers’ motivation for ‘safe obstetric care’. Moreover, 36% of the 
mothers were actually transferred between the EmONC facilities more than once merely due to 
practical constraints within the health care system. The available EmONC facilities in Addis Ababa 
are more than the minimum expected standard and are located within five km distance (unpublished 
data, collected by Addis Ababa Fistula Hospital, Ethiopian Road Authority and the World Bank). 
However, shortage of supplies, shortage of skilled professionals and lack of accountability 
mechanism are common encounters in most of the EmONC facilities across the city. Similar findings 
have been reported from Tanzania where most of the basic EmONC facilities are functioning poorly 
in terms of the quality of the services they are expected to provide and this seems to contribute to the 
excess obstetric complications reported [124, 125].  
The presumably undue transfers between facilities delays the mothers in accessing timely intra-
partum care. This is likely to increase the risk of MTCT because of prolonged labour duration and 
missing of the intra-partum prophylactic dose. More importantly, delays to receive appropriate intra-
partum care can be detrimental to maternal and peri-natal survival [59, 60]. The rate of stillbirth in 
our study was 39/1,000 births, much higher than the 21.3 stillbirths per 1,000 births reported for 
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developing countries [65]. Mothers who were transferred during the intra-partum period were about 
six times more likely to experience stillbirth than those who were not. In a health facility based study 
from Uganda delays to receive care at health facilities (to so-called third delay) was responsible for 
about half of the peri-natal deaths [62].  
In the present study the stillbirths were not associated with the mothers CD4 count, initiating lifelong 
ART and syphilis test result which further suggests possible health system failure. According to 
reports, stillbirths occurring during the intra-partum period can largely be attributed to poor quality 
obstetric care [126]. There is an inverse correlation between the rate of stillbirth and the quality and 
quantity of obstetric care provided during pregnancy and delivery [65, 66]. In the 2010 MDG 
countdown report, most of the countries that show slow progress in reducing maternal and neonatal 
mortality have a poorly functioning health system, Ethiopia is one of them [127, 128]. A recent 
review concluded that provision of quality basic and comprehensive EmONC can reduce intra-
partum stillbirths by about 45% and 75% respectively [58].  
Poor exposed infant follow up services and the rate of MTCT 
The PMTC guidelines recommend an integrated and comprehensive regular follow up for exposed 
infants. In the present study however, the infant follow up services were found to be less organized 
and inconsistent. By six weeks postpartum, large proportions of the exposed infants had received 
their first pentavalent vaccine but only 52% had received early infant diagnoses. Worse still few of 
them had documented HIV test result. Poor early infant diagnostic services appeared to be common 
to many resource-poor settings; 25% in Mozambique [129] and 40% in Kenya [130]. This could 
create unnecessary missed opportunities to early infant diagnosis. There were obvious deficiencies 
within the health care system in coordinating and managing the infant follow up services. In most of 
the study sites, the infant follow up services were scattered all over the health centres often 
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demanding visits to multiple service points and were available only two or three days per week. In a 
study by Nyandiko and colleagues in Kenya, the health system was found responsible for the low 
rate of infant HIV testing [131]. According to Chatterjee and colleague who conducted a study in 
four countries, health facilities providing integrated optimal infant follow up service are more likely 
to have infant diagnosis done at the recommended time [75]. The missed opportunities to early 
infant diagnosis could delay HIV-positive infants in accessing timely treatment and thus negatively 
impact their chance of survival [132]. Therefore, creating integrated strategies to contain the 
necessary procedures pertinent for exposed infant follow up at one single point is required for the 
PMTCT programme to succeed. 
Although implementation gaps were obvious, the national PMTCT programme showed promising 
outcome in terms of averted infections among those who adhered to the programme. All over the 
study sites the majority of infants were breast fed and the cumulative HIV infection was about 15% 
among those on sdNVP regimen who tested at 18 months. This rate was comparable to the rate of 
15.7% MTCT reported in the HIVNET 012 trial among breast fed infants who tested at 18 months 
[49]. In the group that received combined ZDV regimen and was tested at six weeks postpartum the 
rate of MTCT appeared to be higher in our study compared to the Petra clinical trial and a study 
from Abidjan [95, 133]. Yet there was overlap in the confidence intervals. Considering the fact that 
the data in our study were generated from a national programme and the obvious methodological 
differences with the aforementioned trails, the rate of MTCT observed in the present study indicates 
some success of the programme. Nevertheless, unaccounted losses to follow up could underestimate 
the rate of MTCT [134] since less than one quarter of the exposed infants had documented HIV test 
result. Moreover, the HIV testing done at six weeks postpartum did not account for the possible 
MTCT through breast-feeding. For further reduction of MTCT among breast-feeding infants, the 
follow up services for these infants should be well integrated into existing maternal and child health 
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programmes with clear sense of ownership and accountability from staff involved in the care. 
Incorporating prophylactic medication throughout the breast-feeding period as per the recent 
recommendations should also be considered [52].   
Low rate of partners involvement in PMTCT programme
Considering all the mothers who have been tested in the PMTCT programme over the years, the 
rate of partner testing has remained extremely low at a rate of 5%. This is much lower than the 26% 
partner involvement in a PMTCT programme reported from Uganda [135]. However, a much 
higher rate of partner testing was observed among the HIV-positive mothers’ in the present study.  
Partner involvement in the PMTCT programme has paramount importance especially among 
discordant couples. The rate of sero-discordance was 31% in the present study, consistent with 
findings from the eastern and southern African region, including Ethiopia [7, 77]. Pregnancy 
increases the risk of horizontal transmission because of mucosal and hormonal changes [136]. 
Furthermore, mothers with a recent HIV infection are more likely to transmit HIV infection to their 
babies [76]. Involving partner in PMTCT programme and couple counselling could help to identify 
at risk individuals living with infected partners for preventive interventions. According to recent 
reports, early initiation of ART by infected partners and pre-exposure prophylaxis by uninfected 
partners can substantially reduce the risk of horizontal heterosexual transmission, which could be a 
compelling reason to improve partner involvement in the PMTCT programme [79-81].  
Improving mothers’ access to lifelong ART 
According to the trend data, an increasing proportion of HIV-positive pregnant mothers were referred 
for treatment, care and support services year by year. The referral to ART clinics was intended to 
identify mothers eligible for lifelong ART or those who require ARV prophylaxis using CD4 cell 
count as an indicator. According to the 2007 Ethiopian PMTCT guidelines, mothers with CD4 cell 
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count of 200 cells per micro liter or less should initiate lifelong ART irrespective of their clinical 
staging [91]. Over 30% of the mothers in the cohort initiated lifelong ART.  This suggests that the 
PMTCT programme have been increasingly managed to identify those who need treatment for their 
own health. By doing so, the programme is addressing the most important issues that PMTCT 
programmes have been criticized for, i.e the lack of sensitivity to the needs of pregnant mothers. Yet, 
there is a need to further strengthen the link between the PMTCT and the ART programmes to ensure 
that all HIV-positive pregnant mothers have access to prophylaxis or lifelong treatment. 
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Conclusions and recommendations   
Conclusions   
There has been a rapid scaling up of the national PMTCT programme in Addis Ababa accompanied 
by a substantial increase in the rate of HIV counselling and testing from 2004 to 2009. Paralleling 
the programme scale up and the increased number of mothers tested, the HIV prevalence has shown 
a steady decline. The increase in the rate of HIV testing was marked following the shift to routine 
opt-out HIV testing approach. Data collected following the implementation of routine opt-out 
testing, however, have shown that some mothers were tested despite their low intention to test. This 
suggests that in the routine opt-out approach, the mothers’ lack of intention to test may not account 
for the outcome. In order to motivate the low intenders to take HIV testing, one should target the 
mothers’ attitude and subjective norm so that testing follows informed decision.  
Missed opportunities to collect prophylactic medication, infant follow-up, safe obstetric care, and 
partner involvement in HIV testing remained high over the study period. The lack of improvement 
in medication utilization after the shift to routine opt-out testing should be an issue of serious 
concern at national and international level as the shift was intended to facilitate access to 
prophylactic medication. The proportion of mothers who initiated medication during pregnancy was 
much higher than those mother-infant pairs who ingested the medication at birth. The overall 
effectiveness of the national PMTCT programme could have been undermined due to these gaps. 
Optimal efficacy of prophylactic medication can be achieved only when both mother-infant pairs 
are ingesting it as prescribed. Moreover, the proportion of mother-infant pairs ingesting medication 
at birth seems to be a more reliable indicator for PMTCT programme planning and evaluation 
compared to the proxy indicator currently used (i.e the proportion of mothers receiving medication 
during pregnancy).  
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Increasing the mothers’ access to quality obstetric services is critical to increase adherence to intra-
partum medication and to ensure safe delivery. Contrary to the low rate of institutional delivery 
reported in the city, the majority of the studied mothers did seek intra-partum obstetric care at 
EmONC facilities. However, the care that the mothers accessed at the health facilities was sub-
optimal. Many mothers seemed to be unnecessarily transferred between facilities while in labour. 
Even worse, some of them were transferred more than once merely due to practical constraints 
within the health care system. The transfers delayed the mothers in receiving appropriate and timely 
care. This contributed significantly to the high rate of stillbirth and could have increased the risk of 
MTCT. The presumably unnecessary transfer reflects the health systems failure to take advantage of 
the mothers' motivation for “safe obstetric care” and is seriously compromising the mothers’ right 
to appropriate and timely care. Increased attention should be put on this so-called third delay to 
strengthen safe obstetric care services in the city.  
Services pertinent to exposed infants follow up seem to be inconsistent and not well organized, 
contributing significantly to avoidable missed opportunities. By six weeks postpartum, about 90% 
of the infants received pentavalent vaccine but only about 50% attended early infant diagnosis and 
only small proportions had documented HIV test result. This could affect the survival of HIV-
positive infants in particular as about 50% of them could die in the first year of life if they do not 
initiate early ART. In order to maximize the effectiveness of the PMTCT programme and the 
survival of HIV-positive infants, the health system needs to develop targeted interventions. These 
interventions must ensure early infant diagnosis and continuity of care and should be integrated 
within the existing traditional under-five child health services.  
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The other component of the PMTCT programme that showed low utilization is partner involvement. 
Partner involvement in the PMTCT programme has been extremely low over the years (about 5%), 
yet a relatively high proportion of partners of the HIV-positive mothers were involved in the 
PMTCT programme. One third of the partners were sero-discordant. Hence, to reduce the burden of 
MTCT it is crucial to involve partners in PMTCT programmes. By doing so partners who are at risk 
of acquiring new HIV can be identified for pre-exposure prophylaxis. Furthermore, inline with the 
recent concept of “treatment for prevention”, identification of discordant couples could help for 
early initiation of lifelong ART by the infected partner to prevent both horizontal and vertical 
transmission.  
The impact of the national PMTCT programme seems to be promising when the rate of MTCT is 
calculated among the tested infants. However, due to the lack of consideration of the lost to follow 
up, the MTCT reported in the present study could be grossly underestimated.
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Recommendations  
Considerations for health promotion   
Behavioural interventions should be considered to motivate mothers for antenatal HIV testing. 
These interventions should focus on the positive consequences accruing from the testing. There is a 
need to target the wider social network of the mother who could possibly exert positive influence on 
the mother’s decision to test. In particular the need for partner involvement in PMTCT programme 
should be emphasized. 
Creating awareness about the need for optimal adherence to PMTCT recommendations should be 
highlighted using existing information, education and communication channels. There has been 
wide media coverage about the importance of HIV testing during pregnancy, consequently antenatal 
HIV testing has become common knowledge. Such effort should be extended to minimize the rate 
of non-adherence to subsequent PMTCT recommendations.   
Considerations for possible health system strengthening  
Home delivery was associated with a high risk of mother-infant pairs intra-partum medication non-
adherence at birth. Facilitating access to prophylactic medication through provision of the 
medication to be taken at home in the case of home delivery should be considered as the rate of 
facility birth in Ethiopia is very low. 
Safe obstetric care in a PMTCT programme should attract the attention it deserves from the health 
care system and health care workers like the other major PMTCT programme components.  
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The quality of obstetric care services in Addis Ababa should be improved. Especially the basic 
EmONC facilities that the majority of the city population relies on should be fully functional at all 
times. This could be done through skill training, provision of supplies and by introducing 
accountability mechanisms such as audit. Meanwhile, establishing an efficient referral system with 
reliable ambulance services is essential. Strengthening public-private partnership through 
innovative mechanisms could also help to reduce the load from public facilities.  
A system to trace HIV-positive mothers who default from care should be in place in all health 
facilities. In this regard lessons can be learnt from ART clinics that used active tracing mechanism 
for ART defaulters. 
The Addis Ababa City Administration Health Bureau and the sub-cities must devise context specific 
mechanisms to improve the follow up of PMTCT recommendations among HIV-positive mothers 
and to retain the HIV-positive women in the programme until the follow up is completed.  
Considerations for further training   
The PMTCT training should emphasize:- 
• The need to provide clear information/counselling about the mothers’ right to opt-
out.  
• The need to involve partners in the PMTCT programme with due focus on couple 
counselling irrespective of the mothers HIV test result.  
• Counselling for HIV-positive mothers on medication adherence, safe obstetric care, 
infant follow up and partner involvement in HIV testing.  
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• The issue of intra-partum transfers and the “third delay” and the mothers’ rights to 
appropriate and timely care. 
Considerations for programme monitoring and for research 
The national PMCT report should be used regularly for performance evaluation, to assess changes  
before and after implementation of any recommendations and to assess the impact of the national 
PMTCT programme.  
The Addis Ababa City Administration Health Bureau, the sub-cities Health Bureau and the health 
facilities should utilize the monthly reports to evaluate performance and gaps in service 
provision/utilization.  
Further research is imperative to identify and address challenges to ARV prophylaxis adherence, 
safe obstetric care, infant follow up and partner involvement and challenges to PMTCT programme 
follow up. 
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RESEARCH ARTICLE Open Access
Promising outcomes of a national programme
for the prevention of mother-to-child HIV
transmission in Addis Ababa: a retrospective
study
Alemnesh H Mirkuzie1,2*, Sven Gudmund Hinderaker1, Odd Mørkve1
Abstract
Background: Prevention of Mother-to-Child HIV Transmission (PMTCT) is still the most effective intervention in
combating new HIV infections. In 2008, revised national PMTCT guidelines that incorporated new policies on HIV
counselling and testing, antiretroviral prophylaxis regimen and infant HIV diagnosis came into effect in Ethiopia. In
the present study we have examined trends in PMTCT service utilization and assessed the rate of MTCT in relation
to policy changes in the national PMTCT programme.
Methods: Reports from February 2004 to August 2009 were reviewed in 10 sub-cities in Addis Ababa, Ethiopia.
The data was collected from May to October 2009.
Results: The proportion of women who received HIV counselling and testing among new antenatal care attendees
increased from 50.7% (95% CI 50.2-51.2) in 2007 to 84.5% (95% CI 84.1-84.9) in 2009 following the shift to routine
opt-out testing. Nevertheless, in 2009 only 53.7% of the positive women and 40.7% of their infants received
antiretroviral prophylaxis. The HIV prevalence among antenatal attendees decreased significantly from 10.5% in
2004 to 4.6% in 2009 in parallel to the increased number of women being tested. The HIV positive women were
over 18 times (RR 18.5, p < 0.0001) more likely to be referred for treatment, care and support in 2009 than in 2004.
The proportion of partners tested for HIV decreased by 14% in 2009 compared to 2004, although the absolute
number was increasing year by year. Only 10.6% (95% CI 9.9-11.2) of the HIV positive women completed their
follow up to infant HIV testing. The cumulative probability of HIV infection among babies on single dose
nevirapine regimen who were tested at >=18 months was 15.0% (95% CI 9.8-22.1) in 2007, whereas it was 8.2%
(95% CI 5.55-11.97) among babies on Zidovudine regimen who were tested at >=45 days in 2009.
Conclusion: The paper demonstrates trends in PMTCT service utilization in relation to changing policy. There is marked
improvement in HIV counselling and testing service utilization, especially after the policy shift to routine opt-out testing.
However, despite policy changes, the ARV prophylaxis uptake, the loss to follow up and the partner testing have
remained unchanged across the years. This should be a matter of immediate concern and a topic for further research.
Background
Prevention of mother-to-child HIV transmission
(PMTCT) is still the most effective intervention in com-
bating new HIV infections [1]. When the possibility of
having an efficacious vaccine seems questionable, as
reported in a recent vaccine trial, holding on to PMTCT
programmes gives some hope [2]. PMTCT is a multifa-
ceted intervention. It is not just a way to stop vertical
transmission of HIV but also to provide access to treat-
ment, care and support for women who would other-
wise not get the chance to know their HIV status before
it is too late [1].
Despite its importance, a PMTCT programme often
suffers poor resource allocation that could threaten
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programme success [3]. Globally, the challenges in
PMTCT programme implementation combined with
ever changing scientific advances call for frequent revi-
sits of policies and strategies. In Ethiopia, the first
PMTCT guidelines were developed in 2001, incorporat-
ing early recommendations by the WHO on HIV coun-
selling and testing, ARV prophylaxis regimen, infant
feeding counselling, infant HIV diagnosis algorithm,
partner testing and referring HIV positive pregnant
women for treatment, care and support [4]. During the
recent years, the WHO has made several policy changes
to improve PMTCT programme performance. In 2004,
the HIV counselling and testing policy was shifted from
client initiated opt-in approach to routine opt-out
approach in order to improve women’s access to pre-
vention interventions and to contain HIV testing within
the standard of care for pregnant women [5]. In 2006,
the antiretroviral (ARV) prophylaxis regimen was chan-
ged from short course single dose NVP (sdNVP) to a
more efficacious multidrug zidovudine (ZDV) regimen
[1,6]. The infant feeding recommendation was also
revised in 2006, when exclusive breast feeding became
the preferred method for the first six months, plus com-
plementary feeding from six months. As alternative
feeding method, exclusive formula was recommended if
formula was acceptable, feasible, affordable, sustainable
and safe (AFASS) [7].
The national PMTCT guidelines were revised in 2007,
incorporating the policy changes made by the WHO
from 2004 to 2006, while retaining the early recommen-
dations on partner testing [6]. The revised guidelines
state that all pregnant women undergoing HIV counsel-
ling and testing should be advised to bring their partner
for HIV testing [6]. Partner testing and involvement in
PMTCT is intended to facilitate the women’s coping
with their test results, adherence to PMTCT recommen-
dations and to facilitate disclosure [8]. However, the
potentials of partner testing in PMTCT settings for the
prevention of horizontal transmission of HIV is often
neglected. Orne-Gliemann et al. described that the large
proportion of new HIV infections is occurring in conju-
gal relationship [9]. Studies from southern and eastern
Africa also reported that the prevalence of HIV sero-dis-
cordance is within the range of 36%-85% [3,10]. Preg-
nant women who were HIV negative in early pregnancy
could be at risk of acquiring new infection if they had a
positive partner at home, which in turn would increase
the risk of mother-to-child HIV transmission (MTCT).
In Ethiopia a Monitoring and Evaluation system for
HIV/AIDS (M&E) was first launched in 2003 [11]. The
system was established to support and strengthen evi-
dence based performance monitoring for HIV/AIDS
related interventions [4]. As part of the M&E system,
monthly PMTCT reports have been collected from dif-
ferent service outlets to evaluate the performance of the
national PMTCT programme at facility, sub-city and
region level since the launching of the programme.
However, despite the availability of comprehensive
PMTCT reports the impact of the programme has not
been documented. In this study we make use of the
available monthly PMTCT reports from the launching
of the PMTCT programme in 2004 to August 2009 in
order to examine trends in PMTCT service utilization
and to assess the rate of MTCT in relation to policy
changes.
Methods
A retrospective study was conducted from May to Octo-
ber 2009. PMTCT monthly reports from February 2004
to August 2009 were reviewed in all the 10 sub-cities of
Addis Ababa. The population of Addis Ababa is around
three million, and the city is administratively divided
into 10 sub-cities and 99 Kebeles. In 2007, a total of 30
hospitals, 29 health centres and 442 clinics were provid-
ing health care services [12]. Of the 58 health facilities
offering maternity care services, 81% were providing
PMTCT services. In 2007 alone, over 70,000 pregnant
women who were eligible for PMTCT services were liv-
ing in the city. Over 80% of these pregnant women were
attending antenatal care services, yet only 33.1% of the
deliveries were attended by skilled professionals. Of the
24, 584 pregnant women who received HIV counselling
and testing in 2007, 7.2% were HIV positive [12].
The first national PMTCT guidelines were developed
in 2001 in preparation to launch a PMTCT programme
[4]. In 2004, three years after the development of the
first PMTCT guidelines, a free PMTCT programme was
launched in selected public health facilities [4]. Initially,
only six public health centres were offering PMTCT ser-
vices across the city. The PMTCT programme contin-
ued to expand and from 2007 the programme has been
scaled up to private facilities. As of April 2009, of a total
of 52 facilities offered PMTCT services, 25 of them
being private facilities (unpublished report from Addis
Ababa City Administration Health Bureau). All the
PMTCT facilities were integrated with Antenatal Care
(ANC) service and the majority also provided delivery
services.
For the monitoring and evaluation of HIV prevention
programmes, a M&E system was established in 2003. As
part of the M&E system, the monthly PMTCT reporting
started in February 2004 with Addis Ketema sub-city.
From July 2005, all the sub-cities reported. The PMTCT
reporting format developed by the Ministry of Health
includes output indicators. The format has been distrib-
uted to all service outlets by respective sub-city health
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bureaus. The PMTCT reports were first collected from
the log books at the service outlets and then reported to
the respective sub-cities by the end of each month. In
the sub-cities, the reports from all private and public
facilities were compiled and reported to Addis Ababa
City Administration Health Bureau. In this study we col-
lected the monthly PMTCT reports from the 10 sub-
cities where they compiled data from all service outlets
that started reporting at different times.
The first national PMTCT guidelines was revised in
July 2007 to accommodate changes in policies made by
the WHO from 2004 to 2006 [6]. Until the revised
guidelines came into effect in early 2008, the HIV coun-
selling and testing was offered as an opt-in approach
[13], and sdNVP was given to positive women during
pregnancy and to their infants within 72 hours of birth
[14]. The HIV positive pregnant women were advised to
feed exclusive formula if AFASS; if not, exclusive breast
feeding [15].
According to the revised guidelines, pregnant women
attending ANC should be offered HIV counselling and
testing routinely as an opt-out approach [5,6]. The HIV
positive pregnant women should start ZDV from 28
weeks of gestation plus intrapartum lamivudine and
sdNVP followed by ZDV for seven days postpartum. For
the infant, ZDV and sdNVP should be given at birth fol-
lowed by ZDV for seven days if the mother received
prophylaxis for at least one month, otherwise the infant
should receive ZDV for one month postpartum [1,6,16].
The HIV positive pregnant women should receive infant
feeding counselling in accordance with the 2006 WHO
infant feeding update [6,7]. Moreover, HIV antigen test-
ing of infants with polymerase chain reaction (PCR) at
>= 45 days postpartum replaced the former antibody
testing at >=18 months of age [6]. Nonetheless, early
recommendations on partner testing, irrespective of the
woman’s HIV status, and referring HIV positive preg-
nant women for treatment, care and support remained
unchanged with renewed emphasis in the revised guide-
lines [6].
Data analysis
The reports were entered in Microsoft Excel spreadsheet
and analyzed using Pivotal tables and charts. Prevalence
and Relative risk (RR) were determined and c2 test for
trend was analysed using the Epicalc 2000 software. The
c2 trend tests were used to check whether there was a
linear trend in PMTCT service utilization and HIV pre-
valence across the years and were reported as RR with
associated p-values. The c2 tests for trend change for all
outcome indicators were compared across the years tak-
ing 2004 as the reference time. P-value less than 0.05
was considered significant. Proportions are reported
with 95% confidence intervals.
The following outcome indicators were analysed:
1) The proportion of women who received pre-test
counselling, HIV testing and post-test counselling
among new ANC attendees.
2) The proportion of women who tested positive and
partners who received HIV testing among the total
number of women who tested for HIV.
3) The proportion of women (and babies) who
received ARV prophylaxis, infant feeding counselling
and who were referred for treatment, care and support
among women who tested positive for HIV.
4) The proportion of babies who tested positive
among exposed babies tested for HIV.
Ethical consideration
The study was reviewed and approved by the Regional
Committee for Medical Research Ethics in Western
Norway and the Ethical committee of Addis Ababa
Region Health Bureau in Ethiopia. Study permit from
Addis Ababa Region Health Bureau and respective sub-
cities were obtained.
Results
We obtained 565 PMTCT monthly reports from the 10
sub-cities. In Lideta sub-city three reports were missing
and we collected them from the service outlets instead.
In 6.5% (37) of the reports information on revisiting
ANC attendees was either missing, or new and revisit
attendees were not reported separately.
During February, 2004 to August, 2009, a total of 663
603 pregnant women attended ANC in health facilities
offering PMTCT programme, and 24.6% (163 635) of
them were new attendees. Overall, 135 986 women (new
and revisit ANC attendees) and 4.9% (6 664) of their
partners received HIV testing and 6.2% (8 467) of the
women were HIV positive. Of the tested women, 97.1%
(131 992) received post-test counselling. Among the
HIV positive women, 42.4% (3 594) received ARV pro-
phylaxis, 41.0% (3 474) were referred for treatment, care
and support and 82.8% (7 010) received infant feeding
counselling. Among babies born to the HIV positive
women, 31.0% (2 621) received ARV prophylaxis and
10.6% (896) were tested for HIV (See Additional file 1:
Compiled data from February, 2004 to August, 2009
from the 10 sub-cities).
Trends in HIV counselling and testing
Fig 1 presents the year by year trend in HIV counselling
and testing utilization. The proportion of women who
received pre-test counselling, testing and post-test coun-
selling among new ANC attendees was 66.3% (95% CI
64.8-67.7) in 2004 based on the reports from the three
sub-cities that started reporting in 2004. In 2005, following
the PMTCT programme scale up to the rest of the
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sub-cities, the counselling and testing utilization dropped
to 32.1% (95% CI 31.5-32.7). Although the drop appeared
to be marked in the three sub-cities that started reporting
earlier, those that started later also showed a similar trend.
The poor utilization persisted till 2007 when only 50.7%
(95% CI 50.2-51.2) of the new attendees received HIV
counselling and testing. The PMTCT programme gained
momentum in 2008 when the revised guidelines that
incorporated routine opt-out testing offer came into effect.
Utilization of HIV counselling and testing increased to
84.5% (CI 84.1-84.9) in 2009. The trend in receiving post-
test counselling remained stable at high level across the
years which imply that almost all the tested women col-
lected their HIV test result (Fig 1).
There were variations across the sub-cities in the pro-
portion of women who had not received pre-test coun-
selling or testing. In 2009, one year following the shift
to routine opt-out approach, 12.0%, 18.4%, 19.3%, 14.0%,
14.6% and 27.3% of the women attending ANC in Addis
Ketema, Arada, Bole, Kirkos, Lideta and Nifas Silk Lafto
sub-city, respectively, did not receive pre-test counsel-
ling. Similarly, among women who received pre-test
counselling in 2009, 17.3%, 11.3%, 17.0% and 24.8% in
Arada, Bole, Gulele and Kirkos sub-cities, respectively,
did not receive HIV testing.
HIV testing versus HIV prevalence
Fig 2 presents the overall trends in HIV prevalence
among ANC attendees across the years. The HIV preva-
lence among the total ANC attendees (both new and
revisit) who tested for HIV appeared to decline steadily
from 10.5% (CI 9.6 -11.5) in 2004 to 4.6% (95% CI 4.3 -
4.8) in 2009 (RR 0.46) in parallel with the increasing
number of women testing for HIV. During the same
period the trends in HIV prevalence across the sub-
cities showed significant decline, except Yeka sub-city
where the HIV prevalence actually increased by 17% in
2009 compared to 2004 (RR 1.17, p < 0.05) (Table 1).
ARV Prophylaxis uptake
Of the 8 467 HIV positive women, ARV prophylaxis was
given to 42.4% (95% CI 41.4-43.5) and to 31.0% (95% CI
30.0-31.0) of their infants. From early 2008, the prophy-
laxis regimen was shifted from sdNVP to multidrug ZDV
regimen. Despite the big difference in the two regimens,
the reports did not show marked changes of the trend in
prophylactic ARV uptake. In 2004, the ARV prophylaxis
uptake by the women and infants was low, but the gap in
prophylaxis uptake between the women (24.8%. 95% CI
20.8-29.2) and babies (23.2%. 95% CI 19.3-27.5) was nar-
row. In 2005 and 2006 an increased proportion of
women received prophylaxis, 41.6% (95% CI 39.0-44.3)
and 55.0% (95% CI 52.3-57.4) respectively. In 2006 the
proportion and number of women who received ARV
prophylaxis peaked, yet only 35.1% (95% CI 32.8-37.4) of
their infants received prophylaxis, resulting in the widest
gap in prophylaxis uptake. In 2007, the prophylaxis
uptake by the women and infants dropped to 33.8% (95%
CI 31.6-36.1) and 25.4% (95% CI 23.4-27.5), respectively,
and the gap narrowed again. The prophylaxis uptake
shows an increasing trend since 2008 (Fig 3).
Figure 1 Proportion of women who received pre-test counselling, testing and post-test counselling among new ANC attendees. — In
2004 to 2007 when the HIV testing was offered in an opt-in approach. ___In 2008 and 2009 when the HIV testing was offered routinely in an
opt-out approach.
Figure 2 Trends in HIV prevalence among antenatal care
attendees tested in PMTCT settings from 2004 to 2009 in
Addis Ababa.
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Referral for treatment, care and support
The need for referring HIV positive pregnant women for
treatment, care and support gained momentum in
response to the 2004-2006 national roadmap to acceler-
ate access to antiretroviral therapy [17] and the launch-
ing of the revised PMTCT guidelines [6]. The
proportion of HIV positive pregnant women referred for
treatment, care and support increased from 3.2% (95%
CI 1.9-5.5) in 2004 to 59.9% (95% CI 57.2-62.5) in 2009.
In other words, the HIV positive pregnant women in
2009 were over 18 times more likely to be referred for
treatment, care and support than their counterparts in
2004 (RR 18.5 X2 trend p < 0.0001).
Infant feeding counselling
In 2004, when the PMTCT programme was first
launched, 58.3% (95% CI 53.5-63.0) of the HIV positive
women received infant feeding counselling, compared to
87.3% (95% CI 85.3-89.0) in 2009. The HIV positive
women in 2009 had a 50% more chance to receive
infant feeding counselling than the positive women in
2004 (RR 1.5, c2 trend p < 0.001). Despite the changes
in infant feeding recommendation at different times, the
report lack information on the kind of infant feeding
advice given, infant feeding choice made by the women
or pattern of infant feeding.
HIV infection among exposed babies
Overall, only 10.6% (896) (95% CI 9.9-11.2) of the HIV
positive women completed their follow up to child HIV
testing. The rate of MTCT was evaluated based on the
896 babies tested for HIV during the period 2006-2009.
Among the 896 exposed babies 106 were HIV positive.
Of the babies on sdNVP regimen who tested at >=18
months with rapid antibody test, 14.3% (95% CI 7.92-
24.0) in 2006 and 15.0% (95% CI 9.8-22.1) in 2007 were
HIV positive. In 2009, among babies on the multidrug
ZDV regimen who tested at >=45 days postpartum with
Table 1 HIV prevalence among antenatal care attendees who tested for HIV, relative risk and c2 for trend test across
the years by sub-city
Sub-city 2004 2005 2006 2007 2008 2009 c2 trend
% (n) RR % (n) RR % (n) RR % (n) RR % (n) RR % (n) RR
Addis Ketema 12.8(195) Ref 11.1(168) 0.99 7.4(170) 0.66 7.8(231) 0.70 4.6(178) 0.41 4.7(130) 0.42 127.3 *
Akaki Kaliti 8.7(99) Ref 7.0(131) 0.81 6.8(16) 0.78 4.9(136) 0.57 5.3(113) 0.61 22.3 *
Arada 8.9(134) Ref 8.2(185) 0.92 6.3(159) 0.71 5.9(298) 0.66 3.8(123) 0.43 64.4 *
Bole 8.6(89) Ref 10.0(112) 1.17 6.8(149) 0.79 5.5(158) 0.64 4.8(171) 0.56 3.2(130) 0.37 105.4*
Gulele 6.7(77) Ref 6.6(118) 0.98 5.7(156) 0.84 5.0(136) 0.75 4.5(93) 0.67 12.1**
Kirkos 10.2(89) Ref 9.5(188) 0.93 7.1(162) 0.69 6.8(191) 0.66 4.6(122) 0.44 54.3 *
Kolfe Keraniyo 5.4(67) Ref 4.9(75) 0.91 2.8(70) 0.51 3.3(73) 0.62 3.7(81) 0.69 7.7‡
Lideta 9.6(148) Ref 10.2(244) 1.06 6.8(198) 0.71 5.9(228) 0.62 4.8(246) 0.50 4.6(217) 0.48 119.8*
Nifas-silk Lafto 8.0(175) Ref 7.5(253) 0.93 6.0(232) 0.74 4.6(217) 0.57 4.0(140) 0.49 70.5*
Yeka 7.9(161) Ref 7.6(228) 0.96 8.2(206) 1.03 9.3(268) 1.17 9.2(193) 1.17 6.2‡
Ref = Reference *P < 0.0001 **P < 0,001 ‡P < 0,01 ‡ ‡ P < 0,05 NB: The denominator for each cell is different
Figure 3 Percentage of women and babies who received ARV prophylaxis from 2004 to 2009 in Addis Ababa.
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antigen test using PCR, 8.2% (95% CI 5.55-11.97) were
HIV positive (Fig 4).
Partner testing
The overall trend in the proportion of partners tested
among women who received HIV testing remained stable
at low level i.e 6.4% (95% CI 5.7-7.2) in 2004 and 5.3%
(95% CI 5.0-5.5) in 2009. Compared to the women who
were tested in 2004, women tested in 2009 were 14% less
likely to be tested with their partner (RR 0.86, p < 0.01).
However, there was an increase in the absolute number
of partners tested across the years in parallel with the
increased number of women who tested positive. In 2009
the number of partners tested was higher than the num-
ber of women who tested positive (Fig 5).
Discussion
In this study we examined trends in PMTCT service uti-
lization and assessed the rate of MTCT in Addis Ababa,
Ethiopia. The HIV counselling and testing service utili-
zation improved substantially in 2009 following policy
shift to routine opt-out approach. The HIV prevalence
appeared to decrease steadily paralleling the increased
number of women tested for HIV. Irrespective of policy
changes, the uptake of ARV prophylaxis and loss to fol-
low up remained unimproved. Out of the 10.6% (896)
exposed babies tested for HIV, the cumulative probabil-
ity of HIV infection decreased to 15.0% by 2007 among
babies on sdNVP regimen tested at >=18 months of age,
and to 8.2% by 2009 among infants on ZDV regimen
tested at >=45 days of age. The proportion of HIV posi-
tive pregnant women referred for treatment, care and
support increased eighteen-fold in 2009 compared to
2004. Meanwhile, the proportion of partners tested in
the PMTCT setting declined significantly by 14% from
2004 to 2009.
The proportion of women who received HIV counsel-
ling and testing among new ANC attendees increased
significantly from 50.7% in 2007 to 84.5% in 2009 fol-
lowing the shift to routine opt-out testing. Consistent
with our findings, studies from other resource poor set-
tings have revealed significant improvement in HIV test-
ing at ANC from 45% to 99% following the shift to
routine opt-out approach [18-20]. Nevertheless, over
10% of the new ANC attendees had not received pre-
test counselling or testing in 2009. In this regard the
opt-out approach, which seems to be robust to maxi-
mise HIV testing in many settings [18-20], did not show
remarkable success in our study. This could be attribu-
ted to two major reasons. First, most of the studies that
reported nearly a 100% HIV test acceptance when test-
ing was offered routinely as an opt-out approach, were
pilot initiatives [18-20], unlike our study that compiled
Figure 4 HIV infection among exposed babies tested for HIV
from 2006 to 2009 in Addis Ababa.
Figure 5 Trends in partner testing in the PMTCT settings from 2004 to 2009 in Addis Ababa.
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PMTCT reports from a national programme. In line
with our argument, a study in Kenya based on data
from 43 PMTCT service outlets reported a 80.6% HIV
test acceptance [21]. Second, the expansion of the
PMTCT programme to private facilities seem to have
contributed to the persistence of a large proportion of
women who had not received HIV counselling or testing
even after the shift to routine testing. Site factors are
reported to be more relevant than participant factors in
determining HIV test acceptance in a study from Kenya
[21]. In particular, characteristics of the provider appear
to be an important determinant for HIV test acceptance.
For instance, characteristics of the midwives were found
to be an independent determinant for HIV testing
uptake in England [22], whereas high test refusal was
associated with HIV testing being offered by general
practitioners in Canada [21,23]. In almost all the private
facilities in Addis Ababa, ANC and HIV testing was
offered by physicians who had little or no training on
HIV counselling and testing in an opt-in approach. This
indicates that there are gaps in the implementation of
the routine opt-out testing strategy, particularly in pri-
vate facilities. On top of that, the utilization of post-test
counselling and collection of test result by almost all
tested women throughout the years, irrespective of the
testing approach employed, implies that the persistent
gap in pre-test counselling and HIV testing service utili-
zation could be an evidence of failure of the health sys-
tem to deliver the programme rather than a failure of
the women.
The HIV prevalence among the tested women had
reduced by 54% in 2009 compared to the level in 2004, in
parallel to the increased number of women being tested.
Similar declining trend in HIV prevalence has been
observed among adults and from a sentinel surveillance
report in Ethiopia. Synergy between the natural progres-
sion of the HIV epidemic and behaviour changes among
the general population in terms of increased condom use
and reduced risky sexual behaviour seem to contribute to
the declining prevalence [3,4]. The HIV prevalence esti-
mate in our study was lower than that of the ANC senti-
nel surveillance report, i.e 6.2% vs 9.3% in 2007/2008
[12]. Consistent with our finding, a study that compiled
data from Kenya, Ethiopia, and Zimbabwe for 2005
reported that the HIV prevalence in Ethiopia was 6.4%
from PMTCT programme reports and 8.2% from sentinel
surveillance reports [24-26]. The two reports, although
generated from the same population, have differences in
population size and timing of data collection [24-26].
The PMTCT report includes all women who participated
in the PMTCT programme all year round. In the sentinel
surveillance, leftover blood samples were collected from
a smaller number of ANC attendees from selected facil-
ities, often for a period of 3 months biennially.
The decreasing trend in the HIV prevalence estimate
across the years could also be attributed to a more
representative sample of pregnant women tested for
HIV in our study. In other words, the inclusion of more
service outlets and therefore reaching out to a large
population in our study seems to be more representa-
tive, unlike the sentinel surveillance report that relied
on reports from a few public facilities. Even in the senti-
nel surveillance reports, as the number of sentinel sites
increased the estimated HIV prevalence declined [4].
More importantly we included reports from private
facilities where the HIV prevalence is reported to be
lower compared to ANC attendees in public facilities,
2.4% (unpublished report from Addis Ababa City
Administration Health Bureau) vs 9.3% [12] respectively
in 2007/2008. Moreover, the HIV prevention potential
of Highly Active Antiretroviral Therapy (HAART)
should not be ignored [27].
Despite the marked increase in HIV testing following
the shift to routine opt-out approach, neither the pro-
portion nor the number of women receiving ARV pro-
phylaxis have increased. In 2009, only 53.7% of the
women and 40.7% of their babies received ARV prophy-
laxis. Consistent with our findings, in Addis Ababa,
49.3% of the HIV positive women and 35.3% of their
babies received ARV prophylaxis in 2007/2008 [28] and
the programme achieved only 30% compared to 80% as
the target [12]. Actually, poor ARV prophylaxis uptake
is not a new story, even those intervention studies that
show almost 100% successes in HIV testing were in
short of ARV prophylaxis uptake [18-20]. However, the
lack of improvement in ARV prophylaxis utilization fol-
lowing the shift to routine testing is an issue of great
concern as the shift to an opt-out approach was primar-
ily intended to increase the proportion of women and
infants receiving prophylactic ARV drugs [5]. In the era
of routine testing for HIV, the PMTCT programme
appears to be an effective screening programme than a
prevention programme due to the large number of
dropouts after testing. Yet, the gain in HIV testing turn-
out limits the weakness of the routine opt-out approach
in terms of subsequent dropouts and poor adherence to
ARV prophylaxis [29]. Currently the availability of
potent ARV prophylaxis is changing the landscape, and
even mother-to-child HIV transmission through breast
feeding has become less of a concern [30]. Yet, still
more lives are at stake because of the lack of improve-
ment in uptake of this critical component of the
PMTCT programme.
According to Kasenga et al., skilled attendance at birth
is an important determinant of ARV prophylaxis uptake
that requires thorough consideration [31]. In Addis
Ababa, only 30% of the pregnant women had skilled
attendance at birth in 2008 [12] corresponding to the
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proportion of infants who received ARV prophylaxis
[28]. Since infants are given prophylaxis within 72 hours
of birth at the health facility, infants delivered at home
have less chance to receive ARV prophylaxis than
infants delivered in health facilities. An intervention
study from Zambia gives some hope that dropouts and
non-adherence to ARV prophylaxis could be reduced to
zero. This study, which employed multiple interventions,
increased the ARV prophylaxis uptake from 29% at
baseline to 100% within 3 years [32]. This gives reassur-
ance that the official 80% ARV prophylaxis uptake goal
for Ethiopia could be achieved through concerted effort
and renewed commitment.
According to the findings, an increasing proportion of
HIV-positive pregnant women were referred for treat-
ment, care and support services, from 3.2% in 2004 to
59.9% in 2009. The referral is intended for prompt
initiation of ARV prophylaxis or treatment for eligible
women using CD4 or lymphocyte count and WHO sta-
ging criteria [6]. By doing so, the programme is addres-
sing the most important issues that PMTCT
programmes have been criticized for, i.e the lack of sen-
sitivity to the needs of pregnant women. The PMTCT
programme is increasingly successful in bridging the gap
between prevention and treatment to address the moral
and ethical questions raised over the years [1]. The eigh-
teen-fold increase in the proportion of positive pregnant
women being referred for treatment, care and support
from 2004 to 2009 demonstrates the good will and the
potential to integrate new policies and strategies. Yet,
more has to be done to ensure that all HIV-positive
pregnant women have access to prophylaxis or treat-
ment, care and support.
The ultimate objective of a PMTCT programme is to
avert new HIV infections among children. However,
only 10.6% (896) of the HIV positive pregnant women
completed their follow up to infant HIV testing. The
rates of MTCT were therefore assessed based on test
result of the 896 babies tested for HIV. In the absence
of any PMTCT intervention the cumulative probability
of HIV infection among exposed babies aged >=18
months is in the range of 29% to 47% according to a
cohort study conducted in an orphanage in Addis
Ababa [4]. In our study, the cumulative probability of
HIV infection among exposed babies on sdNVP regimen
tested at >=18 months was 14.3% in 2006 and 14.9% in
2007. According to the HIVNET 012 randomized trial,
sdNVP regimen has a 41% efficacy. In this trial, consis-
tent with our findings, the cumulative probability of
infant HIV infection is 15.7% among breast fed infants
tested at >=18 months [14]. However, a methodologi-
cally similar study from Malawi that compiled monthly
reports showed a 15.5% HIV infection rate among
infants on sdNVP regimen tested at 6 weeks postpartum
without accounting for the breast feeding transmission
[33]. Nevertheless, there is a possibility that our estimate
could be biased due to the large loss to follow up.
In 2009, 8.2% of the exposed infants on ZDV regimen
tested at 45 days were HIV positive. In the Petra clinical
trial, multidrug ZDV regimen showed 63% efficacy in
reducing MTCT. In this trial the rate of HIV transmis-
sion among infants on multidrug ZDV regimen tested at
45 days was 5.7% [16]. Considering the fact that our
data are generated from a national PMTCT programme
and the obvious methodological difference with the
Petra trial, the 8.2% infant infection rate reported in our
study indicates the success of the national PMTCT pro-
gramme among those who completed their follow up to
infant HIV testing. A cohort study from similar resource
poor settings that evaluated the effectiveness of a
PMTCT programme among predominantly formula fed
infants on ZDV regimen tested at >=45 days reported a
9.1% cumulative infant HIV infection, higher than the
rate of HIV infection reported in our study [34]. How-
ever, since the HIV testing was done at >=45 days,
those HIV negative infants who continue to breast feed
are still at risk of acquiring new infection. In general,
the rate of MTCT averted by the national PMTCT pro-
gramme appears promising among those who adhered
to the programme. Nevertheless, the possibility of
underestimation cannot be excluded since we lack infor-
mation on loss to follow up. In line with this limitation,
Ahoua et al. found that the cumulative probability of
infant HIV infection among tested infants was 8.3%,
whereas it was 15.5% when HIV related deaths were
included in the analysis [35].
The last, but not least important PMTCT programme
outcome indicator examined in our study was partner
testing. The proportion of partners tested remained very
low with a 14% significant decline in 2009 compared to
2004. A review on couple centred counselling shows
that partner involvement in HIV testing not only helps
to increase disclosure, condom use and uptake of ARV
prophylaxis but also contributes to the lower rate of ser-
oconversion compared to individual counselling [8]. We
noted a parallel trend in the number of partners tested
with the number of women who tested positive across
the years. This indicates that most of the partners who
came for HIV testing were those whose wives tested
positive. Partner testing in the context of PMTCT
seems to facilitate women’s coping, yet missing out the
important prevention aspect by not advising HIV nega-
tive women to bring their partner for testing.
A study from South Africa shows that 3% of the preg-
nant women who were found to be HIV negative in
their first HIV testing during pregnancy became HIV
positive in repeat test in late pregnancy, giving a 10.7%
incidence per year [36]. This indicates that women are
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at risk to acquire new HIV infection from their HIV
positive partner anytime during pregnancy and even
during breast feeding. In eastern and southern African
region, including Ethiopia, 36-85% of HIV positive indi-
viduals are believed to live with an HIV negative partner
[4,10]. Discordant couples are the newly identified high
risk group in Ethiopia, as most infections are occurring
within marriage. Because of mucosal and hormonal
changes during pregnancy, the HIV incidence is four
times higher among pregnant women compared to their
non-pregnant counterparts [37]. Meanwhile, women
having recent HIV infection are more likely to transmit
HIV infection to their babies [36]. Therefore, it is crucial
to focus on partner testing and involvement in the
PMTCT programme to optimise programme effective-
ness. The current strategies in Addis Ababa, that include
giving priority for women coming with their partner for
testing and sending an invitation home to partner
should be encouraged.
One of the limitations of our study is that the rate of
MTCT was examined based on infants tested for HIV,
which could actually be underestimated due to the large
loss to follow up. Considering the lack of a system to
trace loss to follow up, our finding still highlights the
potentially averted infections. Another limitation is that
the PMTCT programme reached out to only 80% of
pregnant women due to incomplete ANC attendance
[12] and the findings seem not to represent the whole
nation, where a high proportion of the population is
rural. However, since it was generated from a national
programme, lessons learnt herein could benefit the
PMTCT programme across the country. We also believe
that our findings are generalisable to the big cities
where the HIV prevalence is higher.
Retrospective data collected primarily for reporting
purposes always have weakness, especially in resource
poor settings where the quality of reports are often
questionable [11]. By limiting our study objectives to
those indicators that could be calculated from the
reports we minimized the risk of having incomplete
data. We obtained almost all the reports from February
2004 to August 2009 from the 10 sub-cities. To validate
our data we checked Addis Ababa City Administration
Health Bureau and NGO reports, and our data were
found to be consistent. For missing reports we obtained
data from log books and reports at service outlets.
Conclusion
Our findings suggest that the proportion of women
receiving HIV counselling and testing has increased sub-
stantially from 2004 to 2009. The shift in HIV testing
approach has further reduced the proportion of women
not receiving HIV counselling and testing. However, the
lack of improvement in ARV prophylaxis uptake after the
shift to routine opt-out testing is an issue of great con-
cern as the shift was intended to facilitate access to ARV
prophylaxis. The health system appeared not only to fail
to deliver the most critical component of the PMTCT
programme, i.e ARV prophylaxis, but also to retain the
HIV positive women to complete their follow up. The
effectiveness of the national PMTCT programme is ques-
tionable as only 10% of the HIV positive women com-
pleted their follow up to infant HIV testing. A tracing
system for loss to follow up should be in place for mea-
suring the actual impact of the programme. In addition,
the sub-cities and the Addis Ababa city Administration
Health Bureau must devise a mechanism to increase pro-
phylaxis uptake and to retain the HIV positive women in
the programme until the follow up is completed. The
counselling Training should emphasize partner testing to
ensure that all women tested in PMTCT settings receive
counselling on partner testing, irrespective of their HIV
status. Further research is imperative to identify and
address challenges to ARV prophylaxis uptake, partner
testing, referral for treatment, care and support and chal-
lenges to follow up. We recommend the health facilities,
sub-cities and the City Administration Health Bureaus to
utilize the monthly reports to identify gaps in service uti-
lization and to come up with context specific solutions
for the realisation of the country’s goal of “HIV free
generation by 2020”.
Additional material
Additional file 1: Compiled monthly PMTCT reports from February,
2004 to August, 2009 for the 10 Sub-cities in Addis Ababa. The
table containes monthly PMTCT reports from February, 2004 to August
2009 collected from the 10 sub-cities. Addis Ketema, Bole and Lideta
sub-cities started reporting from 2004 while the rest of the sub-cities
reported from 2005.
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Applying the theory of planned behaviour to
explain HIV testing in antenatal settings in Addis
Ababa - a cohort study
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Abstract
Background: To facilitate access to the prevention of mother-to-child HIV transmission (PMTCT) services, HIV
counselling and testing are offered routinely in antenatal care settings. Focusing a cohort of pregnant women
attending public and private antenatal care facilities, this study applied an extended version of the Theory of
Planned Behaviour (TPB) to explain intended- and actual HIV testing.
Methods: A sequential exploratory mixed methods study was conducted in Addis Ababa in 2009. The study
involved first time antenatal attendees from public- and private health care facilities. Three Focus Group
Discussions were conducted to inform the TPB questionnaire. A total of 3033 women completed the baseline TPB
interviews, including attitudes, subjective norms, perceived behavioural control and intention with respect to HIV
testing, whereas 2928 completed actual HIV testing at follow up. Data were analysed using descriptive statistics,
Chi-square tests, Fisher’s Exact tests, Internal consistency reliability, Pearson’s correlation, Linear regression, Logistic
regression and using Epidemiological indices. P-values < 0.05 was considered significant and 95% Confidence
Interval (CI) was used for the odds ratio.
Results: The TPB explained 9.2% and 16.4% of the variance in intention among public- and private health facility
attendees. Intention and perceived barriers explained 2.4% and external variables explained 7% of the total
variance in HIV testing. Positive and negative predictive values of intention were 96% and 6% respectively. Across
both groups, subjective norm explained a substantial amount of variance in intention, followed by attitudes.
Women intended to test for HIV if they perceived social support and anticipated positive consequences following
test performance. Type of counselling did not modify the link between intended and actual HIV testing.
Conclusion: The TPB explained substantial amount of variance in intention to test but was less sufficient in
explaining actual HIV testing. This low explanatory power of TPB was mainly due to the large proportion of low
intenders that ended up being tested contrary to their intention before entering the antenatal clinic. PMTCT
programs should strengthen women’s intention through social approval and information that testing will provide
positive consequences for them. However, women’s rights to opt-out should be emphasized in any attempt to
improve the PMTCT programs.
Background
Behavioural change interventions such as sexual risk
reduction and persistent condom use remain critical
HIV prevention strategies, when finding a cure or vac-
cine against the virus is challenging [1,2]. Being part of
the HIV/AIDS prevention strategy, the prevention of
mother- to-child HIV transmission (PMTCT) pro-
gramme aims to curb vertical transmission of HIV from
mothers to their infants. Arrays of interventions that are
recommended for PMTCT include HIV counselling and
testing, antiretroviral (ARV) prophylaxis, safe obstetric
practices and safe infant feeding counselling [3]. The
HIV counselling and testing intends to screen HIV posi-
tive pregnant women for subsequent PMTCT interven-
tions. Until 2004 HIV testing was offered solely in an
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opt-in approach in resource poor settings. In this
approach the testing is initiated by the client and
assumed to be voluntary. However, due to some social
and structural barriers, acceptability and rate of HIV
testing continued to be suboptimal [4,5]. This prompted
the WHO to call for a shift in HIV testing approach [6].
Subsequently, routine opt-out HIV testing has become
the standard of care for all pregnant women.
Following the implementation of routine opt-out
approach a significant improvement in acceptability has
been reported with rates of testing ranging from 55% to
100% [4,7-9]. There is however some evidence that the
pre-test counselling and the right to opt-out are being
compromised. Studies from Kenya and Uganda showed
that the information about the possibility to opt-out was
not well communicated during the group pre-test coun-
selling [10,11]. Many researchers also argue that most
pregnant women in resource poor settings are less
empowered and are thus less likely to resist the pressure
to comply with the advice given by health professionals
in antenatal settings [11-13]. Some women may also get
tested against their intention not to do so, believing that
testing is a necessary condition to access subsequent
care [12,14]. Several researches concerning routine opt-
out testing are primarily focused on the tension between
increasing the rate of testing and the potential violation
of ethical principles [10,11,13,15-17]. Yet, few studies
have considered this issue using cognitive-behavioural
approach.
According to Jessor (1997), the factors influencing any
behaviour, including HIV related behaviour might be
ordered along a dimension of conceptual proximity to
immediate experience with the particular behaviour
[18]. Distal influencing factors including cultural and
socio-demographics are largely operating through or are
mediated by cognitive processes (proximal determinant)
[19]. Taking this point of departure, the more one
knows about the cognitive influencing factors of a parti-
cular behaviour, the easier it will be to change that
behaviour. Being a theory of the proximal cognitive
determinants of behaviour, the TPB constitutes a pro-
mising theoretical framework for explaining and predict-
ing social behaviours [1] (Figure 1). The theory also
seems to constitute a practical tool for the analysis of
HIV testing behaviour in antenatal settings and for the
identification of barriers and facilitators to change of
behaviour.
The TPB includes perceived behavioural control (PBC)
on a level with attitude and subjective norm as predic-
tors of behavioural intention, implying that the three
predictors influence subsequent behaviour indirectly
through behavioural intention (Figure 1). In turn, inten-
tion is the key proximal predictor of behaviour. Accord-
ing to the TPB, behavioural intention is a function of
attitude, reflecting a favourable or unfavourable evalua-
tion of the particular behaviour and subjective norm.
The subjective norm here is referring the perceived
social pressure to perform the behaviour. Perceived
behavioural control reflects the ease or difficulty asso-
ciated with performance. Attitudes, subjective norms
and perceived behavioural control are underpinned by
behavioural, normative and control beliefs, respectively.
A considerable body of research has confirmed the
power of the TPB to predict intentions and behaviours
across a range of health behaviours [20]. In a meta-analy-
sis, Armitage and Conner (2001) reported that attitude,
subjective norms and PBC accounted for 39% of the var-
iance in intention across 154 applications, whereas inten-
tion and PBC accounted for 27% of the variance in
behaviours across 63 applications [21]. Nevertheless, some
studies have reported the explanatory power of the TPB to
be as low as 13% [21] and 7% [22]. Previously, the TPB has
been used in sub Saharan African settings to predict HIV
preventive behaviours [23-27], mostly in small scaled stu-
dies of cross-sectional design. However, the strength of
the intention-behaviour relationship in the domain of rou-
tine HIV testing using objectively assessed behaviours in
prospective studies still remains to be demonstrated.
Empirical works have shown that variables outside the
TPB can capture a substantial proportions of variance in
explaining intention and behaviour [1,28]. Of these vari-
ables past behaviour and descriptive norms had residual
effects on intention and behaviour after the TPB vari-
ables have been taken into account [26-29]. Descriptive
norm here is referring to women’s perceptions of what
other antenatal attendees (friends, sisters, neighbours...)
do with respect to HIV testing. Focusing a cohort of
pregnant women attending public and private antenatal
care facilities for the first time in their current preg-
nancy, this study set out to explain intended and actual
HIV testing using the extended version of the TPB
Figure 1 Theory of planned behaviour.
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framework. According to the TPB, attitudes, subjective
norms and perceived behavioural control would predict
intended HIV testing, whereas intention and perceived
behavioural control would predict actual HIV testing. It
was proposed further that the external variables in
terms of socio-demographics, descriptive norm, PMTCT
knowledge and previous HIV testing experience would
add to the explanation of intended- and actual HIV test-
ing beyond the TPB variables. Finally, this study exam-
ined whether type of pre-test counselling would modify
the strength of the intention behaviour relationship.
Methods
Study settings
The present study was conducted in Addis Ababa, the
capital of Ethiopia. The city is administratively divided
into 10 sub-cities. The HIV prevalence among adults
(15-24 years) in the city is estimated to be 8.8% were
the majority of the infections occur through hetro-sex-
ual contact [30]. In total 54 health facilities were provid-
ing PMTCT services, where 25 were public health
centres. The health services were fairly accessible with a
median distance to the nearest referral centre being less
than 5 km [31]. About 90% of the pregnant women in
the city had antenatal visit at least once and about 90%
of these attended public health facilities [30,32]. In 2009
alone 54 698 women attended PMTCT programmes
across the city, about 79% received HIV counselling and
testing and 4.6% were HIV positive [33].
The first national PMTCT guidelines were developed in
2001 and incorporated an opt-in HIV counselling and
testing approach [34]. Two years following the develop-
ment of the guidelines, PMTCT programmes were
launched in selected public health facilities across the
country. In 2007, when the PMTCT guidelines were
revised, the HIV testing approach shifted from opt-in to
routine opt-out [35]. From early 2008, the routine opt-out
HIV testing has become the standard of practice in public
health facilities [9]. In these facilities, pregnant women
were offered HIV testing routinely following an individual
or group pre-test counselling free of charge. The PMTCT
counsellors attending these women did the HIV testing in
the antenatal clinics and the test result often made avail-
able in 30 minutes. In private health facilities by contrast,
opt-in HIV testing remained the standard of practice since
the launching of the PMTCT programmes in 2007. In
these facilities, pregnant women received antenatal care by
a medical doctor, and were then referred to another room
for HIV testing. Pregnant women were paying service
charges when they attended private health facilities.
Study design and participants
A sequential exploratory mixed methods study was con-
ducted in January-February, 2009. In this study the
qualitative Focus Group Discussions (FGDs) were fol-
lowed by a prospective cohort study. In a mixed meth-
ods design, one of the study designs could have a
primary role while the other design has a supportive
role [36]. In this study, the cohort was the main design
supported by the FGDs. Data were collected in three
phases. In the first phase, three FGDs were conducted
by the principal investigator in three different health
care facilities among first time antenatal attendees.
Twenty seven women were selected purposefully for the
FGDs. Prior to each FGD all women were explained
about the study aim and consents were inquired. During
the discussions women were first asked about their
demographic and obstetric information then the discus-
sion about HIV testing followed. The questions were
“what factors or circumstances would enable you/make
it difficult for you to test for HIV upon first time
antenatal attendance?”, and “ are there any other issues
that come to mind when you think of HIV testing upon
first time antenatal attendance?”. The participants iden-
tified three potential barriers to HIV testing including
“scared to test”, “concerns about confidentiality” and
“fear of disclosing HIV positive results”. The participants
were also probed as to whether “fear of stigma and/or
discrimination”, “fear of being chased from home in the
case of positive test result” and “fear that they would be
denied of proper care” would affect their decision to
test. Of the probed questions only “fear of discrimina-
tion” was mentioned as a potential barrier to HIV test-
ing. All the potential barriers identified by the
participants were included in the questionnaire and
used to measure the concept of perceived behavioural
control. None of the FGD participants were included in
the subsequent questionnaire interviews.
In the second and the third phase, data were collected
from women attending antenatal care in 12 public
health centres and three private hospitals. A four-to-one
public to private ratio was used in selecting health facil-
ities, considering the fact that over 80% of the pregnant
women in the city received care from public health facil-
ities. Then individual health facilities were selected on
the bases of high client flow and to have representation
of all the 10 sub-cities. The inclusion criteria were
attending antenatal care for the first time in the current
pregnancy, attending selected health facilities, attending
during the study period and consenting to be followed
up. Known HIV positive women were excluded as they
were not eligible for further testing. The study covered
44.3% of the eligible women attending antenatal care
across the city. The cohort used a fixed follow up
period.
In the second phase of data collection, a survey was
conducted using a pre-tested structured TPB question-
naire to measure the concepts of attitudes, subjective
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norms, descriptive norms and behavioural intention.
The questionnaire was first translated into Amharic (the
official language fluently spoken by all participants) then
back translated to English for validation. Two days
training was given to 17 field assistants (college stu-
dents) who participated in pre-testing of the question-
naire under close supervision of the principal
investigator. The questionnaire was administered in a
face-to-face interview in the maternity waiting area
before the women received pre-test counselling. The
interviews were conducted in private while the women
waited for their turn for antenatal check up one after
the other in a quite corner of the waiting areas. For
ethical reasons we used the women’s antenatal number
as a unique identifier in the questionnaire. Completed
questionnaires were then handed to PMTCT counsellors
providing antenatal care and/or PMTCT services at the
end of each day. Among the 3082 women approached,
1.5% (49) refused to participate while 3033 had com-
pleted the questionnaire interviews. Intention to test for
HIV was the intermediate outcome in the second phase.
In the third phase, the follow up data were collected
by the PMTCT counsellors from PMTCT log books.
The PMTCT counsellors were routinely conducting the
HIV testing and registering whether the woman received
pre-test counselling (group or individual), testing, post-
test counselling and the HIV test result in the log
books. These questions were also included in the ques-
tionnaire. The registration was done anonymously using
the women antenatal number as a unique identifier. To
be consistent, these unique identifiers were used in the
questionnaires. Thirty three PMTCT counsellors were
trained for two hours on how to collaborate with the
field assistants and on how to match each questionnaire
with the information obtained from the PMTCT log-
books using the unique identifiers and to report incon-
sistencies. Two hours training were found adequate as
they were the ones who did register HIV counselling
and testing information routinely in logbooks. Further-
more, the principal investigator supervised them when
they obtained follow up information for the first time.
Inconsistencies were validated by crosschecking with the
woman’s antenatal folder. The study team were checking
and collecting the questionnaires every day. Of the 3033
women who completed the TPB interview in the second
phase, 2928 were assessed objectively whether they actu-
ally tested for HIV or not during the follow up (Figure
2). The final outcome measured in this third phase was
actual HIV testing.
The study was reviewed and approved by the Ethical
committee of Addis Ababa City Administration Health
Bureau in Ethiopia and the Regional Committee for
Medical Research Ethics in Western Norway. Study per-
mits from Addis Ababa City Administration Health
Bureau and respective sub cities were obtained.
Informed verbal consent was inquired before each
interview.
Study variables
The second phase structured interview covered demo-
graphic- and obstetric information, PMTCT knowledge,
TPB variables and questions related to previous HIV
testing. The TPB variables were assessed in relation to
testing for HIV upon first time antenatal care atten-
dance. A five point response scale was used (1) ‘very
likely’ to (5) ‘very unlikely’, (1) ‘very certain’ to (5) ‘very
uncertain’ and from (1) ‘strongly agree’ to (5) ‘strongly
disagree’. A sum score was constructed by adding the
items corresponding to each variable. The higher the
score the more positive the attitude, the stronger the
intention, the stronger the subjective norm and the
more barriers perceived with respect to HIV testing.
Intention to test for HIV was assessed using three items;
‘I intend/I plan/I want to test for HIV upon first antena-
tal attendance’. A sum score was constructed by adding
the three items. For use in logistic regression model
later, intention was dichotomized. Women who scored
greater than or equal to the mean score were considered
to have high intention; otherwise they were regarded to
have low intention. Attitude towards HIV testing was
assessed using three items; ‘For me, testing for HIV
upon my first antenatal attendance is beneficial/right
thing to do/bad’. A sum score was constructed by add-
ing the three items. Subjective norm was assessed using
four items; ‘People who are important to me think that
I should test for HIV upon my first antenatal atten-
dance, ‘People who are important to me would appreci-
ate that I tested for HIV...’, ‘My husband agreed that I
should test for HIV ...’ and ‘People who are important
to me encouraged me to test for HIV ...’. A sum score
was constructed by adding the four items. Descriptive
norm was assessed using one item. ‘Women who I
know and who are important to me would themselves
test for HIV upon their first antenatal attendance’. Per-
ceived barrier was assessed using four items; ‘For me to
test for HIV upon first antenatal attendance is difficult
because I feel scared to know the result/I do not want
to disclose my HIV status/I suspected that test result
will not be kept confidential/People may discriminate
me if I found HIV positive’. A sum score was con-
structed by adding the four items. For use in a logistic
regression model later, perceived barrier was dichoto-
mized. Women who scored greater than or equal to the
mean score were considered to have perceived barriers
to test for HIV; otherwise they were considered to have
no perceived barriers.
Previous HIV testing experience was assessed using
two questions, i.e ‘How many times have you been
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tested for HIV?’ and ‘How many times have you been
tested for HIV with your partner’ with a response range
from 0 to more than 3 times. The correlation between
the two measures was less than 0.7. Then we decided
not to combine them into a single score but retain them
as separate measures. For use in logistic regression
model later, previous HIV testing experience was
dichotomized. Women who had HIV testing experience/
with partner were grouped as “Yes"; otherwise they were
regarded as “No”. PMTCT knowledge was assessed
using five questions, ’Have you ever heard about
mother-to-child HIV transmission?’, ‘Can an HIV
infected mother infect her baby with HIV during preg-
nancy/delivery/breast feeding?’ ‘Yes, No and Unsure/I
don’t know’. Women who said yes were categorized as
knowledgeable otherwise not knowledgeable. The fifth
question was about the prevention of MTCT; ‘What
measures do you know for the prevention of mother-to-
child HIV transmission?’. A list of prevention interven-
tions was presented with a possibility to choose more
than one. Accordingly women who chose more than
one interventions were considered knowledgeable;
otherwise not knowledgeable. A sum score was con-
structed from the five items (range 5 to 10). The higher
the score the more knowledgeable the woman is.
The third phase actual HIV testing was assessed
objectively through information obtained from the
PMTCT log books, “What kind of pre-test counselling
offered to the woman (individual or group)?”, “Did the
woman receive HIV testing?”, “ What was the HIV test
result?” and “Did the woman receive post-test
counselling?”.
Statistical analyses
The quantitative data was double entered in excel spread-
sheet and checked for inconsistencies by creating a check
file. Then the data was transferred to SPSS version 17 for
analysis. Descriptive statistics, Pearson Chi Square tests,
were used to describe and to explore baseline differences
in socio-demographic, obstetric and other characteristics
between women attending public- and private health facil-
ities. Fisher’s Exact Tests were used to check baseline dif-
ferences in demographic, obstetric and other
characteristics between women who completed their fol-
low up and those who did not. Internal consistency relia-
bility was conducted using Chronbach’s alpha. Pearson’s
correlation was used to examine bivariate linear relation-
ship between intention and the TPB variables, PMTCT
knowledge, descriptive norms and previous HIV testing
experiences. Multiple linear regression analysis was
applied to explain intention from TPB and external vari-
ables to calculate R2 and b values, separately for women
attending private- and public health care facilities and
separately for each health centre and hospital. Forward
conditional logistic regression analysis was applied to
explain actual HIV testing, to examine the relative contri-
bution of the TPB and external variables and to assess the
fit of the model in terms of Nagelkerke R2 and to control
for potential confounding effect. Despite using a cohort
design, Odds Ratio (OR) was used as an effect measure
taking into consideration the fixed follow up time, little
losses to follow up and the low prevalence of not tasting
for HIV in antenatal settings. “In cohort studies on acute
disease without induction period and a short time of fol-
low up, like outbreaks, the risk of disease can be estimated
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Figure 2 The sequential mixed methods design, the three phases of the study and the study participants in each phase.
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directly using the cumulative incidence given a fixed
cohort with fixed period of follow up and a low fraction
of drop-outs” [37]. Moreover, under rare disease assump-
tion, the OR may be an acceptable approximation of the
risk ratio [38-40]. To examine possible moderation effect
of type of pre-test counselling upon the intention-beha-
viour relationship, a two way interaction term between
intention and type of pre-test counselling was added to
the regression model and tested for statistical signifi-
cance. Sensitivity, specificity and predictive values were
calculated to examine the nature of intention-behaviour
relationship. P-values < 0.05 was considered significant
and for the odds ratio, 95% confidence interval (CI) was
used.
Results
Sample profile
Among the 3082 first time antenatal attendees
approached, 49 (3.5%) refused to participate in the
study, where most of them claimed that they had no
time. A total of 3033 women completed questionnaire
interviews in the second phase of the data collection. Of
these 2928 (96.5%) women completed their follow up to
HIV testing in the third phase. Hundred and five
women did not complete their follow up, 98 were not
given pre-test counselling and 7 did not have complete
information regarding pre-test counselling.
Table 1 depicts the characteristics of the participants
according to type of health care facility attended.
Women attending public facilities were younger than
women attending private facilities. The majority of the
women (38.7%) attending public health care facilities
had education less than 5th grade, whereas 95.7%
women attending private health care facilities had edu-
cation above 9 grade. A total of 73.8% of the women
investigated received group pre-test information. The
majority (77.1%) of the women attending public health
care facilities received group pre-test information,
whereas 80.6% of the women attending private health
care facilities received individual pre-test counselling.
There was no statistically significant difference
between women who completed their follow up and
those lost to follow up with respect to age, education,
knowledge of PMTCT, previous HIV testing experience
and previous HIV testing experience with partner (p >
0.05) (not shown in table).
The TPB variables
Cronbach’s alpha for the TPB constructs ranged from
0.75 for attitude and subjective norm to 0.92 for
Table 1 Frequency distribution of women’s soci-demographic and obstetric characteristics, PMTCT knowledge and HIV
testing experience by public- and private health care facilities
Variable Whole sample
N = 3033
n (%)
Public facilities
n = 2751
n (%)
Private facilities
n = 282
n (%)
P-Value
Age in years < 0.001
15-24 1444(48.4) 1378(50.9) 66(23.8)
> 25 1541(51.6) 1330(49.1) 211(76.2)
Education/grades completed < 0.001
0 - 4 1061(35.1) 1060(38.7) 1(0.4)
5 - 8 857(28.4) 846(30.9) 11(3.9)
> 9 1103(36.5) 834(30.4) 269(95.7)
Number of pregnancies < 0.01
1 1524(50.3) 1357(49.3) 167(59.2)
> 2 1508(49.7) 1393(50.7) 115(40.8)
PMTCT knowledge < 0.001
Knowledgeable 2240(76.5) 1987(75.0) 253(91.0)
Not knowledgeable 687(23.5) 662(25.0) 25(9.0)
Previous HIV testing experience < 0.001
Yes 2450(81.0) 2185(79.7) 265(94.0)
No 575(19.0) 558(20.3) 17(6.0)
Previous HIV testing experience
with partner
< 0.001
Yes 1673(57.2) 1465(55.3) 208(75.6)
No 1250(42.8) 1183(44.7) 67(24.4)
Type of pre-test counselling < 0.001
Group pre-test information 2130(73.8) 2098(77.1) 32(19.4)
Individual counselling 757(26.2) 624(22.9) 133(80.6)
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intention (Table 2). In general, the women attending
both private- and public health care facilities had high
intention, favourable attitude, perceived strong norma-
tive pressure, and perceived less barriers to undertake
HIV testing. There were statistically significant differ-
ences between women attending public- and private
health care facilities across all theoretical constructs
considered (p < 0.01), except for descriptive norms.
Thus, women attending public health care facilities
reported slightly stronger intention, more favourable
attitude and stronger perceived normative pressure to
undergo HIV testing, compared to their counterparts
attending private health care facilities (Table 2).
Explaining intention to test for HIV
The bivariate relationships between intention and the
TPB variables, descriptive norm, PMTCT knowledge,
previous HIV testing were examined using Pearson’s
product-moment correlation coefficient, separately for
public- and private health care facility attendees (Table
3). Intention was significantly and positively associated
with attitude, subjective norm, descriptive norm,
PMTCT knowledge, previous HIV testing experience
and previous HIV testing experience with partner
among public health care facility attendees (the correla-
tion above the diagonal in Table 3). Similarly, intention
was significantly and positively associated with attitude,
subjective norm and descriptive norm among women
attending private health care facility (the correlation
below the diagonal in Table 3). By contrast, intention
was negatively associated with perceived barrier both in
public and private facility attendees, yet the association
was not significant among private facility attendees.
All variables that were statistically significantly asso-
ciated in the bivariate analysis (Table 3) were entered
into the multiple linear hierarchical regression models.
Among women attending public health care facilities,
previous HIV testing experience, previous HIV testing
experience with partner and PMTCT knowledge entered
in the first step accounted for 2.3% of the variance in
intention to test for HIV [ΔR2 = 0.023, F change =
18.90 (3, 2443), p < 0.001]. Previous HIV testing experi-
ence (b = 0.056, p < 0.05) and PMTCT knowledge (b =
0.125, p < 0.001) were significantly associated with
intention. Entering the TPB variables and descriptive
norms in the second step, increased the explained var-
iance with 9.2% [(ΔR2 = 0.092, F change = 63.36 (4,
2439), p < 0,001)]. In the final second step, subjective
norm (b = 0.20, p < 0.001) had the strongest impact fol-
lowed in descending order by attitude (b = 0.14, p <
0.001), PMTCT knowledge (b = 0.093, p < 0.001) and
descriptive norm (b = 0.08, p < 0.001). Among women
attending private health care facilities, PMTCT knowl-
edge (b = 0.08, p > 0.05) entered in the first step
accounted for 2.5% variance in intention [(ΔR2 = 0.025,
F change = 6.74 (1, 261), p < 0.01)]. Entering the TPB
components and descriptive norms in the second step
increased the explained variance with 16.4% [(ΔR2 =
0.164, F change = 13.0 (4, 257), p < 0,001)]. In the final
step, the impact of PMTCT knowledge did not remain
statistically significant. Subjective norm (b = 0.32, p <
0.001) had the strongest impact followed by attitude (b
= 0.125, p < 0.05) (Table 4).
Stratified analyses by PMTCT centre showed that, the
explained variance in intended HIV testing from the
TPB variables and descriptive norm ranged from 7.7%
to 32.5%, whereby attitude, subjective norm and descrip-
tive norm explained most of the variance in intention
(not shown in table).
Explaining HIV testing behaviour
Of the 2928 women who completed their follow up in
phase III, 128 (4.4) did not test for HIV. Table 5 depicts
the adjusted odds ratios and 95% CI for actual HIV test-
ing by intention, perceived barriers and the external
variables. Socio-demographic and obstetric variables,
PMTCT knowledge, previous HIV testing experience
and type of pre-test counselling were entered in a first
step. In the first step, the chi-square was significant (c2
= 40.36 [8], p < 0.001) and explained 7% of the variance
in actual HIV testing according to Nagelkerke R2 (0.07,
p < 0.001). Intention and perceived barrier were entered
in the second step and increased the explained variance
with 2.4%. The full model containing all variables was
statistically significant and explained a total of 9.4% of
the variance in HIV testing (Nagelkerke R2 = 0.094, p <
0.01). In the final model, women who had over 8 grade
of education were less likely to test for HIV compared
Table 2 Descriptive statistics for TPB variables and external variables by public and private health care facility
Construct Whole sample, N = 3033 Public, n = 2554 Private, n = 266 P-value
a Items (Range) Mean SD Mean SD Mean SD
Intention 0.92 3(3-15) 11.1 3.53 11.3 3.50 9.2 3.21 0.000
Attitude 0.75 3(3-15) 13.3 1.43 13.4 1.43 12.3 0.99 0.000
Subjective norm 0.75 4(4-20) 15.1 2.94 15.2 2.98 13.9 2.21 0.000
Descriptive norm 1(1-5) 3.3 1.10 3.3 1.12 3.3 0.88 0.538
Perceived barriers 0.71 4(4-20) 9.2 2.88 9.3 2.97 8.7 1.66 0.002
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to women with lower level of education. Similarly
women who received individual pre-test counselling
were 1.85 times [95% CI (1.14, 3.03)] less likely to test
for HIV compared to women who received group pre-
test information. Moreover, women who had low
intention to test for HIV were 2.4 times [95% CI (1.45,
3.85)] less likely to test for HIV compared to their
high intending counterparts. To check whether type of
pre-test counselling moderated the relationship
between intention and actual HIV testing, an interac-
tion term (intention*type of pre-test counselling) was
entered in a third step, after controlling for all other
variables in the model. This interaction term did not
add significantly to the model (Nagelkerkes R2 = 0.098,
P > 0.05) (Table 5).
Based on cross tabulation of intention and behaviour,
epidemiological indices were calculated to examine the
nature of the intention -behaviour link. As shown in
Table 6, sensitivity was 67% indicating that the majority
of the women who tested for HIV had high intention to
do so. The specificity of 46% indicated that even women
who were not tested had high intention to test. The
positive predictive value was 96% indicating that, high
intention was a strong predictor of being tested for HIV.
The negative predictive value was 6% indicating that,
among the women who had low intention the majority
of them were tested (Table 6).
Discussion
This study applied an extended version of the TPB fra-
mework to explain intended- and actual HIV testing
among pregnant women upon their first time antenatal
care attendance. The cognitive variables and previous
HIV testing experience explained 11.5% and 19% of the
variance in intentions to test for HIV among women
attending public- and private health care facilities,
respectively. As indicated by the significant effect of
PMTCT knowledge upon behavioural intention, the
TPB appeared less sufficient to account for intended
HIV testing in public- than in private health care facility
attendees. Nevertheless, most external variables did not
maintain their statistical significance when the TPB
components were considered, suggesting that the TPB
provided a fairly accurate description of the intention
formation process related to HIV testing in both groups
considered. Compared to recent meta analytical reviews,
suggesting a predictive power of 39% in behavioural
intentions, the present results indicate a fit below the
optimal level [21]. The explained variance in intention
from the TPB variables was also lower than what has
Table 3 Pearson’s correlation between TPB variables and external variables in public and private health care facilities
Variable 1 2 3 4 5 6 7 8
1. Intention 1 0.20(**) 0.27(**) 0.19(**) -0.11(**) 0.13(**) 0.11(**) 0.10(**)
2. Attitude 0.24(**) 1 0.19(**) 0.05(**) -0.15(**) 0.16(**) 0.12(**) 0.07(**)
3. Subjective norm 0.41(**) 0.24(**) 1 0.45(**) -0.14(**) 0.05(*) 0.09(**) 0.10(**)
4. Descriptive norm 0.26(**) 0.11 0.60(**) 1 -0.18(**) 0.05(**) 0.08(**) 0.09(**)
5. Perceived barrier -0.01 -0.03 0.12(*) 0.02 1 0.03 -0.12(**) -0.10(**)
6. PMTCT Knowledge 0.17(**) 0.04 0.20(**) 0.13(*) -0.03 1 0.13(**) 0.08(**)
7. Previous HIV testing experience 0.08 0.04 -0.00 0.05 -0.23(**) 0.18(**) 1 0.56(**)
8. Previous HIV testing experience with partner 0.04 0.04 -0.01 -0.05 -0.17(**) 0.18(**) 0.52(**) 1
**p < 0.001, *p < 0.05 (2 tailed)
NB- The correlation above the diagonal is for public health care facility attendees and the one below the diagonal is for private health care facility attendees.
Table 4 Intention to test for HIV regressed on previous HIV testing, PMTCT knowledge, TPB variables and descriptive
norm
Public facility Private facility
Step Variable b final
Step (Sig)
R2 R2
Change
b final
Step (Sig)
R2 R2
Change
Step I Previous HIV testing experience 0.03(0.14)
Previous HIV testing experience with partner 0.14(0.53)
PMTCT Knowledge 0.09(0.00) 0.08(0.15)
0.023 0.023 0.025 0.025
Step II Attitudes 0.14(0.00) 0.12(0.03)
Subjective norms 0.20(0.00) 0.32(0.00)
Descriptive norm 0.08(0.00) 0.07(0.34)
Perceived barriers -0.04(0.07)
0.115 0.092 0.19 0.164
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been reported in previous studies from non-occidental
settings focusing on voluntary HIV counselling and test-
ing [25], condom use [26] and motivation to learn about
HIV/AIDS [24]. Yet, the present figures compare more
favourably to TPB studies in other behavioural domains
[22,41].
The TPB suggests that changing intentions can be
accomplished by influencing attitudes, subjective norms
and perceived behavioural control. Thus, to design
effective interventions, the relative importance of atti-
tudes, subjective norms and perceived behavioural con-
trol in explaining intention becomes vital [1]. As judged
from the standardized regression coefficients, this study
indicates that the decision to test for HIV upon first
time antenatal care attendance was primarily under the
control of subjective norms and attitudes, whereas
descriptive norms and perceived barriers were less
important. This means that pregnant women decided to
Table 5 Actual HIV testing regressed upon TPB and other variables. OR and 95% CI
Variable Tested for HIV
No
n(%)
Yes
n(%)
Step 1
Nagelkerke
R2 = 0.070
OR (95% CI)
n = 2586
Step 2
Nagelkerke
R2 = 0.094
OR (95% CI)
n = 2586
Age
15-24 53(3.7) 1366(96.3) 1
> 25 72(4.9) 1389(95.1) 0.99 (0.58, 1.70)
Education
0 - 4 21(2.0) 1032(98.0) 1 1
5 - 8 17(2.0) 833(98.0) 1.08(0.47, 2.46) 1.06(0.46, 2.43)
> 9 87(8.6) 926(91.4) 0.28(0.15, 0.53) 0.29(0.15, 0.56)
PMTCT knowledge
Knowledgeable 96(4.5) 2053(95.5) 1
Not knowledgeable 30(4.5) 643(95.5) 0.66(0.38, 1.16)
Number of pregnancies
1 71(4.9) 1385(95.1) 1
> 2 57(3.9) 1414(96.1) 0.94(0.56, 1.58)
Previous HIV testing experience
Yes 106(4.5) 2249(95.5) 1
No 22(3.9) 543(96.1) 0.58(0.28, 1.20)
Previous HIV testing experience
with partner
Yes 83(5.2) 1522(94.8) 1
No 38(3.1) 1176(96.9) 1.38(0.75, 2.56)
Type of pre-test counselling
Individual counselling 36(4.8) 720(95.2) 1 1
Group pre-test information 46(2.2) 2078(97.8) 1.92(1.18,3.12) 1.85(1.14,3.03)
Intention
Low 59(6.0) 925(94.0) 1
High 69(3.5) 1875(96.5) 2.38(1.45,3.85)
Perceived barrier
Yes 27(3.6) 717(96.4) 1
No 101(4.7) 2052(95.3) 1.41(0.83,2.38)
Table 6 Levels of intentions and actual HIV testing with associated values of epidemiological indices
Intention HIV testing Predictive value
Yes No Total Sensitivity Specificity Positive Negative
High 1875 69 1944 67% 46% 96% 6%
Low 925 59 984
Total 2800 128 2928
Mirkuzie et al. BMC Health Services Research 2011, 11:196
http://www.biomedcentral.com/1472-6963/11/196
Page 9 of 12
test for HIV if they perceived a positive normative pres-
sure and if they anticipated more positive than negative
personal consequences following testing. In agreement
with our finding, in a review that evaluated barriers to
HIV testing, perceived benefit of taking an HIV test was
an important HIV test promoting factor [42]. This
appears to imply that educational messages to increase
women’s motivation should target attitudinal beliefs
women hold about the consequences of HIV testing.
Such messages could positively influence their attitudes
towards HIV testing, either by changing the strength of
beliefs or by introducing new beliefs. In addition mes-
sages based on normative pressure might be an effective
way to convince pregnant women to test for HIV. In
previous studies among Tanzanian school teachers and
homeless people in the United States of America, inten-
tions to seek voluntary HIV testing are strongly influ-
enced by attitude and subjective norm [25,43]. In the
Ethiopian context, attitude and subjective norms have
also been identified to be the strongest predictors of
intended condom use among youths [26] and strong
predictors of university students’ motivation to learn
about HIV/AIDS [24]. Moreover, in a meta-analysis of
screening attendance generally, subjective norm
appeared to be a strong predictor of intentions in the
prenatal context. This suggests that decisions made in
this context does not only concern the pregnant
women, but also husband, the unborn child and signifi-
cant others [44]. Thus, interventions to improve uptake
of PMTCT services should target the family as a whole
rather than focusing only on the individual pregnant
women. In this regard partner involvement in HIV test-
ing might be an important strategy to be strengthened
particularly to manage fear of disclosure, one of the sali-
ent barriers identified in the FGDs.
Actual HIV testing was significantly associated with
intention; however this was not the case with perceived
barriers (Table 5). The significant intention-behaviour
link is in accordance with the proposition from the TPB
[1]. Our finding is also consistent with findings from a
review and meta-analysis on screening attendance that
reported intentions to be the strongest predictor of par-
ticipation in screening [1,44,45]. In general, the power
of the TPB in explaining actual HIV testing was weak,
accounting for only 2.4% of the total variance in HIV
testing. Various factors could explain this weak associa-
tion. First, it could be due to the low variability in the
data, where 95.2% of the women being tested. Second,
there could be some shared variances being lost due to
measurement discordance [21], as the TPB variables
were self reported whilst the HIV testing was assessed
objectively. Third, it could be attributed to a more
unstable measure of behavioural intention. Although the
internal consistency reliability of intention was
satisfactory, this is a measure of on the spot reliability.
What is important is that intention might change across
time since events crop up as the time between the
assessment of intention and behaviour increases. In this
study the time interval between measuring intention and
actual HIV testing was short but pre-test counselling/
information offered to participants probably contributed
to a change in women’s initial intention not to test.
Finally, the cognitive determinants seem unable to take
account of the full range of variables that could affect
the behavioural outcome, including routines of the facil-
ities and the asymmetric power relationship between
PMTCT providers and the antenatal attendees.
As demonstrated by the epidemiological indices in
Table 6, a possible reason for the intention behaviour
gap was a large proportion of non-intenders who actu-
ally tested or the very low proportion of true negatives
(only 6%). In a previous study of physical activity, false
positives (inclined abstainers) were identified to be the
most important cause of the gap between intended exer-
cise and actual exercise behaviour [46]. It was also
shown that women who attended individual pre-test
counselling were 1.85 times less likely to test for HIV
compared to women who attended group pre-test infor-
mation (Table 5). Gruskin, et al., (2008) pointed out
that insufficient pre-test information given to women in
a routine opt-out approach is detrimental to ensuring
informed consent as well as to coping with a positive
HIV test. More studies from Sub-Saharan Africa
revealed that the information given to pregnant women
in the group pre-test sessions was inadequate and,
mainly focused on getting the women tested without
enabling them to opt out if they did not intend to test
[10,11,13]. From a practical point of view, the present
analysis suggests that in order to promote HIV testing
at first time antenatal visiting, it will be important to
motivate non-intenders but also to focus on women
who have positive intentions but still do not test for
HIV. In addition it is important to ensure that the fun-
damental principle of informed consent is not violated
and that testing follows an informed choice.
To our knowledge this is the first study that applied
the TPB to explain intention and actual HIV testing in
antenatal care settings. One of the strengths of the
study is the use of mixed methods where the qualitative
FGDs had informed the quantitative questionnaire.
Since all the interviews were conducted at health care
facilities using a face-to-face interview, the possibility of
social desirability bias cannot be excluded. There could
be a possibility of inter-rater variability as we have used
17 field assistants. To minimize the inter-rater variabil-
ity, field assistants having similar educational level were
recruited and trained as a group for two days. In addi-
tion, all field assistants participated in pretesting of the
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questionnaire under close supervision of the principal
investigator. A further strength of the study was that,
the actual HIV testing behaviour of the participants was
obtained objectively from PMTCT log books.
Conclusions
This study has brought a new prospect to optimize the
effectiveness of the routine opt-out HIV testing policy by
focusing upon cognitive determinants of intended and
actual HIV testing in antenatal settings. According to the
findings, pregnant women’s intention to test for HIV
upon first time antenatal care attendance was based on
their normative expectations and the likely consequences
following testing, in that order. Thus, women intended to
test for HIV if they perceived social support, but also if
they anticipated positive consequences accruing from
testing. The TPB variables were less sufficient in predict-
ing actual HIV testing, mainly due to a high proportion
of non- intenders who completed HIV testing. This sug-
gests that in the routine opt-out testing, women’s lack of
intention to test may not matter for the end result. Tai-
lored behaviour change communication might be a way
forward to facilitate informed and voluntary HIV testing
decisions. Attempts aimed at increasing women’s motiva-
tion to test for HIV should strengthen their intention to
do so through informed awareness accompanied with
social approval and strengthened conviction that HIV
testing will provide mostly positive consequences for
them. Women’s rights to opt-out from testing should be
highlighted and sufficient pre-test information provided
to strength PMTCT programs.
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Current status of medication adherence and
infant follow up in the prevention of mother to
child HIV transmission programme in Addis
Ababa: a cohort study
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Abstract
Background: Prevention of mother to child HIV transmission (PMTCT) programmes have great potential to achieve
virtual elimination of perinatal HIV transmission provided that PMTCT recommendations are properly followed. This
study assessed mothers and infants adherence to medication regimen for PMTCT and the proportions of exposed
infants who were followed up in the PMTCT programme.
Methods: A prospective cohort study was conducted among 282 HIV-positive mothers attending 15 health
facilities in Addis Ababa, Ethiopia. Descriptive statistics, bivariate and mulitivariate logistic regression analyses were
done.
Results: Of 282 mothers enrolled in the cohort, 232 (82%, 95% CI 77-86%) initiated medication during pregnancy,
154 (64%) initiated combined zidovudine (ZDV) prophylaxis regimen while 78 (33%) were initiated lifelong
antiretroviral treatment (ART). In total, 171 (60%, 95% CI 55-66%) mothers ingested medication during labour. Of
the 221 live born infants (including two sets of twins), 191 (87%, 95% CI 81-90%) ingested ZDV and single-dose
nevirapine (sdNVP) at birth. Of the 219 live births (twin births were counted once), 148 (68%, 95% CI 61-73%)
mother-infant pairs ingested their medication at birth. Medication ingested by mother-infant pairs at birth was
significantly and independently associated with place of delivery. Mother-infant pairs attended in health facilities at
birth were more likely (OR 6.7 95% CI 2.90-21.65) to ingest their medication than those who were attended at
home. Overall, 189 (86%, 95% CI 80-90%) infants were brought for first pentavalent vaccine and 115 (52%, 95% CI
45-58%) for early infant diagnosis at six-weeks postpartum. Among the infants brought for early diagnosis, 71 (32%,
95% CI 26-39%) had documented HIV test results and six (8.4%) were HIV positive.
Conclusions: We found a progressive decline in medication adherence across the perinatal period. There is a big
gap between mediation initiated during pregnancy and actually ingested by the mother-infant pairs at birth.
Follow up for HIV-exposed infants seem not to be organized and is inconsistent. In order to maximize effectiveness
of the PMTCT programme, the rate of institutional delivery should be increased, the quality of obstetric services
should be improved and missed opportunities to exposed infant follow up should be minimized.
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Background
In 2010, the United Nations reported a declining global
incidence of HIV among children under the age of 15
years [1]. Most of the decline happened in sub-Saharan
Africa where the epidemic is most severe. Among fac-
tors that contributed to the decline, prevention of
mother to child HIV transmission (PMTCT) pro-
grammes were the most significant, according to this
report. Currently, a highly efficacious and safe prophy-
laxis regimen and/or lifelong antiretroviral treatment
(ART) that can reduce mother to child transmission
(MTCT) to less than 5% are made available in many
resource-poor settings [2]. In those settings, however,
ensuring uptake and adherence remains a challenge.
Although prophylactic medication coverage during
pregnancy has improved significantly from 15% in 2005
to 68% in 2009 in east and southern Africa, it is still
lower than the 80% target [1]. Ethiopia is among the
worst-performing countries, with less than 20% prophy-
laxis coverage [3]. There is big gap in initiating medica-
tion during pregnancy and mother-infant pairs ingesting
the medication at birth, largely due to progressive
defaulting that could undermine the efficacy of the med-
ications [4-8]. A low rate of institutional delivery can
largely account for a low rate of prophylaxis ingesting at
birth by the mother and infants since medications are
often available only in health facilities [3,4,9,10].
The other element of PMTCT programmes showing
poor uptake and adherence is follow up of exposed
infants. Globally, only 15% of HIV-exposed infants
access early infant diagnosis [11]. Studies showed that
about 20% of HIV-positive infants die before six months
and 35% to 40% die before 12 months [11,12]. Early
infant diagnosis is a crucial step to facilitate access to
ART, to improve infants’ survival and to evaluate the
effectiveness of PMTCT programmes [11-13].
In the context of PMTCT, most adherence studies
from sub-Saharan Africa focus on a single-dose nevira-
pine regimen while a combined ZDV regimen, despite its
complexities and challenges to adherence, has not been
well documented. Moreover, there is a scarcity of
research in resource-poor settings related to follow up of
exposed infants and the rate of MTCT among exposed
infants in programmatic settings. This prospective cohort
study was conducted in Addis Ababa to assess: 1) adher-
ence to medication regimen among mothers and infants
in a PMTCT programme; 2) the proportion of infants
followed up in the PMTCT programmes; and 3) the rate
of MTCT at six weeks postpartum.
Methods
The study was conducted in Addis Ababa. The city is
the home of about three million culturally and
religiously diverse people, and is administratively divided
into 10 sub-cities with varying population sizes. In 2009,
54 health facilities were providing integrated perinatal
care services, including PMTCT, across the city. Of
these, about half were public health centres. Despite the
proportional distribution of public and private facilities,
the public health centres remained the major providers
of perinatal care services, including PMTCT. In public
facilities, PMTCT services were provided free of charge.
These facilities offered antenatal care to 90% of the
pregnant women, conducted 90% of the institutional
deliveries and managed 80% of the obstetric complica-
tions (unpublished data, collected by Addis Ababa Fis-
tula Hospital, Ethiopian Road Authority and the World
Bank), [14]. Of the 54,698 pregnant mothers who
attended PMTCT programmes across the city, 79% were
tested for HIV and 4.6% were HIV positive [3].
Following HIV-positive diagnoses in antenatal clinics,
HIV-positive mothers were referred to ART clinics in
order to determine their eligibility either for prophylaxis
or lifelong ART. The ART clinics provided several ser-
vices including: 1) collecting blood samples for CD4 cell
and lymphocyte count (the blood sample is then sent to
a central laboratory); 2) initiating lifelong ART for
mothers with CD4 count of 200 cells/mm3 and less;3)
regular monitoring of the mothers’ response to ART
based on CD4 cell/lymphocyte count; 4) providing
adherence counselling using expert patients (HIV-posi-
tive volunteer mothers who were trained on adherence);
and 5) tracing of ART defaulters (lost to follow up).
Mothers with CD4 counts of 200 cells/mm3 or more
initiated combined ZDV prophylaxis in antenatal clinics.
The prophylaxis was initiated at 28 weeks of gestation
to be taken twice daily and required monthly refill. The
antenatal clinics neither provided adherence counsellors
nor traced defaulters. Table 1 shows a summary of the
prophylaxis regimen recommended in the revised
national PMTCT guidelines.
During the intrapartum period, mothers who initiated
prophylaxis were given lamuvudine and sdNVP in addi-
tion to ZDV, while those who initiated lifelong ART
were required to continue their daily doses. Infants were
given ZDV and sdNVP within 72 hours of birth. During
the postpartum period, mothers continued taking ZDV
for seven days. Infants continued taking ZDV syrup for
seven days if their mothers received the medication for
one month or more; otherwise the infants took the
syrup for one month. Postnatal follow up for exposed
infants were recommended at six hours, six days, six
weeks, monthly until six months and then every three
months until 18 months of age (Table 1). During the six
weeks of follow up, the first pentavalent vaccine (hae-
mophilusinfluenzae type B, diphtheria, pertussis, tetanus
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and hepatitis B) and early infant HIV testing were done.
The HIV testing was done in a central laboratory using
PCR from DBS, which took a minimum of one month.
The study was a health facility-based prospective
cohort conducted from January to December 2009 in 12
public health centres and three private hospitals in
Addis Ababa. A four-to-one public-to-private ratio was
used in selecting health facilities, considering that more
than 80% of the pregnant mothers in the city initiated
care from public health facilities. Then individual health
facilities were selected on the basis of high client flow
and to provide representation of all the 10 sub-cities.
In 2009 alone, 1976 pregnant mothers were diagnosed
as HIV positive in PMTCT programmes across the city.
Of these, approximately 25% were diagnosed in the first
quarter of 2009 (January to March) and were eligible for
the study taking into consideration the time required for
a baby to be six weeks old by completion of the study.
Of the 479 mothers diagnosed from January to March
across the city and who were eligible for the study, 282
were attending those health facilities selected for our
study, and all consented to be followed up (Figure 1).
The study was reviewed and approved by the Ethical
Committee of Addis Ababa City Administration Health
Bureau in Ethiopia, as well as the Regional Committee
for Medical Research Ethics in Western Norway. Study
permits from the Addis Ababa City Administration
Health Bureau and the respective sub-cities were
obtained.
A semi-structured follow-up format was developed in
English for data collection. Most of the variables in the
format were obtained from PMTCT and exposed infant
logbooks and the national PMTCT guidelines, although
some were added from reviewed literatures. The inclu-
sion of routinely recorded variables was considered to
minimize incomplete information in the case of loss to
follow up; it also ensured data quality as the recruited
data collectors had experience in doing routine record-
ing. Thirty-three PMTCT counsellors working in
antenatal clinics were recruited to collect the data. They
were offered half-day training on the follow-up format
and on how to do the follow up. Data were collected
Table 1 Medication regimens and infant follow up schedules in the 2007 revised national PMTCT guidelines
Antepartum Intrapartum Postpartum
Mother
If CD4 ≥200 cells/mm3; ZDV from
28 weeks of gestation
If CD4 < 200 cells/mm3; ART
Mother
ZDV + lamuvudine + single-dose
nevirapine
ART
Infant
ZDV + single-dose nevirapine
Mother
ZDV + lamuvudine for seven days
ART
Infant
ZDV for 7 days if mother receives the medication ≥ 4 weeks
ZDV for 1 month if mother receives the medication < 4
weeks
Six-hours follow up
• Routine early postpartum services for
mothers and their infants
• Infant feeding counselling
Six-days follow-up service
• Routine postpartum care for mothers and infants
• Infant feeding counselling
Six-weeks follow up services
• Routine postpartum care
• Early infant HIV diagnosis using polymerase chain reaction
(PCR) from dried blood spot (DBS)
• Cotrimoxazole for infants receiving breast milk for
opportunistic infections
• Infant feeding counselling
• First pentavalent vaccine and other routine child health
services
282 women enrolled  
from 15 facilities  50 mothers did not initiate 
medication during pregnancy  
 
11 abortions, two maternal deaths 
5 changed health facilities, 
13 changed addresses 
85 mother-infant pairs did  
not ingest medication at birth 
 
61 mothers 
42 infants (9 stillbirths)  
232 initiated medication   
during pregnancy  
148 mother-infant pairs ingested   
medication at birth 
71 infants had documented  
HIV test result  
115 infants brought for  
six-week follow up   
479 eligible women  
across the city   
Figure 1 Study cohort.
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anonymously using the women’s antenatal numbers as
their unique identifiers for ethical reasons.
At enrolment, mothers were interviewed on socio-
demographic variables, date of HIV testing and gesta-
tional age at enrolment. Follow up data were obtained
from the mothers themselves and from logbooks in the
facilities. The follow-up schedules of the cohort coin-
cided with the women’s regular perinatal visits, i.e., at
28 weeks, 36 weeks, at delivery, six days postpartum and
six weeks postpartum. The follow-up data at the 28-
week visits were CD4 cell count, whether medication
was initiated or not, gestational age medication initiated,
type of medication initiated (prophylaxis or lifelong
ART), disclosing HIV status to partner, and partner
involvement in HIV counselling and testing.
At 36 weeks gestation, adherence to medication was
assessed using a one-week recall period. Follow-up data
at delivery were place of delivery, mode of delivery,
mother prophylaxis during labour, infant sex, infant
birth weight, infant status at birth, and infant prophy-
laxis at birth. For mothers who were transferred to
other health facilities and for those who gave birth at
home, these data were collected when they came for
their six-day and six-week postpartum care visits. The
follow-up data at six weeks postpartum were about the
type of infant feeding practices, first pentavalent vacci-
nation, whether infants were brought in for early infant
diagnosis or not, and whether dried blood spot was
taken or not. Infant HIV test results were collected from
the facilities a minimum of one month following collec-
tions of dried blood spot. Study participants were given
a small incentive (about US$2) for transport at each
visit.
The main study outcomes were the proportions of: 1)
mothers initiating medication during pregnancy; 2)
mother-infant pairs ingesting medication at birth; 3)
infants brought for early infant diagnosis at six weeks
postpartum; and 4) infants tested positive at six weeks
postpartum. In this study, the term, “initiate”, implies
the receiving of medication during pregnancy, and
“ingest” implies actual swallowing of the drug observed
by health professionals or mothers’ self reports at birth.
“Adherence” implied documented or self-reported initi-
ating/ingesting of the medications and bringing infants
for six-week follow up. Analyzing medication initiated
by the mothers during pregnancy, we used abortion and
death of a mother as study endpoints. Analyzing medi-
cation ingested by mother-infant pairs at birth, we used
abortion, death of a mother and stillbirth as study
endpoints.
The data were double entered in Microsoft Excel and
checked for consistencies and then transferred to SPSS
version 17 for analysis. Descriptive statistics, bivariate
and multivariate logistic regression analyses were done.
Variables with p values of less than 0.2 in bivariate ana-
lysis were included in the multivariate model to control
for potential confounding effects. A p value < 0.05 was
considered significant and a 95% confidence interval
(CI) was used. The proportions of mothers who initiated
medication during pregnancy were calculated among
those who were enrolled into the study. The proportions
of mother-infant pairs ingesting medication at birth
were calculated from live births, and twin births were
counted once. The proportions of infants brought for
early infant diagnosis at six weeks were calculated from
the total live births. The rate of MTCT was calculated
among infants with documented HIV test result.
Results
The cohort enrolled a total of 282 HIV-positive preg-
nant women. Of these, 11 mothers had abortions, two
were transferred out, and two died (one while pregnant
and the other one after birth). In total, 217 mothers had
live births of single infants and two mothers had live
birth of twins (Figure 1).
Table 2 shows the demographic and obstetric charac-
teristics of the mothers enrolled in the study. The med-
ian age of the mothers was 25 years and the median
schooling completed was Grade 7. The majority of the
mothers were pregnant for the second time. The median
gestational age during enrolment was 21 weeks. The
mothers had a median CD4 count of 310 cells/mm3. In
total, 160 (57%) disclosed their HIV-positive status to
their partners, 82 partners were involved in HIV coun-
selling and testing, 109 partners reported to be tested,
and 75 (69%) partners were HIV positive. By six weeks
postpartum, 151 (74%) infants were receiving exclusive
breastfeeding, 49 (24%) were receiving exclusive formula
feeding, and four (2%) were receiving mixed feeding.
Of the 282 mothers enrolled, 232 (82%, 95% CI 77-
86%) initiated medication during pregnancy. Of these,
154 (64%) initiated ZDV prophylaxis and 78 (33%) life-
long ART, while 50 (17.7%) did not initiate any medica-
tion during pregnancy. Among the 50 mothers who did
not initiate medication, seven (14%) actively refused the
medication prescriptions and 11 (22%) had abortions,
five changed health facilities, 13 changed their addresses,
two were transferred out, two died, and no reasons were
given for 10 mothers. The changes in health facilities
and addresses were common among mothers who got
to know their HIV status for the first time. These
mothers often went to other health facilities to confirm
their HIV status and to follow PMTCT programme
where they would not be recognized. Two mothers were
found registered in two health facilities with the inten-
tion of obtaining support from both places.
A total of 109 mothers with documented gestation at
medication initiation had come for collecting more of
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their medication at 36 weeks. These women were
assessed for adherence to prescribed medication using a
one-week recall period. Adherence to medication was
not significantly different between mothers who initiated
prophylaxis and those who initiated lifelong ART (p >
0.05). Of the 77 mothers who initiated ZDV prophylaxis,
55 (68%) never missed a dose, 16 (20%) missed one
dose, and 10 (12%) missed more than one dose. Of the
28 mothers who initiated ART, 17 (61%) never missed a
dose, six (21%) missed one dose and five (18%) missed
more than one dose. No significant associations were
observed between receiving medication during preg-
nancy and socio-demographic and obstetric variables,
CD4 cell count, gestational age at enrolment, disclosing
HIV status to partner, partner’s involvement in HIV
counselling and testing, partner’s HIV testing and part-
ner’s HIV test result (p > 0.05).
Out of the 282 enrolled mothers, 171 (60%, 95% CI
55-66%) had ingested medication during labour. Among
mothers who initiated medication during pregnancy 26%
did not ingest any medication during labour. In total,
228 mothers were reported to have given birth: 211
(92%) did this at health facilities and 17 (8%) at home.
Mothers who gave birth at health facilities were more
likely to ingest their medication (77%) than mothers
who gave birth at home (53%) (OR 2.94, 95% CI 1.08-
8.02). Of the 221 infants born alive (including the two
sets of twins), 191 (87%, 95% CI 81-90%) ingested medi-
cation at birth.
There was a strong association between medication
ingested by the mothers and infants at birth and place
of delivery. Infants who were delivered at heath facilities
were more likely (OR 13.64, 95% CI 4.64-40.12%) to
ingest their medication at birth than those who deliv-
ered at home. There was no significant association
between mother and infant ingesting medication and
demographic variables, obstetric variables, CD4 cell
count at enrolment, disclosing HIV status to partner
and partner being involved in HIV counselling and test-
ing (p > 0.05).
Of the 219 live births (twin births were counted once),
148 (68%, 95% CI 61-73%) mother-infant pairs ingested
the medication at birth. Ingesting the medication by the
mother-infant pairs was not significantly associated with
education, age, number of pregnancies, gestational age
at enrolment, CD4 cell count at enrolment, mode of
delivery and disclosing HIV status to partner (Table 3).
The likelihood of mother-infant pairs ingesting the med-
ication was much higher among those who had facility
birth than home birth (OR 6.7, 95% CI 2.90-21.65).
Staff turnover happened in nine of the 15 (60%) study
sites, and those counsellors who were initially recruited
were replaced by other counsellors. In all, 174 mothers
attended facilities that experienced staff turnover, where
49% of the mother-infant pairs did not ingest their med-
ication at birth. Among the 108 mothers who attended
those facilities experiencing no staff turnover, 57% of
mother-infant pairs had ingested their medication at
birth (p > 0.05).
Among the 221 live births, 189 (86%, 95% CI 80-90%)
infants were brought for their first pentavalent vaccine
(haemophilusinfluenzae type B, diphtheria, pertussis,
tetanus and hepatitis B) and 115 (52%, 95% CI 45-58%)
for early infant diagnosis at six weeks postpartum.
Among the infants brought for early infant diagnosis,
Table 2 Socio-demographic and obstetric characteristics
of 282 mothers enrolled into the study
Variable N = 282
n(%)
Age in years
15-24 99(35.6)
25-29 111(39.9)
> 30 68(24.5)
Median (IQR) 25(23-29)
Education (grades completed)
0-4 87(31.8)
5-8 98(35.8)
≥ 9 89(32.5)
Median (IQR) 7(3-10)
Number of pregnancies
First 92(33.1)
Second 101(36.3)
Three or more 85(30.6)
Median (IQR) 2(1-3)
Gestational age at enrolment
< 28 weeks 150(65.8)
≥28 weeks 78(34.2)
Median (IQR) 21(16-28)
CD4 cell count/mm3
< 200 47(26.3)
200-349 55(30.7)
> 349 77(43.0)
Median (IQR) 310(216-433)
Disclosed HIV status to partner
Yes 160(83.8)
No 31(16.2)
Partners involved in HIV
counselling and testing
Yes 82(37.6)
No 136(62.4)
Partners tested for HIV
Yes 109(49.8)
No 110(50.2)
Partners HIV test result
Positive 75(68.8)
Negative 34(31.2)
Due to missing values, the numbers may not add up to the total
Mirkuzie et al. Journal of the International AIDS Society 2011, 14:50
http://www.jiasociety.org/content/14/1/50
Page 5 of 10
only 71 (32%, 95% CI 26-38%) had documented HIV
test results and six (8.4%, 95% CI 4-17%) were HIV
positive. The major reasons for not having documented
HIV test results were: DBS not collected from infants
due to lack of trained staff; DBS tests done, but results
not collected from central laboratory doing the PCR
test; and misplacing of the test results at the facilities.
No significant differences were observed among infants
receiving different feeding modalities with respect to
MTCT. Four infants (8.2%) were HIV positive among 49
infants who received exclusive breastfeeding, two (9.5%)
among 21 infants who received exclusive formula feed-
ing, and none among two infants who received mixed
feeding.
Discussion
The PMTCT programme has great potential to achieve
virtual elimination of MTCT provided that the
recommended interventions are properly followed. Our
study showed progressive and marked decline in medi-
cation adherence across the perinatal period. Although
82% of the mothers initiated medication during preg-
nancy, only 68% of the mother-infant pairs ingested the
medication at birth. There were unnecessary missed
opportunities in exposed infants follow up within the
healthcare system. By six weeks postpartum, 86% of the
infants received their first pentavalent vaccines, but only
53% were brought for early infant diagnosis. These chal-
lenges could seriously undermine the effectiveness of
the PMTCT programme, and need thorough
consideration.
We found that more than 80% of the mothers initiated
medication during pregnancy. This finding compares
favourably with several empirical works from Ethiopia
and other sub-Sahara African countries [4,9,10,15]. It is
also in accordance with the 80% target set by the Joint
Table 3 Bivariate and multivariate associations between mother-infant pairs’ non adherence to medication at birth
and potential determinants
Variable Mother-infant pairs ingested
medication at birth
Unadjusted
OR (95% CI)
Adjusted
OR (95% CI)
Yes
n(%)
No
n(%)
Age in years
15-24 48(63.2) 28(36.8) 1
25-29 60(69.8) 26(30.2) 1.35(0.64-2.85)
≥ 30 37(69.8) 16(30.2) 1.0(0.48-2.11)
Education (grade completed)
0-4 38(62.3) 23(37.7) 1
5-8 55(70.5) 23(29.5) 0.69(0.34-1.41)
≥9 54(73.0) 20(27.0) 0.61(0.30-1.27)
Number of pregnancies
First 48(69.6) 21(30.4) 1 1
Second 59(73.8) 21(26.3) 0.81(0.40-1.66) 0.60(0.27-1.34)
Three or more 39(58.2) 28(41.8) 1.64(0.81-3.32) 1.34(0.62-2.87)
Gestational age at enrolment
< 28 weeks 78(64.5) 43(35.5) 1
≥ 28 weeks 47(71.2) 19(28.8) 0.7(0.38-1.40)
CD4 cell count/mm3
≥ 350 49(75.4) 16(24.6) 1
200-349 31(67.4) 15(32.6) 2.08(0.90-4.80)
< 200 25(59.5) 17(40.5) 1.48(0.64-3.42)
Disclosed to partner
Yes 110(71.9) 43(28.1) 1
No 19(63.3) 11(36.7) 1.48(0.65-3.37)
Medication initiated
ZDV prophylaxis 101(74.8) 34(25.2) 1 1
Lifelong ART 45(63.4) 26(36.6) 1.72(.92-3.19) 1.85(0.96-3.56)
Place of delivery
Health facility 143(70.8) 59(29.2) 1 1
Home 5(29.4) 12(70.6) 5.82(1.96-17.24) 6.72(2.90-21.65)
Due to missing values, the numbers may not add up to the total
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United Nations Programme on HIV/AIDS and the
World Health Organization to offer prophylactic medi-
cation for pregnant mothers in order to halve the
MTCT by the year 2015 [16]. Although the proportion
of mothers who initiated medication during pregnancy
reached the 80% target, only two-thirds of the mother-
infant pairs had ingested their medication at birth.
In a large-scale cross-sectional study conducted in
four African countries, similar gaps are reported.
Among 3196 HIV-positive mothers who gave birth,
2278 (71%) initiated nevirapine during pregnancy while
only 1725 (54%) mother-infant pairs had actually taken
it when checked for cord blood [15]. By contrast, a clini-
cal trial conducted in Zambia and a study from Bots-
wana reported a more than 90% level of adherence to
prophylactic medications [10]. These differences could
be attributed to better coverage and quality of intrapar-
tum obstetric care services. In Botswana, 97% of preg-
nant mothers have access to antenatal care and 94% to
safe institutional delivery whereas in Addis Ababa, 90%
mothers have access to antenatal care, but only 44%
have access to safe institutional delivery [17].
In line with this argument, institutional delivery was a
significant determinant of mother-infant pairs ingesting
medication at birth in our study. It also reflects the
situation in Ethiopia where infant prophylaxis is avail-
able only at health facilities, and infants delivered at
home have less chance to get medications unless they
are brought to health facilities by their parents. Other
researchers have also reported the place of delivery to
be an important and significant predictor of ingesting
medication at birth [9,10].
Nevertheless, 23% of the mothers did not ingest any
medication at birth despite giving birth at health facil-
ities. This could indicate possible failure within the
healthcare system that put the mothers and their infants
at increased risk of MTCT. Staff turnover happened in
60% of the antenatal clinics included in our study, and
there is little reason to think that the turnover in labour
wards is different. There was higher proportion of non-
adherence among those who attended facilities that
experienced staff turnover than those who did not
attend these facilities, although this difference was not
statistically significant. High staff turnover and frequent
rotation can create a gap filled by less experienced staff
with little or no training in PMTCT/ART. Poor knowl-
edge of PMTCT/ART by staff in delivery wards could
possibly reduce mothers’ and infants’ chance of getting
appropriate and timely medications.
Contrary to what is reported by Stringer and collea-
gues, mother-infant pairs’ medication adherence was
lower among the group that initiated lifelong ART than
those who initiated ZDV prophylaxis [15]. At 36 weeks
gestation, more mothers who initiated prophylaxis
reported that they had never missed medication in the
past week compared with those who initiated lifelong
ART. This contrasted with what had been observed in
most ART clinics, where they were providing adherence
counselling using expert clients, regular follow up, and
monitoring and tracing of treatment defaulters.
Studies have also shown that adherence counselling
and active tracing mechanisms can improve adherence
and treatment outcomes, and can also reduce loss to
follow up [18,19]. Alternatively, poor adherence among
mothers’ who initiated lifelong ART could be a reflec-
tion of their poor health status. Sick mothers may not
able to get to the health facilities to collect medication
for themselves, as well as for their infants. As shown in
Table 3, among the group who did not adhere to
mother-infant pair medication, 40% of the mothers had
CD4 counts of 200 cells/mm3 or less. This is consistent
with a review and research in Ethiopia where a low CD4
cell count is reported to be a significant marker of poor
immune status and disease progression [20,21].
Due to the gaps in receiving medication during preg-
nancy and actual ingesting of the drug by the mother-
infant pairs at birth, PMTCT programme effectiveness
could be undermined. Compromised efficacy of prophy-
laxis regimens are reported when the drugs are taken
either by the mothers or their infants only. In a double-
blind, randomized, placebo-controlled trial conducted in
South Africa, Uganda and Tanzania, the rate of MTCT
was 8.9% in the group where mothers and infants
initiated the intrapartum and postpartum prophylaxis
doses, whereas it was 14.2% in the group where
mothers, but not their infants, initiated the intrapartum
dose [7,8]. Moreover, the proportion of mothers’ receiv-
ing medication during pregnancy is a proxy indicator
currently used for measuring PMTCT programme suc-
cess; hence the gaps could threaten the validity of this
indictor. Particularly in resource-poor settings where
there are marked gaps in antenatal care and institutional
delivery coverage, this indicator could overestimate
PMTCT programme effectiveness. Careful consideration
is required in using “the proportion of mothers’ receiv-
ing medication during pregnancy” as the indicator of
PMTCT programme success in these settings.
Our findings suggest that exposed infant follow up
was inconsistent and poorly organized, which could
negatively impact the success of the PMTCT pro-
gramme. The 2007 revised PMTC guidelines clearly sta-
ted the need for integrated and comprehensive follow-
up services for exposed infants [22]. Despite immuniza-
tion coverage of more than 80% among the HIV-
exposed infants, slightly more than 50% of them
attended infant follow up at six weeks and less than
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one-third had documented HIV test result. This shows
lack of integration of HIV care with the under-five child
health clinics leading to avoidable missed opportunities.
Consistent with our findings, only 25% of exposed
infants were tested for HIV in Mozambique [23]; in
Kenya, among 2477 exposed infants, only 40% were
tested [5]; and only 59% of babies were tested in Zim-
babwe by the age of 15 months [24]. This implies that
large missed opportunities are occurring within the
health system despite having clear guidelines. In the
majority of health facilities, the infant follow-up services
were scattered over at least at six service points and
were available only two or three days in a week. In a
study by Nyandiko and colleagues, the health system
was shown to be responsible for the low rate of infant
HIV testing [25]. The missed opportunities in infant
diagnosis can also delay HIV-positive infants from
accessing timely treatment, which is detrimental to their
survival [11,13,26]. Therefore, creating integrated strate-
gies to contain the necessary procedures pertinent to
exposed infant follow up at one single point within the
existing under-five child health clinic could be a way
forward for a successful PMTCT programme.
The majority of infants were receiving exclusive
breastfeeding and were tested for HIV at six weeks post-
partum. The rate of MTCT was 8.4%, which is consis-
tent with the reported rate from a similar study
undertaken in Addis Ababa [4]. By contrast, lower rates
of MTCT were reported from outside of Ethiopia, 5.7%
in the Petra clinical trial and 4.7% in a cohort study for
Abidjan among predominantly exclusive breastfed
infants tested at six weeks postpartum, but there is an
overlap in the confidence intervals [6,7]. The rate of
MTCT observed in our study seems to be encouraging
compared with the 15-25% MTCT expected at six
weeks in the absence of any interventions [27]. None-
theless, the MTCT reported in our study could be
underestimated primarily due to the large proportions
of potential non-adherence to medication among the
lost-to-follow-up cases.
Secondly, the HIV testing was done at six weeks post-
partum and did not account for possible MTCT through
breastfeeding. To get further reduction in MTCT among
breastfed infants, the 2010 revised guidelines advocates
for continuation of mothers’ or their infants’ medication
throughout the breastfeeding period [28]. In this regard,
continuous adherence support for extended period can
be extremely impotent. This calls for tailored follow-up
services integrated into existing maternal and child
health programmes with a clear sense of ownership and
accountability from staff involved in the care.
One of the limitations of our study is that the rate of
MTCT was calculated among infants who completed
their follow up to six weeks. This could result in
overestimation of the effectiveness the PMTCT pro-
gramme and also threaten the external validity of the
study. Attempts were made to minimize the non-adher-
ence using existing defaulter tracers. Moreover, a quali-
tative account of mothers’ perspectives would have
added to the explanation for the loss to follow up.
Although the study was conducted as part of a national
PMTCT programme and the levels of non-adherence
were not different from PMTCT programmes in many
sub-Saharan African settings [4,5,23,25,29,30], care
should be exercised in generalizing the study findings.
Another limitation is that the internal validity of the
study could be affected due to employing several data
collectors, but we sought to minimize this risk through
the following steps:1) the data collectors were all
PMTCT counsellors, who were well acquainted with the
issue under study; 2) almost all the variables in the fol-
low-up format were drawn from log books in the facil-
ities used to record routine activities; and 3) all the data
collectors were given training.
So far, few cross-sectional studies have reported pro-
phylactic medication coverage in Ethiopia. Our research
is the first prospective cohort that has estimated level of
non-adherence to PMTCT recommendations and
averted infections among HIV-exposed infants. The fol-
low up helped us to identify critical points that many
clients are failing in PMTCT programmes.
Conclusions
Despite the large proportion of mothers initiating medi-
cation during pregnancy, the majority of them and their
infants did not actually ingest the drugs according to
the recommendations at birth. This could challenge the
overall effectiveness of the national PMTCT programme.
The proportion of mother-infant pairs ingesting medica-
tion at birth seems to be a more reliable indicator for
PMTCT programme planning and evaluation compared
with the proxy indicator currently used (i.e., the propor-
tion of mothers receiving medication during pregnancy).
Increasing access to quality intrapartum obstetric care
services seems to be fundamental to increasing adher-
ence to the recommended medication at birth to reduce
MTCT. The focus should also be on increasing the
women’s awareness on high level adherence to medica-
tion regimen for optimal result and removing barriers to
institutional delivery.
Meanwhile, facilitating access to medication in the
case of home deliveries should also be focused on. Ser-
vices pertinent to follow up of exposed infants seem to
be inconsistent and undeveloped, and might contribute
significantly to avoidable missed opportunities and nega-
tively impact the survival of HIV infected infants. Creat-
ing a system to contain the necessary procedures for
follow up of exposed infants at a single service point
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should be considered. Targeted interventions should be
developed specifically for HIV-exposed infants within
the PMTCT package, which should be integrated within
the existing traditional under-five child health services
to ensure continuity of care for these children.
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Despite the importance of safe obstetric practice in reducing mother-to-child HIV transmission and 
adverse perinatal outcomes, little is known about access to intrapartum obstetric care for HIV positive 
women. A cohort of HIV positive women were followed to assess the rate of intrapartum transfers and 
associated adverse outcomes in Addis Ababa. Overall, 282 HIV positive pregnant women were followed, 
75% gave birth at Emergency Obstetric and Neonatal Care facilities, 42% of them transferred between 
health facilities during the intrapartum period and 36% were transferred two or more times. Sixty four 
percent of the first time transfers were due to obstetric complications, while all subsequent transfers 
were due to practical constraints. Women in their second pregnancy were less likely (OR 0.3 95% CI 0.2-
0.6) to be transferred than women in their first pregnancy. Transferred women experienced more 
stillbirths than women who were not transferred. The rate of stillbirths was not significantly associated 
with the syphilis test result, the CD4 count and initiating antiretroviral therapy. There appeared to be 
serious challenges within the health care system compromising the intrapartum care for our 
participants and increasing the risk of stillbirth and MTCT. Undue transfers during the intrapartum 
period should be addressed at all levels of the health care system. 
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INTRODUCTION  
 
Safe obstetric practice is one of the components of the 
prevention of mother-to-child HIV transmission (PMTCT) 
programme (Read and Newell, 2005). The rate  of  MTCT  
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ART, Antiretroviral therapy; CI, confidence interval; DHS, 
demographic and health survey; EmONC, emergency obstetric 
and neonatal care; IQR, inter quartile range; MTCT, mother-to-
child HIV transmission; OR, odds ratio; PMTCT, prevention of 
mother-to-child HIV transmission. 
during pregnancy is about 10% while it reaches 20% 
during the intrapartum period (De Cock et al., 2000). The  
intrapartum HIV transmission is responsible for about 
75% of the HIV infection in non-breast feeding infants 
and 50% among infants receiving breast feeding for 18 to 
24 months (De Cock et al., 2000; Gaillard et al., 2000; 
Read and Newell, 2005). Certain obstetric procedures 
during the intrapartum period such as episiotomy and 
artificial rupture of membrane can increase the risk of 
mother-to-child HIV transmission (MTCT). The rate of 
MTCT also increases with increasing duration of labour 
especially after membrane rupture, indicating the need 
for prompt attention during the intrapartum period. In 
obstetric literature, the “three delays” modelis  often  used 
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to explain the non-obstetric causes for poor maternal and 
perinatal outcomes (Barnes-Josiah et al., 1998; WHO et 
al., 2009; Waiswa et al., 2010). The “first delay” refers to 
delay in making decision to seek care, the “second delay” 
refers to delay in reaching health care facilities and the 
“third delay” refers to delay in receiving appropriate care 
after reaching health facility. Studies from resource poor 
settings show that women often encounter considerable 
delay in receiving appropriate obstetric care even after 
reaching a health facility (Coley et al., 2001; WHO et al., 
2009). The Interval between admission and treatment 
often determines the pregnancy outcomes: The shorter 
the interval the better the outcome and vice versa (WHO 
et al., 2009). In particular referrals between facilities 
increase delays that women in labour may not have time 
for (Ramanathan, 2009; WHO et al., 2009). In resource 
poor settings, 25% of the stillbirths are caused by 
prolonged labour and asphyxia, largely a result of lack of 
prompt attention and poor intrapartum obstetric 
management (McClure et al., 2009).  
In PMTCT programmes, a lot of attention and debate 
has surrounded medication and infant feeding, while safe 
obstetric practice despite being an important component 
of a PMTCT programme has been given less attention. 
Reviews and Meta analyses have shown that the risk of 
MTCT is higher in vaginal deliveries compared to elective 
caesarean deliveries (The International Perinatal HIV 
Group, 1999; Read and Newell, 2005). Nevertheless, for 
practical and technical reasons safe vaginal delivery 
remains the standard of care in many resource poor 
setting. In these settings including Ethiopia, HIV positive 
women’s access to safe obstetric care and the actual 
care these women receive have not been well 
documented. There is also scarcity of evidence showing 
the relationship between access to intrapartum obstetric 
care and prenatal outcomes among HIV positive women. 
Focusing on a cohort of HIV positive women in Addis 
Ababa, we assessed the rate of institutional delivery, the 
rate of transfers between health facilities during the 
intrapartum period and the occurrence of stillbirths. 
 
 
METHODS  
 
Study setting  
 
The study was conducted in Addis Ababa, the capital of Ethiopia in 
2009. Peripartum care including PMTCT and EmONC services 
were provided both in public and private health facilities across the 
city (MOH, 2008). The PMTCT services include HIV counselling 
and testing, provision of antiretroviral prophylaxis/ treatment to 
women and their babies, safe obstetrics practices and infant 
feeding counselling. In 2009 alone 54,698 pregnant women 
attended antenatal care across the city, 43,128 (78.8%) were tested 
for HIV in PMTCT programmes and 4.6% were HIV positive 
(FHAPCO, 2010). 
According to a report by the ministry of health, 90% of the 
pregnant women in Addis Ababa had at least one antenatal visit 
and 44% gave birth at health facilities (MOH, 2008). Basic EmONC 
was provided in all the public health centres and hospitals provided 
comprehensive  EmONC  (unpublished  data,  collected   by   Addis  
 
 
 
 
Ababa Fistula Hospital, Ethiopian Road Authority and the World 
Bank). The signal functions supposed to be provided in basic 
EmONC include administration of parenteral antibiotics, parenteral 
uterotonic drugs, parenteral anticonvulsants, manual removal of the 
placenta and retained products, assisted vaginal delivery and basic 
neonatal resuscitation. However, according to a report by the 
Ministry of Health, all the public EmONC facilities in Addis Ababa 
were missing one or more signal functions to be offered at their 
level and were only partially functioning. The signal functions in 
comprehensive EmONC include all the basic EmONC services plus 
blood transfusion and caesarean section. Women identified to have 
serious obstetric complications in the basic EmONC facilities before 
and after the onset of labour should usually be referred to 
comprehensive EmONC units. In such cases, the woman should be 
given a referral slip with information about the reasons for the 
referral, the treatment given and the HIV status of the woman. 
These formal procedures for referrals are not always followed. In 
this study, we use the concept ‘transfers’ to describe situations 
where the woman is told to seek care at another health facility for 
obstetric and non-obstetric reasons. Although 33 public and 24 
private facilities were providing EmONC services across the city, 
actual utilization of the services were biased towards public health 
facilities. Nine out of ten deliveries and 80% of obstetric 
complications in Addis Ababa were managed in public facilities. The 
median distance to the nearest referral centre was less than 5 km. 
Only 47% of the health facilities had ambulance services. The 
number of skilled staff per 1,000 people is 4.6, compared to the 
recommended 2.3 staff per 1,000 (WHO, 2005, 2006). 
 
 
Study design, data collection and data analysis 
 
The data was obtained from a prospective cohort study conducted 
primarily to assess HIV positive women’s adherence to PMTCT 
recommendations from January to December 2009. Study 
participants were HIV positive women attending 12 public and three 
private facilities providing PMTCT and EmONC. We used 
proportionate allocation in selecting public and private facilities. A 
ratio 4:1 public to private was used by considering the fact that over 
80% of the pregnant women in the city received care from public 
health facilities. Then individual health facilities were selected on 
the basis of high client flow and to have representation of all the 10 
sub-cities. In 2009 alone, 1,976 pregnant women were diagnosed 
HIV positive in the PMTCT programmes across the city and 
approximately 25% were diagnosed in the first quarter of 2009 
(January to March). Of the 479 women diagnosed from January to 
March, 282 (59%) women who consented to be followed up were 
enrolled in our study. At enrolment, women were interviewed by 
trained PMTCT counsellors at the respective health facilities, using 
a structured questionnaire. Follow up data were obtained from the 
women themselves and from log books in the facilities. For women 
who were transferred to other health facilities and for those who 
gave birth at home, follow up data about the delivery were collected 
when they came for six or 42 days postpartum care. Reasons for 
transferring the women between health facilities both before and 
after the onset of labour were inquired in an open ended question. 
Later these responses were coded into three categories: Obstetric 
complications, practical constraints (including lack of bed and lack 
of electric power supply) and reason not stated. Reasons for the 
first transfer were obtained from log books at the health centres. 
Since the reasons for subsequent transfers were not recorded, the 
women were asked directly what was said to them. Study endpoints 
were abortion, delivery or death of a woman. Women were 
regarded as lost to follow-up when they had not shown up for 
regular visits and or we failed to trace them. 
 The study was reviewed and approved by the Ethical committee 
of Addis Ababa City Administration Health Bureau in Ethiopia and 
the Regional Committee for  Medical  Research  Ethics  in  Western  
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Figure 1. Cohort flow chart. 
 
 
 
Norway. Research permits from Addis Ababa City Administration 
Health Bureau and respective sub cities were obtained. Data were 
double entered in excel spreadsheet and checked for consistency. 
Data analyses were done using SPSS version 17. Descriptive 
statistics and Pearson Chi-Square tests were used to compare 
baseline characteristics of women who completed their follow up 
and women who did not. We also used Fisher Exact Test when the 
expected counts in the cells are less than five. P-values less than 
0.05 were considered statistically significant. Odds ratio (OR) with 
95% confidence intervals (CI) were used to assess bivariate 
associations. The rate of institutional delivery was calculated 
among women enrolled into the study while comparison between 
transferred and not transferred during the intrapartum period was 
made only among women who completed the study. The rate of 
intrapartum transfers was calculated among women who visited 
health facilities during labour and delivery. The rate of stillbirth was 
calculated among the total births and stratified by transfer status. 
Due to the large proportion of women who did not complete their 
follow up to delivery sensitivity analyses were done to assess 
potential biases.  
 
 
RESULTS  
 
Of a total of 282 HIV positive pregnant women, 228 
(81%) completed their follow up to delivery. There were 
226 singletons and two twin births. Among the 54 women 
who did not complete their follow up, 11 (20%) had an 
abortion, 2 (4%) died while pregnant, 2 (4%) were 
transferred to other health facilities, whereas about the 
rest 39 (72%) we have no information (Figure 1).Table 1 
presents  characteristics   of   the   HIV   positive   women  
stratified by follow up status. The age range was 15 to 38 
years. The median educational status of the women were 
seventh grade (Inter quartile range (IQR) = 3 to 7). One 
third (33%) of the women were pregnant for the first time. 
The majority of the women (66%) were enrolled at 28 
weeks of gestation or earlier and had a CD4 count of 350 
and above at enrolment. A total of 214 women were 
tested for Venereal Disease Research Laboratory 
(VDRL) and six (2.8%) were reactive for syphilis. There 
was no statistically significant difference between women 
who completed their follow up and women who did not 
with respect to their socio-demographic characteristics, 
obstetric profiles and CD4 cell count, gestational age at 
enrolment and the women syphilis test result (Table 1). 
 Among the 282 HIV positive women enrolled, 211 
(75%, 95% confidence interval (CI) 69.4 to 79.5) gave 
birth at health facilities. One hundred and two (48%, 95% 
CI 41.7 to 55.0) women were transferred between health 
facilities before or after the onset of labour, 89 (42%, 95% 
CI 35.7 to 48.9) being transferred during the intrapartum 
period. Of the 72 (34%, 95% CI 28.0 to 40.8) women 
transferred due to obstetric complications, 58 were 
transferred during the intrapartum period from basic to 
comprehensive EmONC facilities. Some of the women 
had multiple intrapartum transfers. The number of 
transfers for one woman ranged from one to ten, where 
57 (64%) were transferred once, 17 (19%) twice and 15 
(17%) were transferred three times or more. All first time 
intrapartum transfers were from  basic  EmONC  facilities. 
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Table 1. Baseline characteristics of 282 HIV positive women in Addis Ababa by follow up status. 
 
Variable 
Completed follow up 
 
P-value Yes = 228 No = 54 
n (%) n (%) 
Age 
15-24 79 (35.3) 20 (37.0) 
0.89 25-29 91 (40.6) 20 (37.0) 
30 54 (24.1) 14 (25.9) 
Median (IQR) 25 (23-29) 25 (22-28) 
 
Education /grades completed 
0 - 4 65 (29.3) 22 (42.3) 
0.17 5 - 8 81 (36.5) 17 (32.7) 
>9  76 (34.2) 13 (25.0) 
Median (IQR) 8 (4-10) 6 (0-9) 
 
Number of pregnancy 
1 73 (32.4) 19 (35.8) 
0.77 2 84 (37.3) 17 (32.1) 
3 68 (30.2) 17 (32.1) 
Median (IQR*) 2 (1-3) 2 (1-3) 
 
CD4 cell count at enrolment   0.80 
<200 42 (26.3) 5 (26.3)  
200-349 48 (30.0) 7 (36.8)  
350 70 (43.8) 7 (36.8)  
Median (IQR) 312 (186-450) 306 (197-512)  
 
Gestational age at enrolment (weeks) 
28  128 (65.3) 22 (68.8) 0.84 
>28 68 (34.7) 10 (31.3)  
Median (IQR) 22 (18-28) 18 (14-28)  
 
Syphilis test (VDRL)     
Reactive  4 (2.0) 2 (7.1) 
0.15 Non-reactive  184 (92.9) 24 (85.7) 
Test not done  10 (5.1) 2 (7.1) 
 
* IQR, Inter quartile range. Due to missing values, the numbers may not add up to the total. 
 
 
 
Obstetric complications and practical constraints 
accounted for 65 and 25% of the reasons for the first time 
transfers respectively, while all subsequent transfers 
were due to practical constraints such as lack of bed and 
lack of electric power supply. Unavailability of bed was 
the sole reason for transferring labouring women from 
public comprehensive EmONC facilities to other health 
facilities. In the case of transfers due to practical 
constraints, the transfers were made between facilities 
irrespective of the level of care provided in those facilities 
and often the women were not given a referral slip but 
were informed verbally to go to other facilities.  
Women in their second pregnancy  were  less  likely  to  
be transferred during the intrapartum period compared to 
women who were pregnant for the first time (OR 0.3 95% 
CI 0.2 to 0.6). There was no significant association 
between being transferred during the intrapartum period 
and age, education, CD4 cell count and gestational age at 
enrolment (Table 2). To account for the 19% of women 
who did not complete their follow up, sensitivity analyses 
were performed in two scenarios, (1) considering all 
these women as transferred during the intrapartum period, 
and (2) considering all these as not transferred during the 
intrapartum period. Both scenarios yield similar result to 
the main analysis.  
Of the 193 singleton newborns whose birth weight  was 
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Table 2. Bivariate association between transfer during the intrapartum period and age, education, 
number of pregnancy, CD4 cell count and gestational age among 228 HIV positive pregnant women in 
Addis Ababa. 
 
Variable 
Transferred during the intrapartum period 
OR Yes =89 No=139 
n (%) n (%) 
Age 
15-24 28 (35.4) 51 (64.6) 1 
25-29 39 (42.9) 52 (57.1) 1.4 (0.7- 2.5) 
30 20 (37.0) 34 (63.0) 1.1 (0.5 - 2.2) 
 
Education 
0 – 4 21 (32.3) 44 (67.7) 1 
5 – 8 34 (42.0) 47 (58.0) 1.5 (0.8 - 3.0) 
9 30 (39.5) 46 (60.5) 1.4 (0.7 - 2.7) 
 
Number of pregnancy 
1 39 (53.4) 34 (46.6) 1 
2 22 (26.2) 62 (73.8) 0.3 (0.2 - 0.6) 
3 26 (38.2) 42 (61.8) 0.5 (0.3 - 1.1) 
 
CD4 cell count 
350 29 (41.4) 41 (58.6) 1 
200-349 16 (33.3) 32 (66.7) 1.2 (0.5-2.5) 
<200 19 (45.2) 23 (54.8) 0.7 (0.3-1.5) 
 
Gestational age (weeks) 
28 54 (42.2) 74 (57.8) 1 
>28 28 (41.2) 40 (58.8) 1.0 (0.5 - 1.7) 
 
Due to missing values, the numbers may not add up to the total 
 
 
 
measured, the median birth weight was 3,000 g (IQR 
3,200 to 2,500). No preterm deliveries were reported. 
Transfer during the intrapartum period was not 
significantly associated with birth weight. Of the total of 
nine stillbirths (corresponding to 39 stillbirths per 1,000 
births, 95% CI 19.2 to 73.7 per 1,000 births), seven 
occurred among the women transferred during the 
intrapartum period, one among the women transferred 
during the antepartum period and one among the women 
who were not transferred. Seven stillbirths were among 
women who were non reactive to VDRL test for syphilis, 
one among women who did not have VDRL test whereas 
no still birth among women who were reactive to VDRL 
test. All the stillbirths were among women who had 
spontaneous vaginal delivery. Three stillbirths were 
weighed, and all of them were within the range of 2,500 
to 3,900 g. Five stillbirths were registered among women 
with CD4 cell count at enrolment of 350 and above and 
two stillbirths were registered among women with CD4 
cell count at enrolment between 200 and 349. No stillbirth 
was registered among women with CD4 cell count less 
then 200. Two stillbirths  were  registered  among  the  73  
women who initiated antiretroviral therapy while seven 
among the 139 women initiated zidovudine prophylaxis 
(OR = 2.0, 95% CI 0.4 to 5.0).  
 
 
DISCUSSION  
 
A cohort of HIV positive women was followed to assess 
the magnitude of intrapartum transfers and its potential 
adverse outcomes. We identified serious challenges 
within the health care system compromising the 
intrapartum care for HIV positive women and increasing 
the risk of adverse pregnancy outcomes and risk of 
MTCT. Even though safe obstetric practice has been one 
of the components of the PMTCT programme in all the 
study sites, the risk of MTCT due to delays in receiving 
obstetric care during labour did not seem to be an issue 
that received sufficient attention in the health care 
system. Our findings show that the majority of the HIV 
positive women visited EmONC facilities for delivery. 
However, a large proportion of them did not receive 
appropriate  obstetric  care   due   to   transfers   between 
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health facilities. While, obstetric complications were the 
major reason for first time transfer, practical constraints 
were the sole reason for subsequent transfers. Undue 
transfers leading to the so called “third delay”, that is, the 
delay in receiving appropriate care after reaching a health 
facility and this may have contributed to an increased risk 
of stillbirth and MTCT. The HIV disease progression, 
initiating ART and having a positive syphilis test result 
seemed not to be related to the risk of stillbirth.  
Our findings suggest that delays in receiving 
appropriate care after arrival at health facility is a 
common experience among HIV positive women seeking 
birth care in Addis Ababa. This seems to a considerable 
extent related to transfers between health facilities during 
established labour. Overall, 48% of the pregnant women 
were transferred to other health facilities either before or 
after the onset of labour, 42% were transferred during the 
intrapartum period, and 34% were transferred due to 
obstetric complications. In general, compared to the 19% 
referrals for complications related to pregnancy and 
labour reported from a multi country survey across nine 
Asian countries and the 15% obstetric complications 
expected to happen during pregnancy, labour, delivery 
and during the postnatal period, the rate of transfer in our 
study is high (WHO et al., 2009; Lumbiganon et al., 
2010). The risk of intrapartum transfer was lower among 
women in their second pregnancy than among women 
who were pregnant for the first time, and this corresponds 
to a higher risk of obstetric complications such as pre-
eclampsia and dystocia among primigravidae (Duckitt 
and Harrington, 2005).  
The high rate of transfer in this study seems to be 
related to deficiencies within the health care system. In 
Addis Ababa city where the study was conducted, 
availability and accessibility of EmONC facilities was not 
an issue, but access to care and the quality of care 
provided in those facilities (unpublished data, collected by 
Addis Ababa Fistula Hospital, Ethiopian Road Authority 
and the World Bank). Efficient functioning of a health 
system can be affected by shortage of supplies, shortage 
of trained staff, poor competence among available staff 
and poor staff motivation as well as lack of accountability. 
Studies from Ethiopia and Tanzania reported that most of 
the basic EmONC facilities were functioning poorly in 
terms of the quality of the services they were expected to 
provide (unpublished data, collected by Addis Ababa 
Fistula Hospital, Ethiopian Road Authority and the World 
Bank). Poor competence among health care providers in 
basic EmONC facilities may lead to over-diagnosis and 
failure to handle obstetric complications that could be 
managed at their level. This argument is supported by the 
fact that nationally, only 3.3% of the health care workers 
assisting women in labour had received training in 
EmONC (unpublished data, collected by Addis Ababa 
Fistula Hospital, Ethiopian Road Authority and the World 
Bank). In their study from Tanzania, Olsen et al. (2004) 
observed  that  over-diagnosis  was  one  of  the  possible  
 
 
 
 
reasons for the excess obstetric complications seen in 
Tanzanian health care facilities. Transfers often cause 
overburden and fatigue in the already constrained 
comprehensive EmONC facilities. This in turn affects the 
quality and quantity of care provided in those facilities 
and may further increase transfers from comprehensive 
EmONC facilities. Hence a vicious circle is created. Lack 
of bed came out as the sole reason for transferring the 
HIV positive women during the intrapartum period from 
hospitals. In these comprehensive EmONC facilities, a 
minimum of 30 to 32 beds including delivery couches are 
recommended for 1,000 deliveries per year (WHO, 1991), 
yet the available beds including delivery couches for 
1,000 deliveries per year in Addis Ababa were 22, much 
lower than the minimum requirement (unpublished data, 
collected by Addis Ababa Fistula Hospital, Ethiopian 
Road Authority and the World Bank; WHO et al., 2009). 
Therefore, reducing the work load at comprehensive 
EmONC facilities by limiting unnecessary transfers from 
basic EmONC facilities and having a functioning referral 
system with reliable ambulance services are some of the 
fundamental prerequisites for improved maternal and 
perinatal outcomes in Addis Ababa. 
One can also associate the high rate of transfer to the 
HIV disease progression of the women. According to 
studies, asymptomatic HIV-positive women do not have a 
higher risk of obstetric complications than HIV-negative 
women and they do not require special obstetric 
interventions (Bucceri et al., 1997; Coley et al., 2001; 
Onah et al., 2007). Our finding showed that about 75% of 
the women had a CD4 cell count over 200 and they were 
asymptomatic. It is therefore difficult to attribute the high 
rate of intrapartum transfer to the HIV disease 
progression of the women. Furthermore, in a case control 
study from Nigeria, the rate of caesarean section was not 
significantly different among HIV positive cases and HIV 
negative controls, 8.3 vs 11.0% (Onah et al., 2007).  
Whatever the reasons for the transfers, they cause 
delays in receiving appropriate obstetric care. Of the 
women transferred during the intrapartum period, 36% 
were actually transferred more than once while in labour. 
Multiple transfers of a woman will delay provision of the 
care needed and may be detrimental to maternal and 
perinatal survival, as some obstetric complications can 
claim the lives of the women or their babies within a very 
short time (Ramanathan, 2009; WHO et al., 2009). 
According to studies from resource poor settings, the 
“third delay” significantly contributes to maternal morbidity 
and mortality (Ramanathan, 2009; Samuel, 2009). 
Maternal disabilities such as obstetric fistula and 
incontinence are common consequences of delays in 
receiving appropriate intrapartum obstetric care for 
obstructed labour (Ekanem et al., 2010). Although there 
was no maternal death related to intrapartum transfers in 
our study, the many transferred women may have 
suffered consequences of the transfers. In a study from 
Sweden, women who were transferred after the  onset  of 
  
 
 
 
labour were more stressed of fear of the unknown and 
more often had a feeling of rejection than those who were 
not transferred (Wiklund et al., 2002). Some of the 
practical challenges experienced by the Swedish women 
were associated with long distance travel and 
transportation. This problem is even more important in 
the Ethiopian context where a major barrier to women’s 
health is their low socio-economic status (CSA, 2006). 
Over 65% of the women in our study had only 8th grade 
of schooling or lower. The feeling of being rejected may 
be a major issue to the women in our study, as HIV/AIDS 
is still a disease with stigma in Ethiopia. This could affect 
the trust the women have in the health system and may 
contribute to disruption in the continuity of care. Transfers 
during the intrapartum period can also put the women at 
risk of HIV status disclosure through the information 
provided in the transfer slips. Furthermore, a serious 
concern is that the delays caused by the transfers can 
increase the risk of MTCT both because of delayed 
labour duration and missing the dose of antiretroviral 
prophylaxis that should be taken during the intrapartum 
period.  
The delays to receive appropriate care due to intra-
partum transfers seem to contribute to adverse prenatal 
outcomes. The overall rate of stillbirth in our study was 
39/1,000 births, where the majority of the stillbirths were 
among women who were transferred during the 
intrapartum period. Our finding is consistent with the 31.6 
stillbirths per 1,000 births reported in the 2005 Ethiopia 
demographic and health survey (DHS) for Addis Ababa 
city but higher than the 21.3 stillbirths per 1,000 births 
reported for developing countries (CSA, 2006; 
Goldenberg et al., 2007). This could reflect the sub-
optimal intrapartum obstetric care that pregnant women 
are offered in Addis Ababa despite the city being most 
privileged in terms of availability and accessibility of 
skilled attendants at birth as well as EmONC facilities. 
Report has shown that the “third delay” is common in 
Addis Ababa and a labouring woman waits on average 
1.7 h to receive obstetric care after reaching a health 
facility (unpublished data, collected by Addis Ababa 
Fistula Hospital, Ethiopian Road Authority and the World 
Bank). Similarly, in a health facility based study from 
Uganda, the “third delay” was responsible for about half 
of the perinatal deaths (Waiswa et al., 2010).  
Although several risk factors are identified for stillbirths, 
stillbirths occurring during the intrapartum period can 
largely be attributed to poor quality obstetric care 
(Mohammad, 2011; Sidra, 2011). Large scale studies 
reported an inverse correlation between the rate of 
stillbirth and the quality and quantity of obstetric care 
provided during pregnancy and delivery (Goldenberg et 
al., 2007; McClure et al., 2009). For instance, in Nepal, 
the rate of stillbirth was 54.6/1,000 births with a 9% 
Skilled attendant at birth, while in Tanzania 29.4/1,000 
births with a 35% skilled attendant at birth. Reviews on 
interventions to improve maternal and newborns outcome  
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reported that about 25% of intrapartum stillbirths can be 
reduced by providing skilled attendants at birth 
(Mohammad, 2011; Sidra, 2011). Nonetheless, this does 
not seem to be the case in our study, despite 75% of the 
women being given birth at EmONC facilities in the hands 
of skilled professionals, the rate of stillbirth was 
unacceptably high. This could reflect the poor functional 
status of the EmONC service in the city. In support of this 
argument, a baseline survey conducted to asses the 
status of EmONC facilities by the ministry of health of 
Ethiopia revealed that none of the basic EmONC facilities 
in the Addis Ababa were fully functional (unpublished 
data, collected by Addis Ababa Fistula Hospital, 
Ethiopian Road Authority and the World Bank). Similarly, 
the 2010 countdown report indicated that maternal 
mortality and neonatal mortality in Ethiopia have not 
shown promising decline by the fact that interventions for 
these problems require properly functioning health care 
system (Bhutta et al., 2010). Provision of quality basic 
and comprehensive EmONC can reduce intrapartum 
stillbirths by about 45 and 75% respectively (Mohammad, 
2011; Sidra, 2011).  
The stillbirths did not seem to be associated with the 
HIV disease progression in the women, since no stillbirth 
was reported among women with CD4 cell count less than 
200, but five among women with CD4 cell count 350 or 
more. Similarly, the rate of stillbirth among women 
initiated antiretroviral therapy was also lower than those 
initiated zidovudine prophylaxes. A study from Tanzania 
that followed 1,075 HIV positive and 502 HIV negative 
pregnant women showed no statistical significant 
difference between HIV positive and HIV negative women 
with respect to the rate of stillbirth. By contrast, in a study 
from South Africa that followed 1,449 HIV infected and 
1,401 HIV uninfected women, adverse pregnancy 
outcomes were in general more prevalent among HIV 
positive women and in particular among those with lower 
CD4 cell count (Rollins et al., 2007). Interestingly, no 
stillbirth was reported among the four women who had 
positive test result for syphilis. Although we have 
limitation to make inference due to small sample size, our 
finding is in accordance with other studies showing that 
maternal syphilis as a less likely cause of intrapartum 
stillbirths (Chalumeau et al., 2002; McClure et al., 2009). 
The last, but not least important finding of our study 
was the high rate of institutional deliveries among HIV 
positive women. In contrast with the low rate of 
institutional delivery (43.5%) reported among the general 
female population in the city (MOH, 2008), 75% of the 
HIV positive women in our study gave birth at health 
facilities. Various factors could have influenced the HIV 
positive women’s decision to deliver at health facility. 
Safe obstetric practice has been promoted for the 
reduction of MTCT since 2004 (Olsenetal., 2005). 
The public health message has been that safe delivery 
among HIV positive women is delivery in health facilities. 
The  high  rate  of  institutional  delivery  for  HIV  positive 
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women in our study reflects that this message has 
reached out to the target groups. It may also be an 
indication of women's high motivation to adhere to health 
workers’ advice to secure an HIV negative status of their 
baby. Moreover, the high rate of institutional delivery may 
be partly attributed to the study project activities 
(Hawthorne effect), with improved communication 
between the women and their PMTCT counsellors and 
incentives and more focus on the outcome than in routine 
care. 
One of the limitations of the study is that 19% of the 
women did not complete their follow up. This might 
threaten the external validity of the study. The fact that 
HIV/AIDS is still a disease with stigma, the possibility of 
abortion among women enrolled in early pregnancy, the 
low rate of institutional delivery in the city (43.5%) (MOH, 
2008) and the high reported dropout rate in a national 
PMTCT programme (Mirkuzie et al., 2010) were taken 
into account while considering the sample size. During 
the follow up, substantial effort were made to trace the 
lost to follow up through telephone, house to house 
search using existing tracing mechanisms, visiting 
different hospitals for transferred women, checking ART 
clinics and the under five clinics. In the analysis, there 
were no statistical significant differences in the baseline 
characteristics between women who completed the study 
and those who did not. Besides, the losses to follow up 
were not related to the intrapartum transfers and hence 
less likely to bias our findings. Moreover, the study 
covered about 60% of the eligible women and we used 
proportionate allocation to population size when selecting 
public and private facilities. Hence, we believe that the 
findings of this study could still be generalized to HIV 
positive women who attend antenatal care in Addis 
Ababa. Yet, there could be a Hawthorne effect that 
increased the rate of institutional delivery. There is no 
doubt that the study would be stronger if there was an 
HIV negative comparison, especially to unveil the role of 
stigma and discrimination in caring for HIV positive 
women. The reason for not including a comparison group 
was that the data were drawn from a cohort study set out 
to assess HIV positive women’s adherence to PMTCT 
recommendations. The possibility of having a historic 
cohort for comparison was not feasible as the routine 
information in the delivery logbooks at the facilities do not 
indicate the women’s HIV status for confidentiality 
reasons.  
In conclusion, this study has drawn attention to the 
problems of safe delivery practices in a PMTCT 
programme that seem not to attract the attention it 
deserves from the health care system and health care 
workers unlike some of the other PMTCT programme 
components. The study revealed a high rate of institu-
tional delivery among the HIV positive women that may 
indicate the women’s awareness of the importance of 
institutional delivery to lower the risk of HIV transmission 
to their babies. However, despite  the  expressed  goal  of  
 
 
 
 
reducing maternal and perinatal mortality, the health 
system appeared unable to take advantage of the HIV 
positive women’s motivation for ‘safe delivery’. 
Meanwhile, due to deficiencies within the health care 
system, the women’s right to appropriate care seem to be 
violated. Over one third of the HIV positive women were 
transferred during the intrapartum period, and this could 
partly be due to over-diagnosis of obstetric complications 
and practical constraints within the health facilities. This 
delayed the women from receiving timely obstetric care 
and may have contributed to adverse pregnancy 
outcomes and increased MTCT. Especially the basic 
EmONC facilities that the majority of the women relied 
on, appeared not to be functioning properly, and may 
have subjected the pregnant women to unnecessary 
transfers. Improvement in the quality of obstetric care 
services in Addis Ababa is imperative for the health 
system to succeed in reducing the rate of stillbirth and the 
rate of MTCT. The PMTCT training for health workers 
should also address the issue of intrapartum transfers 
and the “third delay” so that HIV positive women’s access 
to appropriate and timely intrapartum obstetric care can 
be ensured. 
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Annex 3a: Information letter for the questionnaire interview   
This is a study conducted by Alemnesh Hailemariam Mirkuzie, a student at the Centre for International 
Health university of Bergen, Norway and a staff of Hawassa University, Ethiopia. She is currently preparing 
to carry out field work in connection with her PhD study entitled “Challenges to PMTCT service utilization 
in Addis Ababa”. The aim of this study is to contribute to the prevention of mother to child transmission of 
HIV efforts, and to elevate the understanding of challenges to successful implementation of the PMTCT 
programme in Ethiopia. The ultimate goal of the project is to enable HIV-positive women and their infants 
properly follow the PMTCT recommendations. Therefore, all mothers attending antenatal care for the first 
time in the index pregnancy are invited to participate.  
I would like to ask if you would be willing to participate in this study. I would like to ask you about PMTCT, 
intention, attitude, subjective norm and perceived barriers to HIV testing and previous HIV testing. The 
interview will take about half an hour. I would like to emphasise that participation in the study is voluntary 
and that you can withdraw from the research at any time in the research process without any consequences 
for you whatsoever. If you decide not to continue the interview at some point, you have the right to do so. If 
you agree to be interviewed, I will take your antenatal number. Any information you give will be confidential 
and no one identify you. All identifying information will be removed from this questionnaire and destroyed 
as soon as all data has been collected. 
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Annex 3b: Information letter and consent form for HIV-positive mothers to be 
followed up  
This is a study conducted by Alemnesh Hailemariam Mirkuzie, a student at the Centre for International 
Health university of Bergen, Norway and a staff of Hawassa University, Ethiopia. She is currently preparing 
to carry out field work in connection with her PhD study entitled “Challenges to PMTCT service utilization 
in Addis Ababa”. The aim of this study is to contribute to the prevention of mother to child transmission of 
HIV efforts, and to elevate the understanding of challenges to successful implementation of the PMTCT 
programme in Ethiopia. The ultimate goal of the project is to enable HIV-positive women and their infants to 
properly follow the PMTCT recommendations. Therefore, all HIV-positive women are invited to participate.  
I would like to enrol if you would be willing to participate in this study. I would like to follow you up until 
six weeks after birth. There will be three follow up visits to be held while you come for your routine 
antenatal check up, delivery service and six week infant check up. I would like to emphasise that 
participation in the study is voluntary and that you can withdraw from the research at any time in the 
research process without any consequences for you whatsoever. If you decide not to continue the interview at 
some point, you have the right to do so. If you are agreed to be interviewed I will take your antenatal number 
to facilitate follow up. Any information you give will be confidential and no one identifies you. All 
identifying information will be removed from this questionnaire and destroyed as soon as all data has been 
collected.  
Finally, if you have any questions please ask either during the interview or afterwards.  
The study has been explained to me and I agree to participate. I acknowledge that I can withdraw from the 
study at any time without any consequences. 
Date: ____________ 
Signature (thumb print) of participant:______________________________
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Annex 4: Focus group discussion guide 
I- Background information  
Name ________________________________________________________ 
Age _________________________________________________________ 
Marital status __________________________________________________ 
Education _____________________________________ (grade completed) 
Occupation ___________________________________________________ 
Number of children _____________________________________________ 
II- Barriers to HIV testing upon first antenatal attendance  
1. What factors or circumstances would make it difficult for you to test for HIV upon first time 
antenatal attendance? 
2. Are there any other issues that come to mind when you think of HIV testing upon first time 
antenatal attendance?
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Annex 5: Questionnaire  
PMTCT site ______                                        Code Number ________ 
Part I: Demographic and Socioeconomic characteristics    
1. Antenatal care number _________ 
2. How old are you? ________ years                                                                                             
3. Where is your current address?    ___________                                                               
4. What is your marital status?                                                                          
a) Single                     
b) Married  
c) Divorced  
d) Widowed   
5. What is your religion? If you feel comfortable to answer                                                                                                   
a) Orthodox Christian 
b) Protestant Christian  
c) Muslim 
d) Others, specify ____________  
6. What is the highest level of education you completed? ________                                                
7. What is the highest level of education your husband completed? __________ 
8. Where are you working?                                                                                                        
a) Government employee                          
b) Petty trading  
c) House wife                                           
d) Others, specify _________  
9. What is your husband’s occupation? 
10. How much is your family’s earning per month? _________Eth. Birr  
11. How many people are living in your household (including you)  
Successes and challenges of the national PMTCT programme  
96
12. What kind of toilet do you have? 
a) Communal pit latrine 
b) Private pit latrine 
c) Communal water carriage 
d) Private water carriage 
e) Others specify ______________________________ 
13. Do you have fridge?  
a) Yes  
b) No  
Part II: Obstetric characteristics  
1. How many pregnancies do you ever had? _______                                                                                       
2. How many deliveries do you ever had? ________      
3. How many living children do you have? _________    
4. Where did you deliver your last child?   
a) Health institutions  
b) En route to health institution   
c) Home                                              
5. How many months pregnant are you now? ______                                                                           
Part III: Knowledge about MTCT/PMTCT 
1. Pregnant women who are HIV infected transmit HIV to their babies  
a) Always 
b) Sometimes 
c) Not at all  
d) I don’t know 
2. Can an HIV infected mother infect her baby with HIV during pregnancy?  
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a) Yes                 
b) No              
a) Unsure  
3. Can an HIV infected mother infect her baby with HIV during delivery?  
a) Yes                 
b) No              
c) Unsure/I don’t know  
4. Can an HIV infected mother infect her baby with HIV during breast-feeding?  
a) Yes                 
b) No              
c) Unsure/I don’t know  
5. What preventive measures do you know for MTCT? 
a) Anti-retroviral prophylaxis  
b) Safe delivery practice  
c) Not to breast feed  
d) Safe sex practice during pregnancy and throughout the breast-feeding period 
Part IV: Predicting intention to use PMTCT services – an application of the TPB 
Please rate each statement on the extent to which you agree 
The following are statements about whether or not you plan to test for HIV upon your first antenatal 
care attendance (behavioural intention) 
1. I intend to test for HIV upon my first antenatal care attendance 
        5.  Very likely 
        4.  Likely 
        3.  Neither likely nor unlikely 
Successes and challenges of the national PMTCT programme  
98
        2.  Unlikely 
        1. Very unlikely 
2. I plan to test for HIV upon my first antenatal care attendance 
         5. Strongly agree 
         4. Agree 
         3. Neither agree nor disagree 
         2. Disagree 
         1. Strongly disagree 
3. I want to test for HIV upon my first antenatal care attendance 
        5. Strongly agree 
        4. Agree 
        3. Neither agree nor disagree 
        2. Disagree 
        1. Strongly disagree 
 We would like to know how you feel about testing for HIV at your first antenatal care attendance [attitudes]
4. For me testing for HIV upon my first antenatal care attendance is beneficial 
        5.  Strongly agree 
        4.  Agree  
        3.  Neither agree nor disagree 
        2.  Disagree 
        1.   Strongly disagree 
5. For me testing for HIV upon my first antenatal care attendance is the right thing to do 
      5.  Strongly agree 
      4.  Agree  
       3.  Neither agree nor disagree 
       2.  Disagree 
       1.  Strongly disagree 
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6. For me testing for HIV upon my first antenatal care attendance is bad 
      5. Strongly agree 
      4. Agree  
      3. Neither agrees nor disagrees 
      2. Disagree 
      1. Strongly disagree 
We would like to know how you think that other people who are important to you (such as 
husband/parents/ friends/neighbour/counsellors) think about you testing for HIV upon your first 
antenatal care attendance (subjective norms) 
8.  People who are important to me think that I should test for HIV upon my first antenatal care attendance 
      5. Completely true 
      4. True 
      3. Neither true nor false          
      2. False 
      1. Completely false  
9.  People who are important to me (husband, parent, neighbour, friends, counsellors) would appreciate that I 
test for HIV upon my first antenatal care attendance 
       5. Completely true 
       4.  True 
       3.  Neither true nor false 
       2.   False 
       1.   Completely false  
50. My husband agreed that I should test for HIV upon my first antenatal care attendance 
       5. Completely true 
       4.  True 
       3.  Neither true nor false 
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       2.  False 
       1. Completely false  
11. Women who I know and who are important to me would themselves test for HIV upon their fist antenatal 
care attendance 
        5. Completely true 
        4. True 
        3.  Neither true nor false 
        2.  False 
        1.  Completely false  
We would like to know how easy or difficult you think it is for you to test for HIV upon your first 
antenatal care attendance (perceived behavioural control) 
12. How easy or difficult do you think it will be for you to test for HIV upon your first antenatal care 
attendance 
       5.  Very easy 
       4.  Easy 
       3.  Neither easy nor difficult 
       2.  Difficult 
       1. Very difficult   
13.  For me to test for HIV upon my first antenatal care attendance is difficult because I feel scared to know 
the result  
     5.  Completely certain  
     4.  Certain 
     3.  Neither certain nor uncertain 
     2.  Uncertain 
     1.  Completely uncertain 
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14. For me to test for HIV upon my first antenatal care attendance is difficult because I do not want to 
disclose my HIV status 
     5.  Completely certain  
     4.  Certain 
     3.  Neither certain nor uncertain 
     2.  Uncertain 
     1.  Completely uncertain 
15. For me to test for HIV upon my first antenatal care attendance is difficult because I suspect that test 
results will not be kept confidential 
     5.  Completely certain  
     4. Certain 
     3.  Neither certain nor uncertain 
     2.  Uncertain 
     1.  Completely uncertain 
16. For me to test for HIV upon my first antenatal care attendance is difficult because people may 
discriminate me if I found HIV-positive  
     5.  Completely certain  
     4. Certain 
     3.  Neither certain nor uncertain 
     2.  Uncertain 
     1.  Completely uncertain 
Part V:  Perceived risk  
1. How likely do you think that you are already infected with HIV? 
5. Very likely  
4. Likely  
3. Neither likely nor unlikely 
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2. Unlikely  
1. Very unlikely  
2. How likely do you think that you can transmit HIV to your infant? 
5. Very likely  
5. Likely  
3. Neither likely nor unlikely 
2. Unlikely  
1. Very unlikely 
Part VI: Past HIV testing behaviour 
1. How many times have you been tested for HIV during the previous years?  
1. Four or more times 
2. Three times 
3. Two times  
4. Once  
5. Never been tested before 
2. How many times have you been tested for HIV with your partner/husband? 
1. Four or more times 
2. Three times 
3. Two times  
4. Once  
5. Never tested together with my partner/husband  
Part VII: Follow up questions to be filled by PMTCT counsellors  
1. Did mother receive pre-test counselling/information? 
a) Yes                        
b) No  
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2. If yes, specify the type   
a) Group pre-test information                
b) Individual pre-test counselling              
3. Did the mother tested for HIV?    
a) Yes                  
b) No   
4. If the mother got tested, what was the test result?   
a) Positive             
b) Negative  
5. Did the mother receive post-test counselling?  
a) Yes                    
b) No  
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Annex 6: Follow up format  
Follow up format for mothers enrolled in the cohort study Name of PMTCT centre 
1. Card number ___________ 
2. Address: Sub - city ___________Kebele _________House/telephone number  
3. Confidentiality code ______________ 
4. Age _________________years  
5. Gestational age at enrolment to the study __________weeks  
I. Ante-partum data  
6. Date of HIV testing ___________ 
7. Date of enrolment to the study _____________  
8. CD4 count at enrolment __________cells per micro liter 
9. VDRL(syphilis test) result  
1) Reactive  
2) Non-reactive  
3) Not done  
10. Did the mother initiate prophylaxis at first antenatal visit?  
1) Yes  
2) No  
11. Gestational age at prophylaxis initiation _____weeks  
12. What kind of prophylaxis regimen did the mother initiate during pregnancy?  
1) Combined Zidovudine  
2) Single dose nevirapine  
3) Lifelong ART  
4) None  
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13. Which infant feeding options has the mother counselled on?  
1) Exclusive breast-feeding  
2) Exclusive formula feeding  
3) Both  
4) None  
14. Was the mother referred for treatment, care and support?  
1) Yes  
2) No  
3) Refused or not applicable  
15. Did the mother notify her partner about her HIV status?  
1) Yes  
2) No  
16. Did the mother bring her partner for HIV counselling and testing?  
1) Yes  
2) No  
17. Has the partner ever tested for HIV?  
1) Yes  
2) No  
18. What was partner’s HIV test result?  
1) Positive  
2) Negative  
II. Prophylaxis adherence at 36 weeks gestation  
19. How many doses of prophylaxis medication the mother missed in the last week?  
1) Never missed  
2) One dose  
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3) Two doses  
4) More than two doses  
III. Intra-partum data  
20. Date of delivery  
21. Place of delivery  
1) Health institution  
2) Home  
3) Others (specify) _________________ 
 22. Did the mother ingest medication during labour?  
1) Yes  
2) No  
23. What type of prophylaxis medication did she ingest during labour? 
1) Zidovudine + lamivudine + single dose nevirapine  
2) Zidovudine only  
3) Single dose nevirpaine  
4) Highly active antiretroviral treatment  
5) None  
24. Mode of delivery  
1) Spontaneous vaginal delivery  
2) Caesarean delivery  
3) Instrumental delivery  
4) Others (specify) ______________ 
25. Was episiotomy performed during delivery?  
1) Yes  
2) No  
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26. Was the amniotic membrane ruptured artificially?  
1) Yes  
2) No  
27. Infant birth weight ___________grams  
28. Sex of infant ____________ 
29. What was the infant status at birth?  
1) Live birth  
2) Still birth  
30. If the infant was alive, when did the infant ingest the prophylaxis (date)?_____________ 
31. What kind of prophylaxis the infant ingested at birth?  
1) Zidovudine + single dose nevirapine  
2) Single dose nevirapine  
3) None  
32. Which infant feeding decision has been made by the mother?  
1) Exclusive breast-feeding  
2) Exclusive formula feeding  
3) Mixed feeding  
4) Others (specify)  
IV. Post-partum data  
33. Has the mother disclosed her HIV-positive status to her partner?  
1) Yes  
2) No  
34. Has the mother ever used condom after knowing her HIV-positive status? 
1) Yes  
2) No  
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35. If yes for question # 34, how often?  
1) Always  
2) Occasionally  
3) Never  
36. Did the mother get transferred between facilities during delivery?  
1) Yes  
2) No  
37. If yes to question number 36, how many times she was transferred? ___________ 
38. What was the reason for the transfers? ____________ 
39. How long the mother took the prophylactic medication before birth? ______________ 
40. How long the mother took the prophylactic medication after birth?  
41. How long the infant prescribed the prophylactic medication?  
42. Which infant feeding practice did the mother report?  
1) Exclusive breast-feeding  
2) Exclusive formula feeding  
3) Mixed feeding  
43. If the mother is exclusively breast-feeding, for how long she intends to continue? _____months  
44. How was the breast condition of the mother?  
1) Normal  
2) Cracked nipple  
3) Mastitis  
4) Breast abscess  
5) Others (specify)  
45. Did the infant ever experienced feeding difficulty? 
1) Yes  
2) No  
46. How was the oral condition of the infant?  
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1) Normal  
2) Inflamed (sore)  
3) Others (specify) _____________ 
47. Did the infant receive the first pentavalent vaccine at six weeks postpartum?  
1) Yes  
2) No  
48. How many grams the infant weighed at six weeks postpartum? ____________grams  
49. Was a dried blood spot taken at six weeks for early infant diagnosis?  
1) Yes  
2) No  
3) Mother refused the test  
50. If early infant diagnosis was done, what was the test result?  
1) Positive  
2) Negative  
3) No test result available  
51. If the infant was HIV negative, did the mother intend to continue breast-feeding after having a negative 
HIV test result?  
1) Yes  
2) No  
3) Not decided  
52. Counsellor remark  
_____________________________________________________________________________
_____________________________________________________________________________
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Annex 7: Errata  
Thesis  
Page 1, paragraph 1, line 9 “heterosexual” should read “homosexual” 
Page 17 figure 4, the figure to the right, the legend in blue colour “HIV positive women” should 
read “ Mothers who received prophylactic medication” and the legend in red colour “Mothers who 
received prophylactic medication” should read “HIV positive women”  
Page 44, second paragraph line 9, “39/1000 live births” should read “39/1000 births” 
Reference 12, “Giuseppe P, Anthony F” should read “Pantaleo G, Anthony F” 
Reference 22, “Creek L, Ntumy R …” should read “Creek TL, Ntumy R…” 
Reference 23, “Bolu O, Allread V, Creek T, Stringer E, Forna F, Bulterys M, Shaffer N” should read 
“Bolu OO, Allread V, Creek TL, Stringer E, Forna F, Bulterys M, Shaffer N” 
Reference 114, “Jillian JF, Eccles MP…” should read “Francis JJ, Eccles MP …” 
Reference 117, “Kenneth JR, Sander G” should read “Rothman KJ, Greeland S” 
Reference 119, “Kenneth JR” should read “Rothman KJ ” 
Reference 126, “Mohammad YY, Mahrukh AA, Mohammad UA, Aamer I, Lawn. JE, Nynke VB, 
Zulfiqar AB” should read “Yakoob MY, Ali MA, Ali MU, Imdad A, Lawn JE, van den Broek NR, 
Bhutta ZA” 
Reference number 58 and 126 are the same 
